M (2010-2018)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2018


+Studies in 2000-2009 List
*Studies in Pre-2000 List
>Information in Another Section

MACROPHAGES + (Your Body’s ‘Clean-up Crew’ Cells)
MACULAR DEGENERATION +
MAD COW/CRUETZFELDT-JACOB DISEASE + (See Also PRIONS)
MAGNETIC STIMULATION
MALARIA
MALE SEXUAL FUNCTION*+
MARFAN SYNDROME
MASSAGE
MAST CELLS (Immune Cells Involved With Allergies, Wound Healing and Fighting Germs)
MEDICAL MARIJUANA-STUDIES*+
>MEIGE’S SYNDROME (See Pre-2000 List)
MELANOGENESIS (Formation of Melanin, Skin Pigment)
>MEMORY (See IQ/MEMORY/COGNITIVE EFFECTS)
>MENIERES SYNDROME (See News Articles 2010-2018)
MENINGITIS*
MENOPAUSE/OVARIECTOMY*+ (See Also AGING, GYNECOLOGY)
>MENTAL DISORDERS (See SCHIZOPHRENIA/MENTAL DISORDERS, DEPRESSION, PTSD)
METABOLIC SYNDROME
METHODS OF USE-CAPSULES*+
METHODS OF USE-‘DABS’/HASH OIL/CONCENTRATES
METHODS OF USE-DECARBOXYLATION + (Method to Increase Potency)
METHODS OF USE-E-CIGARETTES/VAPE PENS
METHODS OF USE-EDIBLES (GENERAL)*+
METHODS-EDIBLES (BEVERAGES, CANNABIS TEA*+ (See Also News Articles 2010-2018)
METHODS-EDIBLES (BEVERAGES, OTHER)*+
METHODS-EDIBLES (FOODS)*+
METHODS-EDIBLES (RAW UNHEATED CANNABIS JUICE) +
METHODS-EDIBLES (RECIPES) + (No Date Restrictions)
METHODS OF USE–HASHISH
METHODS OF USE-INHALERS +
METHODS OF USE-INJECTION* DO NOT TRY! (See Also Pre-2000 Studies)
METHODS OF USE–MICRODOSING/LOW DOSE
METHODS OF USE-NANOPLATFORMS/NANOPARTICLES/MICROSPHERES Etc
METHODS OF USE-NASAL SPRAYS +
METHODS OF USE–ROSIN (Extract Made With a Method Involving Only Heat and Great Pressure)
METHODS OF USE-RSO/RICK SIMPSON’S OIL/HEMP OIL/PHOENIX OIL +
METHODS OF USE-SECOND-HAND SMOKE/VAPOR
METHODS OF USE-SMOKING + (See Also SMOKED CANNABIS AS MEDICINE)
METHODS OF USE–SUB-LINGUAL/OROMUCOSAL
METHODS OF USE-SUPPOSITORIES
METHODS OF USE-TINCTURES +
METHODS OF USE-TOPICAL OINTMENTS +
METHODS OF USE-TRANSDERMAL PATCH*+
METHODS OF USE-VAPORIZERS*+
METHODS OF USE-VARIOUS*+
MIDLIFE ADULT (Ages 30-65 in Humans, or Equivalent in Animals)
MIGRAINE/HEADACHE*+
MILITARY and CANNABINOIDS
MISCELLANEOUS STUFF-STUDIES + (Fun Section-No Date Restrictions)
MITOCHONDRIA +
MOOD/EMOTIONS
MORNING SICKNESS (See Also NAUSEA) +
MORTALITY RATES/DEATH*+
MOTION SICKNESS +
MRSA/METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS*+
MULTIPLE SCLEROSIS/MS*+
MUSCLES/MUSCLE RELAXANT +
MUSCULAR DYSTROPHY/MD*+
>MYOCLONUS DIAPHRAGMATIC FLUTTER (See News Articles 2010-2018)


MACROPHAGES +
Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846023/?tool=pubmed
Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity (full-2010) http://www.nature.com/aps/journal/v31/n12/full/aps2010155a.html
Cannabinoid receptor expression in HIV encephalitis and HIV-associated
neuropathologic comorbidities (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135748/
Administration of 2-arachidonoylglycerol ameliorates both acute and chronic  Experimental Autoimmune Encephalomyelitis (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/21406188/abstract/Administration_of_2_arachidonoylglycerol_ameliorates_both_acute_and_chronic_Experimental_Autoimmune_Encephalomyelitis_
Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection (full–2012) http://stroke.ahajournals.org/content/43/1/211.long
DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513945/
N-arachidonoyl glycine induces macrophage apoptosis via GPR18 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22266325
Cannabinoid receptor type 2 is time-dependently expressed during skin wound healing in mice (abst–2012) https://link.springer.com/article/10.1007%2Fs00414-012-0741-3
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6 (full–2013) http://www.pnas.org/content/110/43/17558.long
Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629438/
G-protein coupled receptor 18 (GPR18) in channel catfish: expression analysis and  efficacy as immunostimulant against Aeromonas hydrophila infection (abst–2013)  http://www.sciencedirect.com/science/article/pii/S1050464813006554
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages  and increases the resistance of mice against infections (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080545/
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor  formation, and cell activity of autism-derived macrophages (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996516/
Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces  macrophage susceptibility to HIV-1 infection (full–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24562630
Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces  macrophage susceptibility to HIV-1 infection (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019698/
Detailed characterization of the endocannabinoid system in human macrophages and  foam cells, and anti-inflammatory role of type-2 cannabinoid receptor (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/24529123
Protective Role of CB2 Receptor Activation in Galactosamine/LPS-induced Acute Liver Failure Through Regulation of Macrophage Polarization and miRNAs (full–2015) http://jpet.aspetjournals.org/content/early/2015/03/06/jpet.114.220368.long
top
Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/bph.12747/full
Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages (full-2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126839
Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451551/
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium (full–2015) http://tinyurl.com/pv5snej
Human lung-resident macrophages express CB1 and CB2 receptors whose activation
inhibits the release of angiogenic and lymphangiogenic factors (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787289/
The GPR55 antagonist CID16020046 protects against intestinal inflammation (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587547/
Endocannabinoid signaling in innate and adaptive immunity (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/imm.12441/full
Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i / o / RhoA / ROCK signaling pathway (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25545473
Lipid signaling in adipose tissue: Connecting inflammation & metabolism (abst–2015) http://www.sciencedirect.com/science/article/pii/S1388198114002091
Editorial: Lung macrophages high on cannabinoids: jamming PAMs and taming TAMs? (full–2016) http://www.jleukbio.org/content/99/4/518.full
Targeting Cannabinoid CB2
Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Cannabinoid 2 Receptor Agonist Improves Systemic Sensitivity to Insulin in High-Fat Diet / Streptozotocin-Induced Diabetic Mice (full–2016) https://www.karger.com/Article/FullText/453171
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017608/
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves  plaque stability in ApoE-knockout mice (full–2016)  http://www.sciencedirect.com/science/article/pii/S0021915015301933
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts  potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2  pathways (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757881/
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27488857
Selective activation of CB2 receptor improves efferocytosis in cultured macrophages (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27474129
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23–IL-17 signalling in macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302499
Oxyradical Stress Increases the Biosynthesis of 2-Arachidonoylglycerol: Involvement of NADPH Oxidase (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27784678
The combination of β-caryophyllene, baicalin and catechin synergistically suppresses the proliferation and promotes the death of RAW267.4 macrophages in vitro (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27840942
Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung
cancer by downregulation of EGFR pathway (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26741322
Docosahexaenoic acid attenuates in endocannabinoid synthesis in RAW 264.7
macrophages activated with benzo(a)pyrene and lipopolysaccharide (abst–2016)
http://www.sciencedirect.com/science/article/pii/S0378427416301667
Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9-
tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages  (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303395
Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity  and Breadth of Antigen-specific Antibody Responses in Young and Aged mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314369/
Cannabinoid CB2 Receptors are Involved in the Protection of RAW264.7 Macrophages  Against the Oxidative Stress: An in Vitro Study (full–2017)  http://www.ejh.it/index.php/ejh/article/view/2749/2659
Endocannabinoid system acts as a regulator of immune homeostasis in the gut (full–2017) http://www.pnas.org/content/early/2017/04/18/1612177114.long
Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation
Link between Inflammatory State and Neuro-Immune Alterations (full–2017)  http://www.mdpi.com/1422-0067/18/7/1425/htm
Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid
anandamide in prostate cancer cells (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599064/
Cannabinoid Receptor 1 Participates in Liver Inflammation by Promoting M1  Macrophage Polarization via RhoA/NF-κB p65 and ERK1/2 Pathways, Respectively, in
Mouse Liver Fibrogenesis (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625548/
Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively
activated macrophages (full–2017)  https://www.jci.org/articles/view/83626
Cannabis in fat: high hopes to treat obesity (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29035279
Investigation of Diacylglycerol Lipase Alpha Inhibition in the Mouse Lipopolysaccharide  Inflammatory Pain Model (link to download–2017)  http://jpet.aspetjournals.org/content/early/2017/10/02/jpet.117.243808.long
Cannabidiol as a Therapy for ASIA Syndrome? An Editorial on a Novel Study (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4046
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type-2 Diabetes (abst–2017) http://diabetes.diabetesjournals.org/content/early/2017/01/11/db16-1199.long
N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition
differentially affect N-acylethanolamine levels and macrophage activation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28065729
Dual therapy targeting the endocannabinoid system prevents experimental diabetic  nephropathy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28387811
Exercise versus targeting of endocannabinoid system for atheromatic plaque stabilization. Opposing or complementary roles? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1109966617301422
Electroacupuncture Inhibits NLRP3 Inflammasome Activation through CB2 Receptors in  Inflammatory Pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28782714
Liposomal Delivery of Diacylglycerol Lipase-Beta Inhibitors to Macrophages  Dramatically Enhances Selectivity and Efficacy in Vivo (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00657
Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29079445
N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition  differentially affect N-acylethanolamine levels and macrophage activation (abst–2017) http://www.sciencedirect.com/science/article/pii/S138819811730001X
Endocannabinoid hydrolases in avian HD11 macrophages identified by
chemoproteomics: inactivation by small-molecule inhibitors and pathogen-induced  downregulation of their activity (abst–2017)  https://link.springer.com/article/10.1007%2Fs11010-017-3237-0


MACULAR DEGENERATION
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
The role of Cannabinoid receptors on light-induced photoreceptor degeneration (abst–2013) http://iovs.arvojournals.org/article.aspx?articleid=2149928&resultClick=1
Protective role of the cannabinoid receptor system in A2E-mediated photo-toxicity to retinal pigment epithelium (RPE) cells in an in-vitro model of age-related macular degeneration (AMD) (abst–2014) http://iovs.arvojournals.org/article.aspx?articleid=2271845&resultClick=1
CB2 receptor activation causes an ERK1/2-dependent inflammatory response in human  RPE cells (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701010/
Rimonabant, a selective cannabinoid1 receptor antagonist, protects against light-induced retinal degeneration in vitro and in vivo (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014299917301887
Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative  diseases (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28738764
Involvement of cannabinoid receptor type 2 in light-induced degeneration of cells from  mouse retinal cell line in vitro and mouse photoreceptors in vivo (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014483516304456?via%3Dihub


MAD COW/CRUETZFELDT-JACOB DISEASE
Alteration of the endocannabinoid system in mouse brain during prion disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21195746


MAGNETIC STIMULATION
Summary of evidence-based guideline: Complementary and alternative medicine in  multiple sclerosis (full–2014) http://www.neurology.org/content/82/12/1083.full
Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: The role of the endocannabinoid system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24479995
top

A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by  Modulating the Endocannabinoid System in HT22 Cells (full–2017)  http://journal.frontiersin.org/article/10.3389/fnins.2017.00042/full


MALARIA
Effect of anandamide in Plasmodium Berghei-infected mice (full–2010) http://www.karger.com/Article/Pdf/320559
Adult mortality and blood feeding behavioral effects of α-amyrin acetate, a novel bioactive compound on in vivo exposed females of Anopheles stephensi Liston (Diptera: Culicidae) (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22167372
Cannabidiol attenuates the long lasting cognitive deficits and anxiogenic-like behaviors promoted by murine cerebral malaria (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.9?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/jphp.12267/full
Minor oxygenated cannabinoids from high potency Cannabis sativa L. (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883105/
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism (full–2016) http://www.jbc.org/content/early/2016/07/29/jbc.M116.746594.long
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390
The oxylipin and endocannabidome responses in acute phase Plasmodium falciparum  malaria in children (full–2017)  https://malariajournal.biomedcentral.com/articles/10.1186/s12936-017-2001-y


MALE SEXUAL FUNCTION*
Energetic Metabolism and Human Sperm Motility: Impact of CB1 Receptor Activation (full–2010) http://endo.endojournals.org/content/151/12/5882.full
Characterization of the Endocannabinoid System in Human Spermatozoa and Involvement of Transient Receptor Potential Vanilloid 1 Receptor in Their Fertilizing Ability (full–2010) http://endo.endojournals.org/content/150/10/4692.full?sid=f5b14012-9fbe-4f10-890c-386313060cf8
Human sperm anatomy: ultrastructural localization of the cannabinoid1 receptor and a potential role of anandamide in sperm survival and acrosome reaction (full–2010) http://onlinelibrary.wiley.com/doi/10.1002/ar.21042/full
Endocannabinoids and Human Sperm Cells (link to PDF–2010) http://www.mdpi.com/1424-8247/3/10/3200
Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19147270
Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of  palmitoylethanolamide (full–2010)  http://painmedicine.oxfordjournals.org/content/11/5/781.long
Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037938/?tool=pubmed
Bilateral testicular self-castration due to cannabis abuse: a case report (full–2011)  (warning-very graphic pictures) http://www.jmedicalcasereports.com/content/5/1/404
Treatment with tetrahydrocannabinol (THC) prevents infertility in male cystic fibrosis mice (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22865360
Effect of capacitation on the endocannabinoid system of mouse sperm (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21723369
top

Anandamide Induces Sperm Release from Oviductal Epithelia through Nitric Oxide Pathway in Bovines (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281848/?tool=pubmed
Differences in the endocannabinoid system of sperm from fertile and infertile men (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0047704
Anandamide regulates the expression of GnRH1, GnRH2, and GnRH-Rs in frog testis (full–2012) http://ajpendo.physiology.org/content/303/4/E475.long
Minireview: Endocannabinoids and Gonadal Hormones: Bidirectional Interactions in Physiology and Behavior (full–2012) http://press.endocrine.org/doi/full/10.1210/en.2011-1643
The role of endocannabinoids in gonadal function and fertility along the evolutionary axis (full–2012) http://www.sciencedirect.com/science/article/pii/S0303720712000445
Sex Hormones Levels as Influenced by Cannabis sativa in Rats and Men (full–2012) http://scialert.net/qredirect.php?doi=pjn.2012.419.422&linkid=pdf
Impact of reference gene selection for type 2 cannabinoid receptor gene expression studies in human spermatozoa (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/and.12006/abstract
Long-term use of HU210 adversely affects spermatogenesis in rats by modulating the endocannabinoid system (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2605.2012.01259.x/abstract
Honokiol attenuates torsion/detorsion-induced testicular injury in rat testis by way of suppressing endoplasmic reticulum stress-related apoptosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22285174
Anandamide Transforms Noncopulating Rats into Sexually Active Animals (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22906359
Treatment with CB 2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice (full–2013) http://www.hindawi.com/journals/cdi/2013/263846/
Estrogens and Spermiogenesis: New Insights from Type 1 Cannabinoid Receptor Knockout Mice (full–2013) http://www.hindawi.com/journals/ije/2013/501350/
Anandamide Levels Fluctuate in the Bovine Oviduct during the Oestrous Cycle (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0072521
The Endocannabinoid System and Spermatogenesis (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864102/
Endocannabinoids as markers of sperm quality: hot spots (full–2013) http://www.frontiersin.org/Journal/10.3389/fendo.2013.00169/full
Brain Levels of Prostaglandins, Endocannabinoids, and Related Lipids Are Affected by Mating Strategies (full–2013) http://www.hindawi.com/journals/ije/2013/436252/
Low 17beta-Estradiol Levels in Cnr1 Knock-Out Mice Affect Spermatid Chromatin Remodeling by Interfering with Chromatin Reorganization (full–2013) http://www.biolreprod.org/content/88/6/152.long
top

Anandamide modulates human sperm motility: implications for men with asthenozoospermia and oligoasthenoteratozoospermia (full–2013) http://humrep.oxfordjournals.org/content/28/8/2058.long
Endocannabinoids are Involved in Male Vertebrate Reproduction: Regulatory Mechanisms at Central and Gonadal Level (full–2014) http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00054/full
A role for endocannabinoids in acute stress-induced suppression of the hypothalamic pituitary-gonadal axis in male rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913894/
Involvement of cannabinoid receptor-1 activation in mitochondrial depolarizing effect of lipopolysaccharide in human spermatozoa (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24692267
Endocannabinoids as biomarkers of human reproduction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24516083
The biological networks in studying cell signal transduction complexity: The examples of sperm capacitation and of endocannabinoid system (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212279/
Priapism in a patient with sickle cell trait using marijuana (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24798364
Low anandamide doses facilitate male rat sexual behaviour through the activation of CB1 receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24671517
Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24698342
Fenitrothion action at the endocannabinoid system leading to spermatotoxicity in Wistar rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24998969
Endocannabinoid signaling at the periphery: 50 years after THC (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420685/
Type 2 cannabinoid receptor contributes to the physiological regulation of  spermatogenesis (full–2015)  http://www.fasebj.org/content/early/2015/12/15/fj.15-279034.long
Anandamide Reduces the Ejaculatory Threshold of Sexually Sluggish Male Rats: Possible Relevance for Human Lifelong Delayed Ejaculation Disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25808995
Anandamide acts via kisspeptin in the regulation of testicular activity of the frog, Pelophylax esculentus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26586207
Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26226145
top

Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26226145
Effects of Neuroendocrine CB1 Activity on Adult Leydig Cells (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891325/
Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18 (full–2016) http://www.nature.com/articles/srep32255
Progesterone and Endocannabinoid Interaction Alters Sperm Activation (full–2016) http://www.biolreprod.org/content/95/1/9.long
Unconventional endocannabinoid signaling governs sperm activation via sex hormone progesterone (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26989199
Sexual dysfunction in men diagnosed as substance use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26940022
PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase (abst–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13448/abstract
2-arachidonoylglycerol levels are increased in leukocytospermia and correlate with seminal macrophages (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27863106
Intra-VTA anandamide infusion produces dose-based biphasic effects on male rat sexual behavior expression (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302258
Activation of Both CB1 and CB2 Endocannabinoid Receptors Is Critical for
Masculinization of the Developing Medial Amygdala and Juvenile Social Play Behavior  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272923/
Endocannabinoid system in sexual motivational processes: is it a novel therapeutic  horizon? (full–2017)  http://www.sciencedirect.com/science/article/pii/S1043661816312385
Overactive type 2 cannabinoid receptor induces meiosis in fetal gonads and impairs  ovarian reserve (full–2017)  http://www.nature.com/cddis/journal/v8/n10/full/cddis2017496a.html?foxtrotcallback=true
Developmental Patterns of Adolescent Marijuana and Alcohol Use and Their Joint  Association with Sexual Risk Behavior and Outcomes in Young Adulthood (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28083726
Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study (abst–2017)  http://link.springer.com/article/10.1007%2Fs00213-017-4601-1
Human sperm motility, capacitation and acrosome reaction are impaired by 2-
arachidonoylglycerol endocannabinoid (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28585678
Participation of hypothalamic CB1 receptors in reproductive axis disruption during  immune challenge (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28665507
Expression and distribution of key proteins of the endocannabinoid system in the human seminal vesicles (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28786134
Masturbation to Orgasm Stimulates the Release of the Endocannabinoid 2-
Arachidonoylglycerol in Humans (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29110806
Incubation of spermatozoa with Anandamide prior to cryopreservation reduces  cryocapacitation and improves post-thaw sperm quality in the water buffalo (Bubalus  bubalis) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29277315
Association Between Marijuana Use and Sexual Frequency in the United States: A  Population-Based Study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29110804>


MARFAN SYNDROME
Regarding Marfan Syndrome (forum post–2010) http://forum.grasscity.com/medical-marijuana-usage-applications/708198-regarding-marfan-syndrome.html
An interaction between warfarin and cannabidiol, a case report (full–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789126/


MASSAGE
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951193/
Endocannabinoids and related lipids in blood plasma following touch massage: a randomised, crossover study (full–2015) http://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-015-1450-z


MAST CELLS +
Systemic mastocytosis and medical marijuana (case report-undated) http://cannabisclinicians.org/view-all-case-reports/entry/645/
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936031/?tool=pubmed
Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of  palmitoylethanolamide (full–2010)  http://painmedicine.oxfordjournals.org/content/11/5/781.long
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis (full–2011) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028159
Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117838/
New cannabinoid-like chromane and chromene derivatives from Rhododendron anthopogonoides (full–2011) https://www.jstage.jst.go.jp/article/cpb/59/11/59_11_1409/_pdf
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606913/
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21354467
Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21601562
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3312.long
top

Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitis (full–2012) http://www.biomedcentral.com/1746-6148/8/230
Endocannabinoids limit excessive mast cell maturation and activation in human skin (full–2012) http://www.jacionline.org/article/S0091-6749%2811%2901796-9/fulltext
Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: a case report (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22998138
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22772472
Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22738050
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643547/
Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ (full–2013) http://www.jacionline.org/article/S0091-6749%2813%2900057-2/fulltext
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067427
New insights in mast cell modulation by palmitoylethanolamide (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23394523
Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23394519
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
Vestibulodynia: synergy between palmitoylethanolamide + transpolydatin and transcutaneous electrical nerve stimulation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23343704
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22697514
top

Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis (full–2014) http://www.biomedcentral.com/1746-6148/10/21
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1 (full–2014) http://www.jleukbio.org/content/95/4/609.long
Palmitoylethanolamide regulates development of intestinal radiation injury in a mast celldependent manner (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213290/
Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD) (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24602801
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24440533
Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24178954
Systemic mastocytosis and medical marijuana (case report-undated)  http://cannabisclinicians.org/view-all-case-reports/ 
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519555/
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the  Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo (full–2015) http://www.jimmunol.org/content/194/11/5211.long
Endocannabinoid signaling in innate and adaptive immunity (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/imm.12441/full
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation (link to PDF–2015) http://www.haematologica.org/content/early/2015/12/21/haematol.2015.136523.long
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model (full–2016) http://anndermatol.org/DOIx.php?id=10.5021/ad.2016.28.1.22
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts
potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2
pathways (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757881/
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact  allergic dermatitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27720681
Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic
Symptoms in the Mouse (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732963/
Randomised clinical trial: the analgesic properties of dietary supplementation with  palmitoylethanolamide and polydatin in irritable bowel syndrome (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28164346
The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin  Inflammation in Mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28214870


MEDICAL MARIJUANA*+
MEDICINAL USE OF CANNABIS: HISTORY AND CURRENT STATUS (full–undated) http://www.parl.gc.ca/content/sen/committee/371/ille/presentation/kalant-e.htm
Indian hemp and the dope fiends of Old England (article-undated) http://www.idmu.co.uk/indian.htm
Medical Marijuana and the Law (full-2010) http://content.nejm.org/cgi/content/full/362/16/1453?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=2080&resourcetype=HWCIT
DEA Listing of Approved Drug Products Containing Dronabinol in Schedule III (full–2010) http://www.deadiversion.usdoj.gov/fed_regs/rules/2010/fr1101.htm
Historical essay: An Arabic surgeon, Ibn al Quff’s (1232-1286) account on surgical pain
relief (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173333/
Illicit and Nonmedical Drug Use Among Older Adults: A Review (link to PDF–2010) http://journals.sagepub.com/doi/abs/10.1177/0898264310386224
Standardized Cannabis in Multiple Sclerosis: A Case Report (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?tool=pubmed
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant  for administration by ingestion or other means (Health Canada) (full–2010)  http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Summary of Product Characteristics- Sativex Oralmucosal Spray (full–2010)  http://www.medicines.org.uk/EMC/medicine/23262/SPC/Sativex+Oromucosal+Spray/
Do patients think cannabis causes schizophrenia? – A qualitative study on the causal  beliefs of cannabis using patients with schizophrenia (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954921/?tool=pmcentrez
New Era Dawns on Sickle Cell Pain (full-2010)  http://bloodjournal.hematologylibrary.org/cgi/reprint/116/3/311
Necessity or nastiness? The hidden law denying cannabis for medical use (full/news-2010) http://profdavidnutt.wordpress.com/2010/12/13/necessity-or-nastiness-the-hidden-law-denying-cannabis-for-medicinal-use/
Accommodating the medical use of marijuana: surveying the differing legal approaches in Australia, the United States and Canada (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20329455
Denial of hepatic transplantation on the basis of smoking: is it ethical? (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20154621
The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=309
Sleep and Medicinal Cannabis (abst-2010) http://www.cmcr.ucsd.edu/index.php/2015-11-20-20-52-15/completed-studies/33-sleep-and-medicinal-cannabis
Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption (full–2011) http://ftp.iza.org/dp6112.pdf
top

An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673028/
The prevalence of cannabis-involved driving in California (full–2011) http://www.sciencedirect.com/science/article/pii/S0376871611004741
Medical marijuana: medical necessity versus political agenda (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628147/
“But my Doctor Recommended Pot”: Medical Marijuana and the Patient-Physician Relationship (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208453/
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (full–2011) http://www.lufg.com.au/files/media/Popular_intoxicants_what_lessons_can_be_learned.pdf
The intersection between cannabis and cancer in the United States (full–2011) http://www.croh-online.com/article/S1040-8428(11)00231-9/fulltext
Examining the Health and Drug Exposures among Canadian Children Residing in Drug Producing Homes (full–2011) http://www.jpeds.com/article/S0022-3476(11)00522-1/fulltext
Alternative therapy in glaucoma management: Is there any role? (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038502/?tool=pubmed
Cannabis and Its Derivatives: Review of Medical Use (full–2011)  http://www.jabfm.org/cgi/content/full/24/4/452
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Assessment of hospice health professionals’ knowledge, views, and experience with medical marijuana (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22077541
The Rhode Island medical marijuana program: an exploratory study (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21511683
High on Life? Medical Marijuana Laws and Suicide (full–2012) http://ftp.iza.org/dp6280.pdf
Medical Marijuana Laws and Teen Marijuana Use (full–2012) http://ftp.iza.org/dp6592.pdf
The medicalisation of revolt: a sociological analysis of medical cannabis users (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1467-9566.2012.01476.x/full
Clinical Service Desires of Medical Cannabis Patients (full–2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-12.pdf
Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538401/
Societal images of Cannabis use: comparing three countries (full–2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-21.pdf
Exploring the ecological association between crime and medical marijuana dispensaries (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364319/
Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251168/
Medical marijuana: the supremacy clause, federalism, and the interplay between state and federal laws (full–2012) http://fas.org/sgp/crs/misc/R42398.pdf
It can’t hurt to ask; a patient-centered quality of service assessment of health Canada’s medical cannabis policy and program (full–2012) http://www.harmreductionjournal.com/content/9/1/2
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients (full–2012) https://philippelucasvictoria.files.wordpress.com/2012/12/rx-mj-as-a-substitute-for-aod-addiction-researchand-theory-2012-in-press.pdf
top

Do medical marijuana laws increase marijuana use? Replication study and extension  (full–2012) http://www.annalsofepidemiology.org/article/S1047-2797%2811%2900372-3/fulltext
Cannabis—A Valuable Drug That Deserves Better Treatment (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498425/ P
The Relationship between Plants Used to Sustain Finches (Fringillidae) and Uses for Human Medicine in Southeast Spain (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350861/?tool=pubmed
The medicalisation of revolt: a sociological analysis of medical cannabis users (link to PDF–2012) http://www.stcm.ch/en/files/paper_pedersen—sandberg.pdf
Use of cannabis among 139 cluster headache sufferers (download–2012)  http://scholar.google.com/scholar_url?url=https://www.researchgate.net/profile/Elizabeth_Leroux/publication/278871004_Cluster_Headache_Cluster_Headache_and_Cannabis/links/563f912008ae45b5d28d30e8.pdf&hl=en&sa=X&scisig=AAGBfm2FeWNia7xmI9Y7qQcIo3XFnscxeA&nossl=1&oi=scholarr
Prospectively Surveying Health-Related Quality of Life and Symptom Relief in a Lot Based Sample of Medical Cannabis-Using Patients in Urban Washington State Reveals Managed Chronic Illness and Debility (full–2012) http://journals.sagepub.com/doi/full/10.1177/1049909112454215
Therapeutic use of cannabis (abst–2012) https://www.ncbi.nlm.nih.gov/pubmed/22479766
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System  (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22583441
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in  Multiple Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23072659
From cannabis to the endocannabinoid system: refocussing attention on potential clinical benefits (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23155985
Marijuana: modern medical chimaera (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22873011
The New Politics of Marijuana Legalization: Why Opinion is Changing (full–2013) http://www.brookings.edu/research/papers/2013/05/29-politics-marijuana-legalization-galston-dionne
Medical Marijuana and Related Legal Aspects (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875249/
Colorado family physicians’ attitudes toward medical marijuana (full–2013) http://www.jabfm.org/content/26/1/52.long
The pharmacologic and clinical effects of medical cannabis (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/full
Legalization of medical marijuana and marijuana use among youths (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638722/
Availability of tobacco products associated with use of marijuana cigars (blunts) (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883305/
Effects of State Medical Marijuana Laws on Adolescent Marijuana Use (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007871/
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use (full–2013) http://www.ijdp.org/article/S0955-3959%2813%2900135-7/fulltext
The economic geography of medical cannabis dispensaries in California (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162636/
Establishing expertise: Canadian community-based medical cannabis dispensaries as embodied health movement organisations (full–2013) http://www.ijdp.org/article/S0955-3959%2813%2900232-6/fulltext
Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929256/
The role of child protection in cannabis grow-operations (full–2013) http://www.canorml.org/child.welfare.pdf
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation  (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663904/
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584982/
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana In Daily  Marijuana Smokers (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746706/
Clinical decisions. Medicinal use of marijuana-polling results (article–2013) http://www.nejm.org/doi/full/10.1056/NEJMclde1305159
Medical Marijuana Coverage Still Lost in the Legal Weeds (article–2013) http://www.managedcaremag.com/linkout/2013/1/23
Integrating Cannabis Into Clinical Care (article–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875042/
Medicinal Cannabis and Painful Sensory Neuropathy (editorial–2013) http://virtualmentor.ama-assn.org/2013/05/oped1-1305.html
top

Cannabis and the Lung: No More Smoking Gun? (editorial–2013) http://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201302-034ED?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
Correspondence (letter to the editor): Cannabis Therapy (letter–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601285/
Anticipated Medical Effects on Children From Legalization of Marijuana in Colorado and Washington State (1st page–2013) http://archpedi.jamanetwork.com/article.aspx?articleid=1691419&resultClick=3
Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized
medical marijuana: 125 dogs (2005-2010) (abst-2013)  https://www.researchgate.net/publication/233874975_Evaluation_of_trends_in_marijuana_toxicosis_in_dogs_living_in_a_state_with_legalized_medical_marijuana_125_dogs_2005-2010
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1531/full
Effects of Schedule I drug laws on neuroscience research and treatment innovation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23756634
From 32 ounces to zero: a medical geographic study of dispensing a cultivated batch of “plum” cannabis flowers to medical marijuana patients in Washington State (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23909002
Characteristics of adults seeking medical marijuana certification (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23683791
The medicinal use of cannabis and cannabinoids–an international cross-sectional survey on administration forms (abst–2013) http://www.unboundmedicine.com/medline/citation/24175484/The_medicinal_use_of_cannabis_and_cannabinoids–an_international_cross-sectional_survey_on_administration_forms.
Still Dazed and Confused: Midlife Marijuana Use by the Baby Boom Generation (abst–2013) http://www.tandfonline.com/doi/abs/10.1080/01639625.2014.889994
Sleep Quality Moderates the Relation between Depression Symptoms and Problematic
Cannabis Use among Medical Cannabis Users (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23721537
Distress, Coping, and Drug Law Enforcement in a Series of Patients Using Medical  Cannabis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23538974
Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations (full–2014) http://www.cfp.ca/content/60/12/1083.long
The Effect of Medical Marijuana Laws on Crime: Evidence from State Panel Data, 1990-2006 (full–2014)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0092816
Physicians, Medical Marijuana, and the Law (full–2014) http://journalofethics.ama-assn.org/2014/09/hlaw1-1409.html
The DEA: Four Decades of Impeding And Rejecting Science (full–2014) http://www.drugpolicy.org/sites/default/files/DPA-MAPS_DEA_Science_Final.pdf
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program (full–2014)  http://www.tandfonline.com/doi/full/10.1080/02791072.2013.873843#tabModule
Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints (full–2014) http://www.biomedcentral.com/content/pdf/1471-2474-15-258.pdf
top

Health Poll – Legalizing Marijuana (full–2014) http://truvenhealth.com/Portals/0/NPR-Truven-HealthPoll/TRU_13728_0414_NPRPulseMarijuanaStudy.pdf
The Impact of State Medical Marijuana Legislation on Adolescent Marijuana Use (full–2014) http://www.jahonline.org/article/S1054-139X%2814%2900107-4/pdf
Words Can Be Deceiving: A Review of Variation Among Legally Effective Medical Marijuana Laws in the United States (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314612/
Physicians as gatekeepers in the use of medical marijuana (full–2014) http://www.jaapl.org/content/39/4/460.long
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010 (full–2014) http://archinte.jamanetwork.com/article.aspx?articleid=1898878
Medical marijuana: more questions than answers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243838/
High-Intensity Cannabis Use and Adherence to Antiretroviral Therapy Among People Who Use Illicit Drugs in a Canadian Setting (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289662/
Positive posttraumatic stress disorder screens among first-time medical cannabis patients: Prevalence and association with other substance use (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299455/
The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients via a Written Document (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417655/
Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime
Canada (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950986/
Pharmacological management of chronic neuropathic pain: Revised consensus statement from the Canadian Pain Society (full–2014) http://tinyurl.com/p7ugyjf
Cannabis and related impairment: the unique roles of cannabis use to cope with social
anxiety and social avoidance (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240501/
Early phytocannabinoid chemistry to endocannabinoids and beyond (link to download–2014) https://www.researchgate.net/publication/266945311_Early_phytocannabinoid_chemistry_to_endocannabinoids_and_beyond
Political and medical views on medical marijuana and its future (link to download–2014)  https://www.researchgate.net/publication/259650013_Political_and_Medical_Views_on_Medical_Marijuana_and_its_Future
Cannabis Use and its Effects on Health, Education and Labor Market Success (link to PDF-2014) http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2414469
The Effect of Medical Marijuana Laws on Marijuana, Alcohol, and Hard Drug Use (link to PDF–2014) http://www.nber.org/papers/w20085#fromrss
Marijuana Resource Center: State Laws Related to Marijuana (article–2014) http://www.whitehouse.gov/ondcp/state-laws-related-to-marijuana
Medical marijuana: 4 experts on benefits vs. risks (article–2014) https://www.elsevier.com/connect/medical-marijuana-4-experts-on-benefits-vs-risks
A Review and Critique of Dr. Sanjay Gupta’s Weed 2: Cannabis Madness on CNN (article–2014) http://cms.herbalgram.org/heg/volume11/04April/CNNGupataWEED2critique.html
Does the legalization of medical marijuana increase completed suicide? (abst–2014)  https://www.ncbi.nlm.nih.gov/pubmed/24949839
Medical Marijuana Laws and Suicides by Gender and Age (abst–2014) http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2013.301612?journalCode=ajph
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24205805
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical Grade Cannabis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747979
Assessing Marijuana Use in Bariatric Surgery Candidates: Should It Be a Contra-indication? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24913244
top

Barriers to access for Canadians who use cannabis for therapeutic purposes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24947993
Medical use of cannabis in Australia: “medical necessity” defences under current Australian law and avenues for reform (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25087368
Growing medicine: Small-scale cannabis cultivation for medical purposes in six different countries (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123694
Legalising medical use of cannabis in South Africa: Is the empirical evidence sufficient to support policy shifts in this direction? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25214244
Prevalence of medical marijuana use in California, 2012. (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25255903
Use and medicalization of marihuana in cancer patients (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25508539
Re-branding cannabis: the next generation of chronic pain medicine? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25537695
Medical marijuana and children (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25647865
Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in los angeles (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25188696
Therapeutic Potential of Cannabinoids—Perspectives for the Future (abst in English & Japanese–2014) http://www.tandfonline.com/doi/abs/10.1080/15440478.2013.878604
Medical Marijuana Use in Patients With History of Head and Neck Squamous Cell  Carcinoma Treated With Radiation Therapy (abst–2014)  http://www.redjournal.org/article/S0360-3016(14)02729-1/fulltext
Is the Clinical Use of Cannabis by Oncology Patients Advisable? (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24606496
Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of  Parkinson Disease: An Open-Label Observational Study (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24614667
Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary  investigation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25052875
Cannabis social clubs in Belgium: Organizational strengths and weaknesses, and threats  to the model (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25179934
Illegal drugs laws: clearing a 50-year-old obstacle to research (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002047
Cannabis in medicine: a national educational needs assessment among Canadian physicians (full–2015) http://www.molecularneurodegeneration.com/content/pdf/s13024-015-0012-0.pdf
top
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
The cannabis conundrum: Thinking outside the THC box (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/jcph.511/full
Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys (full–2015) http://press.thelancet.com/AdolescentMarijuana.pdf
Current Status and Future of Cannabis Research (full–2015) http://cannabisclinicians.org/wp-content/uploads/2015/05/Russo-et-al-Current-status-and-future-ofcannabis-research-Clin-Researcher-2015.pdf
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Stigma among California’s Medical Marijuana Patients (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715067
Cannabis – the Israeli perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0091/jbcpp-2015-0091.xml
Plant derived substances with anti-cancer activity: from folklore to practice (full–2015) http://journal.frontiersin.org/article/10.3389/fpls.2015.00799/full
Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development (full–2015)
http://www.hindawi.com/journals/ecam/2015/238482/
Human rights, public health and medicinal cannabis use (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662098/
Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec (full–2015) http://cmajopen.ca/content/3/2/E251.full?sid=139f05c1-b441-476b-99ff-addf8c918e1a
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251&resultClick=24
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies (full–2015) http://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-015-0082-x
Medical marijuana’s public health lessons-implications for retail marijuana in Colorado (full–2015) http://www.nejm.org/doi/full/10.1056/NEJMp1500043
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318349/
top

U.S. Policy Responses to Calls for the Medical Use of Cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553645/
Medicinal cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674028/ Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review (full–2015) http://jama.jamanetwork.com/article.aspx? articleid=2338266
Marijuana Legalization: Impact on Physicians and Public Health (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900958/
Sequelae of Cannabis as Medicine (full–2015) http://painmedicine.oxfordjournals.org/content/16/7/1447
Responsible and controlled use: Older cannabis users and harm reduction (full–2015) http://www.ijdp.org/article/S0955-3959(15)00075-4/fulltext
Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol (full–2015) http://file.scirp.org/Html/5-2500582_53912.htm
THE EFFECT OF MEDICAL MARIJUANA LAWS ON BODY WEIGHT (full–2015) http://www.os-extra.cannabisclinicians.org/wp-content/uploads/2016/03/MMJ_laws_Body-weight.pdf
An Overview of Products and Bias in Research (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604179/
ADOLESCENTS’ USE OF MEDICAL MARIJUANA: A SECONDARY ANALYSIS OF MONITORING THE FUTURE DATA (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514911/
Marijuana: A Time-Honored but Untested Treatment for Epilepsy (full–2015) https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/divclasstitlemarijuana-a-time-honored-but-untested-treatment-forepilepsydiv/DDEDDD9EAA09918D3D69CC7CA047AE5C/core-reader
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549715/
The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation : a case report (full–2015) http://link.springer.com/article/10.1007%2Fs12630-015-0525-6
Prevalence of Marijuana and Other Substance Use Before and After Washington State’s  Change from Legal Medical Marijuana to Legal Medical and Non-Medical Marijuana:
Cohort Comparisons in a Sample of Adolescents (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744815/
In the weeds: a baseline view of cannabis use among legalizing states and their  neighbours (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216038/
Medicinal use of cannabis in Europe (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328738/
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution
Experience (full–2015) http://www.jpsmjournal.com/article/S0885-3924(14)00312-1/fulltext
Marijuana for Glaucoma: A Recipe for Disaster or Treatment? (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553646/
Investigation of traditional medicinal floral knowledge of Sarban Hills, Abbottabad, KP,  Pakistan (full–2015) http://www.sciencedirect.com/science/article/pii/S0378874115303020
Cannabis microbiome sequencing reveals several mycotoxic fungi native to dispensary grade Cannabis flowers (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897766/
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604175/
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient
Data (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666747/
Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by
Parkinson’s Disease Patients in Colorado (full–2015)  http://www.hindawi.com/journals/ecam/2015/874849/
The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update (link to PDF–2015) http://pediatrics.aappublications.org/content/early/2015/01/20/peds.2014-4147.long
Assessment of Israeli Physicians’ Knowledge, Experience and Attitudes towards Medical Cannabis: A Pilot Study (link to PDF–2015)

http://www.ima.org.il/IMAJ/ViewArticle.aspx?year=2015&month=07&page=437
Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers? (link to PDF-2015) https://www.semanticscholar.org/paper/Do-Medical-Marijuana-Laws-Reduce-Addiction-and-Dea-PowellLiccardo/de1ed809a834f74de4cb902b7546bc3dc17ef231
Ending the U.S. government’s war on medical marijuana research (report–2015) https://www.brookings.edu/research/ending-the-u-s-governments-war-on-medical-marijuana-research/
Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates (article–2015) http://journalofethics.ama-assn.org/2015/06/pfor2-1506.html
Marijuana gears up for production high in US labs (article–2015) http://www.nature.com/news/marijuana-gears-up-for-production-high-in-us-labs-1.17129
Marijuana Research with Human Subjects (article–2015) http://www.fda.gov/newsevents/publichealthfocus/ucm421173.htm
Peaceful feeling, or up in smoke? Medical marijuana in medicolegal context (article–2015) http://www.mdedge.com/currentpsychiatry/article/102099/practice-management/peaceful-feeling-orsmoke-medical-marijuana
The entourage effect: Synergistic actions of plant cannabinoids (letter–2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015)  http://jama.jamanetwork.com/article.aspx?articleid=2338230
Medical marijuana: Policy topic for 2015 APhA House of Delegates (1st page–2015) http://japha.org/article.aspx?articleid=2090052
High prevalence of cannabis use among Aka foragers of the Congo Basin and its possible
relationship to helminthiasis (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/26031406
Profiles of medicinal cannabis patients attending compassion centers in rhode island (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715068
Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661483
(1)H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26048837
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26151582
Do Cannabinoid Receptor Agonists Have A Role In The Intensive Care Unit? … Totally Dude! (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A1657
From badness to illness: Medical cannabis and self-diagnosed attention deficit hyper-activity disorder (abst–2015) http://informahealthcare.com/doi/abs/10.3109/16066359.2014.954556
Polypharmacology Shakes Hands with Complex Aetiopathology (abst–2015) http://www.cell.com/trends/pharmacological-sciences/abstract/S0165-6147(15)00171-6
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26364922
Medicinal Cannabis: A Survey Among Health Care Providers in Washington State (full–2015) http://journals.sagepub.com/doi/full/10.1177/1049909115604669
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325482
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26451996
Cannabis and cancer: reality or pipe dream? (abst–2015)  http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2815%2900302-2/abstract
Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of
Medical Cannabis Legalization (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26317379
Proving personal use: the admissibility of evidence negating intent to distribute  marijuana (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26030944
Medical education on cannabis and cannabinoids: Perspectives, challenges, and
opportunities (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25728558
Use of medical cannabis to reduce pain and improve quality of life in cancer patients  (abst–2015) http://meetinglibrary.asco.org/content/155674-165
Options for pharmacoresistant epilepsy in children: when medications don’t work (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25658218
Clinical pharmacology of medical cannabinoids in chronic pain (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26267945
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic  Implications in Medicine and Headache: What a Long Strange Trip It’s Been …. (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26015168
A safer alternative: Cannabis substitution as harm reduction (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25919477
Merck Manual – Marijuana (Cannabis) Professional version (full–2016) http://www.merckmanuals.com/professional/special-subjects/recreational-drugs-and-intoxicants/marijuanacannabis
Merck Manual – Marijuana (Cannabis) Consumer version (full–2016) http://www.merckmanuals.com/home/special-subjects/recreational-drugs-and-intoxicants/marijuana
top

A collaboration investigating endocannabinoid signalling in brain and bone (full–2016) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0125/jbcpp-2015-0125.xml
Cannabinoids for pediatric epilepsy? Up in smoke or real science? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
Cannabis sativa: The Plant of the Thousand and One Molecules (full–2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00019/full
Medical marijuana programs – Why might they matter for public health and why should we better understand their impacts? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721313/
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists’ Perspectives (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155113
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13390/full
Medicinal cannabis in Australia: the missing links (full–2016) https://www.mja.com.au/journal/2016/204/10/medicinal-cannabis-australia-missing-links
Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00108/full
Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for  Rheumatic Disorders (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839539/
Is the medical use of cannabis a therapeutic option for children? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758425/
Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: Commentary on and reanalysis of US National Survey on Drug Use in Households data 2002-2011 (full–2016) http://www.ijdp.org/article/S0955-3959(16)00038-4/fulltext
Model Guidelines for the Recommendation of Marijuana in Patient Care (full–2016) http://www.fsmb.org/Media/Default/PDF/BRD_RPT_16-2_Marijuana_Model_Guidelines.pdf
Tracking Dabbing Using Search Query Surveillance: A Case Study in the United States (full–2016) http://www.jmir.org/2016/9/e252/
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00355/full
Medical cannabis use in Canada: vapourization and modes of delivery (full–2016) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9 Federal barriers to Cannabis research (full–2016) http://science.sciencemag.org/content/352/6290/1182.1.long
Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00285/full#B14
Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines (full–2016) http://www.ajtr.org/files/ajtr0030292.pdf
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Minnesota Pharmacists and Medical Cannabis: A Survey of Knowledge, Concerns, and Interest Prior to Program Launch (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083080/
Establishment of a New Drug Code for Marihuana Extract. Final rule (full–2016) https://www.federalregister.gov/documents/2016/12/14/2016-29941/establishment-of-a-new-drug-code-formarihuana-extract
Opinions of Hospital Pharmacists in Canada Regarding Marijuana for Medical Purposes (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853179/
Metagenomic analysis of medicinal Cannabis samples; pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold tests (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089129/
Therapeutic Use of Cannabis in Inflammatory Bowel Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193087/
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Medical Marijuana for Epilepsy? (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911937/
Medical cannabis: considerations for the anesthesiologist and pain physician (full in English, abst in French–2016) https://link.springer.com/article/10.1007%2Fs12630-016-0598-x
Endocannabinoid system: Role in depression, reward and pain control (Review) (full–2016) https://www.spandidos-publications.com/10.3892/mmr.2016.5585
Tackling the Pharmaceutical Frontier: Regulation of Cannabinoid-Based Medicines in  Postwar Japan (full–2016) http://online.liebertpub.com/doi/full/10.1089/can.2015.0011
Stakeholders’ Views on Barriers to Research on Controversial Controlled Substances  (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559713/
Smoking, vaping, eating: Is legalization impacting the way people use cannabis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010515/
Tasty THC: Promises and Challenges of Cannabis Edibles (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260817/
David Casarett’s Stoned: A Doctor’s Case for Medical Marijuana (full–book review-2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938260/
American Attitudes toward Substance Use in the United States (click “Cancel” for link to download–2016) http://www.apnorc.org/projects/Pages/american-attitudes-toward-substance-use-in-the-united-states.aspx
The US as an example of how not to legalize marijuana? (download–2016)  http://onlinelibrary.wiley.com/doi/10.1111/add.13498/pdf
Marijuana: Medical Applications, Recreational Use and Substance Abuse Disorders
(link to download – 2016) http://www.eurekaselect.com/85221/article
Applications To Become Registered Under the Controlled Substances Act To
Manufacture Marijuana To Supply Researchers in the United States. Policy statement.
(click “Link out” for download – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27529905
COMPREHENSIVE MEDICAL MARIJUANA PATIENT STUDY (link to PDF–2016) https://www.hellomd.com/medical-marijuana-patient-survey
Marijuana – How Safe is it Really? (article- link to PDF–2016)  https://journals.mcmaster.ca/iScientist/article/download/1104/991
Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal  Markets (link to PDF–2016) http://biorxiv.org/content/early/2016/10/26/083444
Use of marijuana for medical purposes (link to PDF–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27660881
Medical experts warn Australia’s understanding of medicinal cannabis lacking (link to PDF-2016) http://apo.org.au/resource/medical-experts-warn-australias-understanding-medicinal-cannabis-lacking
Cannabis Legalization: Focusing on Patient Needs: Five Recommendations on Access, Affordability, and Research (report–2016) http://cfamm.ca/patient-recommendations/ Cannabis in the United States (report–2016) http://self.gutenberg.org/article/WHEBN0020566488/Cannabis%20in%20the%20United%20States
Dose of Reality: The Effect of State Marijuana Legalizations (report–2016) http://www.cato.org/publications/policy-analysis/dose-reality-effect-state-marijuana-legalizations#full
Evidence for Medicinal Use of Cannabis (article–2016) http://www.physio-pedia.com/Evidence_for_Medicinal_Use_of_Cannabis
Why I chose to use cannabis (article–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791147/ Cannabis and Dr Piffard-A Cannabis and Dr Piffard-A Century Ahead of the Curve (article–2016)  http://archderm.jamanetwork.com/article.aspx?articleid=2547236
Opioids Out, Cannabis In (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2576617
Cannabis and Cannabinoids (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2592497
Expectations for Physicians Prescribing Marijuana (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2592491
Farming medical ganja in Jamaica (1st page–2016) http://www.ijdp.org/article/S0955-3959(16)30089-5/fulltext
The old open question of marijuana and healthcare: Flares from NANHES (1st page–2016) http://www.ejinme.com/article/S0953-6205(16)30256-4/fulltext
Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D (abst–2016) http://content.healthaffairs.org/content/35/7/1230.long
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population  (abst–2016) http://onlinelibrary.wiley.com/doi/10.1002/phar.1673/full
Marijuana: Views on Its Medical Use Recorded at the Slovak Social Network (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27282988
Medicinal Use of Marijuana: What School Nurses Need to Know (abst–2016)  http://nas.sagepub.com/content/31/3/170.long
The Effect of Medical Marijuana on Sickness Absence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27416978
A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26750641
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
Dental treatment planning considerations for patients using cannabis: A case report (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26768516
Chapter 2 – Biosynthesis and Pharmacology of Phytocannabinoids and Related Chemical Constituents (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000023
Chapter 3 – Medical Cannabis Formulations (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000035
Chapter 4 – Analytical Methods in Formulation Development and Manufacturing (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000047
Chapter 6 – The Roles of Research and Regulation (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000060
Chapter 7 – The Future of Cannabinoid Therapeutics (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000072
The Changing Drug Culture: Medical and Recreational Marijuana (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26881768
Cannabinoids: Medical implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26912385
Cannabis – Position Paper of the German Respiratory Society (DGP) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935046
Cannabis in Pain Treatment: Clinical & Research Considerations (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26961090
Weeding Out the Truth: Adolescents and Cannabis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26985645
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26889611
Medical cannabis associated with decreased opiate medication use in retrospective crosssectional survey of chronic pain patients (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27001005
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target (abst–2016) http://www.eurekaselect.com/141330/article
“Those edibles hit hard”: Exploration of Twitter data on cannabis edibles in the U.S. (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716%2816%2930056-4/abstract
Pain, Cannabis Species, and Cannabis Use Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27172585
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
The Use of Medical Marijuana in Cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215434
Need for Methods to Investigate Endocannabinoid Signaling (abst–2016) http://link.springer.com/protocol/10.1007%2F978-1-4939-3539-0_1

Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method (abst–2016) http://www.sciencedirect.com/science/article/pii/S0731708516302722
Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27285147
Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262964
MEDICINAL CANNABIS LAW REFORM IN AUSTRALIA (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27323630
Pediatric oncology providers and use of medical marijuana in children with cancer (abst–2016) http://meetinglibrary.asco.org/content/170798-176
Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27389672
Qualitative research in Spanish cannabis social clubs: “The moment you enter the door, you are minimising the risks” (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27461986
Early Survey Results from the Minnesota Medical Cannabis Program (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27464390
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475408
Evidence-based policy? The re-medicalization of cannabis and the role of expert committees in the UK, 1972-1982 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27477790
Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27492746 Targeting the endocannabinoid system: future therapeutic strategies (abst–2016) http://www.sciencedirect.com/science/article/pii/S1359644616302926
The Dangerous Drugs Act Amendment in Jamaica: Reviewing goals, implementation, and challenges (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27596698
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27530738
State Medical Marijuana Laws and the Prevalence of Opioids Detected Among Fatally Injured Drivers (abst–2016) http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2016.303426?journalCode=ajph
Medical Marijuana: Just the Beginning of a Long, Strange Trip? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27660328
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26809974
Cannabis: A Treasure Trove or Pandora’s Box? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27719666
Clearing the haze: the complexities and challenges of research on state marijuana laws (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27723946
Prevalence and correlates of “Vaping” as a route of cannabis administration in medical cannabis patients (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27770657
Pseudo-Underage Assessment of Compliance With Identification Regulations at Retail Marijuana Outlets in Colorado (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27797687
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27842047
Medical Cannabis – another piece in the mosaic of autoimmunity? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27859024
Understanding and learning from the diversification of cannabis supply laws (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27891693
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27919478
Phytocannabinoids: a growing family of plant natural products with increasing pharmacological and clinical importance (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596088
Substance Use, Health, and Functioning Characteristics of Medical Marijuana Program Participants Compared to the General Adult Population in Ontario (Canada) (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28001910
Storage and disposal of medical cannabis among patients with cancer: Assessing the risk of diversion and unintentional digestion (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27420392
US Traffic Fatalities, 1985–2014, and Their Relationship to Medical Marijuana Laws (abst–2016) http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2016.303577
Cannabinoids – a new weapon against cancer? (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/28100841
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst-2016) http://www.epilepsybehavior.com/article/S1525-5050(16)30334-1/fulltext
Cannabinoids for treatment of glaucoma (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26840343
Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with  HIV: a systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27267445
Pain in Extrapyramidal Neurodegenerative Diseases (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27623111
Islamic theology and the principles of palliative care (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27109307
Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst–2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/
Migraine Frequency Decreased by Medical Marijuana (news & abst–2016) http://neurosciencenews.com/medical-marijuana-migraine-3440/
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and  Recommendations for Research (book-link to PDF–2017)  https://www.ncbi.nlm.nih.gov/books/NBK423845/
Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey (full–2017) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0129-7 Cannabinoid concentrations in Canada’s regulated medical cannabis industry (full–2017) http://onlinelibrary.wiley.com/doi/10.1111/add.13738/full
Cannabis in Chinese Medicine: Are Some Traditional Indications Referenced in Ancient  Literature Related to Cannabinoids? (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00108/full
Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory  Phytocompounds (full–2017) http://www.mdpi.com/1422-0067/18/4/709/htm
Pharmacogenetics of Cannabinoids (full–2017)  https://link.springer.com/article/10.1007%2Fs13318-017-0416-z

Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65755/
Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives (full–2017)  http://meetinglibrary.asco.org/record/140727/edbook#fulltext
Two steps forward, one step back: current harm reduction policy and politics in the  United States (full–2017)  https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-017-0157-y
Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312634/
The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law (full–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30585-6/fulltext
Medical use of cannabis in Switzerland: analysis of approved exceptional licences (full–2017) https://smw.ch/article/doi/smw.2017.14463
Cannabis and Multiple Sclerosis—The Way Forward (full–2017)  http://journal.frontiersin.org/article/10.3389/fneur.2017.00299/full
Understanding Patients’ Process to Use Medical Marijuana: A Southern New Jersey
Community Engagement Project full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513646/
An Australian nationwide survey on medicinal cannabis use for epilepsy: History of  antiepileptic drug treatment predicts medicinal cannabis use (full–2017)  http://www.epilepsybehavior.com/article/S1525-5050(17)30073-2/fulltext
Cannabis as a substitute for prescription drugs – a cross-sectional study (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422566/
Measuring cannabis consumption: Psychometric properties of the Daily Sessions,  Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446174/
Cannabis Users’ Recommended Warnings for Packages of Legally Sold Cannabis: An  Australia-Centered Study (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531364/
Training and Practices of Cannabis Dispensary Staff (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531366/
Cannabis and Pain: A Clinical Review (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549367/
A Guide to the National Academy of Science Report on Cannabis: An Exclusive Discussion with Panel Members (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569624/

Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569620/
Challenges towards Revitalizing Hemp: A Multifaceted Crop (full–2017)  http://www.cell.com/trends/plant-science/fulltext/S1360-1385(17)30177-2
The current status of artisanal cannabis for the treatment of epilepsy in the United States (full–2017)  https://www.projectcbd.org/sites/projectcbd/files/downloads/the_current_status_of_artisanal_cannabis_for_the_treatment_of_epilepsy_in_the_united_states.pdf
Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use (full–2017)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Physicians-in-training are not prepared to prescribe medical marijuana (full–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30441-6/fulltext
Are dispensaries indispensable? Patient experiences of access to cannabis from medical
cannabis dispensaries in Canada (full–2017)  http://www.ijdp.org/article/S0955-3959(17)30150-0/fulltext
Patterns of Twitter Behavior Among Networks of Cannabis Dispensaries in California  (full–2017) http://www.jmir.org/2017/7/e236/
Cannabinoids in Pain Management and Palliative Medicine (full–2017)  https://www.aerzteblatt.de/int/archive/article?id=193441
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders (full–2017) http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of  Hospitalization due to Vaso-Occlusive Crises (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627667/
Expert Panel on Understanding Cannabis: Medicine, Society, Government (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657088/
Cannabis use in persons with traumatic spinal cord injury in Denmark (full-2017) https://www.medicaljournals.se/jrm/content/html/10.2340/16501977-2105
PTSD and Cannabis-Related Coping Among Recent Veterans in New York City (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475281/
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues  for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions,  Possibilities, and Challenges (full–2017)  https://www.frontiersin.org/articles/10.3389/fimmu.2017.01487/full
Impact of Cannabis Use on Treatment Outcomes among Adults Receiving Cognitive Behavioral Treatment for PTSD and Substance Use Disorders (full–2017)  http://www.mdpi.com/2077-0383/6/2/14/htm
Medical cannabis Q&A (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661684/
Associations between medical cannabis and prescription opioid use in chronic pain  patients: A preliminary cohort study (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187795
Frequency of Cannabis Use Among Primary Care Patients in Washington State (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769869/
The Use of Medical Cannabis with Other Medications: A Review of Safety and Guidelines [Internet] (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29293302
Medical Cannabis in Residential Transition or Addiction Programs: A Review of Clinical
and Cost-Effectiveness and Guidelines [Internet] (full–2017)  https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0097462/
Medical Decision-Making Processes and Online Behaviors Among Cannabis Dispensary  Staff (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570116/
The Role of Cannabinoids in the Treatment of Cancer in Pediatric Patients (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4044
Medical Cannabis for Pain: Anecdote or Evidence (article–2017)  http://www.tandfonline.com/doi/full/10.1080/15360288.2017.1313358
Cannabis Guidelines (article–2017)  https://cjon.ons.org/cjon/21/4/cannabis-guidelines
Cannabis: high time for evidence-based policies (editorial–2017) http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(16)30642-8/fulltext Rocky Mountain High: Preventing Cannabis-Related Injuries (1st page–2017) http://www.jenonline.org/article/S0099-1767(16)30339-7/abstract
Systematic review of safeness and therapeutic efficacy of cannabis in patients with
multiple sclerosis, neuropathic pain, and in oncological patients treated with
chemotherapy (abst in English–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29119763
(full in Italian) http://www.epiprev.it/articolo_scientifico/revisione-sistematica-sull%E2%80%99efficacia-terapeutica-e-la-sicurezza-della-cannabis
Experts’ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured interview study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28040884
Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28089286
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28088054
Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107687 Phytochemistry of Cannabis sativa L. (abst–2017) http://link.springer.com/chapter/10.1007%2F978-3-319-45541-9_1
Traditional uses of medicinal plants reported by the indigenous communities and local herbal practitioners of Bajaur Agency, Federally Administrated Tribal Areas, Pakistan (abst–2017) http://www.sciencedirect.com/science/article/pii/S037887411730197
Social factors in marijuana use for medical and recreational purposes (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28132734
Cannabis cultivation: Methodological issues for obtaining medical-grade product (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30588-1/fulltext
Medical cannabis access, use, and substitution for prescription opioids and other  substances: A survey of authorized medical cannabis patients (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28189912
Cannabidiol: State of the art and new challenges for therapeutic applications (abst–2017) http://www.sciencedirect.com/science/article/pii/S0163725817300657
Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A  literature review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28245077
Cannabinoid signaling in health and disease (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28263083
Observations of the role of science in the United States medical cannabis state policies:
Lessons learnt (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28190671
The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0376871617300881
Opioid-sparing Effect of Cannabinoids: A Systematic Review and Meta-analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28327548
Development of a rapid LC-MS/MS method for the quantification of cannabidiol,  cannabidivarin, Δ9-tetrahydrocannabivarin and cannabigerol in mouse peripheral tissues (abst–2017) http://pubs.acs.org/doi/abs/10.1021/acs.analchem.7b01094
Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28340421
Chronic Pain Patients’ Perspectives of Medical Cannabis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28328576
Self-medication with cannabidiol oil in a patient with primary lateral sclerosis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28397674
Marijuana on the Mind? The Impact of Marijuana on Cognition, Brain Structure, and  Brain Function, and Related Public Policy Implications (abst–2017)  http://journals.sagepub.com/doi/full/10.1177/2372732216684851
Cannabinoids as Modulators of Cell Death: Clinical Applications and Future Directions  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28425013
Cannabis: a neurological remedy or a drug of abuse in India (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28440191
State and National Contexts in Evaluating Cannabis Laws: A Case Study of Washington  State (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28458396
Cannabis Use, Medication Management and Adherence Among Persons Living with HIV (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28456895
Medical cannabis use among patients with chronic pain in an interdisciplinary pain  rehabilitation program: Characterization and treatment outcomes (abst–2017)  http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(16)30261-6/fulltext
Cannabidiol in Medical Marijuana: Research Vistas and Potential Opportunities (abst–2017) http://www.sciencedirect.com/science/article/pii/S1043661817303559?via%3Dihub
Bioethical analysis to the therapeutic use of Cannabis: Integrative review (abst–2017) http://journals.sagepub.com/doi/abs/10.1177/0969733017703699
Therapeutic potential of Cannabis sativa (abst in English–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28548193 (full in Spanish)  http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000300010&lng=en&nrm=iso&tlng=en
The Cannabis Information Helpline: Assessing Interest in the Medicinal Use of Cannabis  in Australia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28557590
Mapping regulatory models for medicinal cannabis: a matrix of options (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28553995
Analysis of Natural Product Regulation of Cannabinoid Receptors in the treatment of  Human Disease (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0163725817301511
Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance  and Medication Use, and Health and Disability Characteristics (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28595191
Marijuana Use in the Elderly: Implications and Considerations (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28595684
Attitudes Toward Medical Cannabis Legalization Among Serbian Medical Students (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605305
Loose regulation of medical marijuana programs associated with higher rates of adult  marijuana use but not cannabis use disorder (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28600874
The association of cannabis use on inpatient psychiatric hospital outcomes (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28613973
Utilizing Big Data and Twitter to Discover Emergent Online Communities of Cannabis  Users (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28615950
Daily-level associations between PTSD and cannabis use among young sexual minority  women (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28618391
Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28636769
Medical Cannabis in Serbia: The Survey of Knowledge and Attitudes in an Urban Adult  Population (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28632077
Effects of the 2009 Medical Cannabinoid Legalization Policy on Hospital Use for  Cannabinoid Dependency and Persistent Vomiting (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28711691
Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28696583
Cannabis use, attitudes, and legal status in the U.S.: A review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28705601
Perioperative Patient Beliefs Regarding Potential Effectiveness of Marijuana  (Cannabinoids) for Treatment of Pain: A Prospective Population Survey (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28796754
Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28811049
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28811670
Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads (abst–2017) http://www.sciencedirect.com/science/article/pii/S1054358917300273?via%3Dihub
The potential role of cannabinoids in epilepsy treatment (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28845714
How Does Marijuana Effect Outcomes After Trauma in ICU Patients? A Propensity  Matched Analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28787375
Cannabis use in Epilepsy. Current situation in Argentina and abroad (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28898306
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and  the ugly (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28905873
Preferences for Medical Marijuana over Prescription Medications Among Persons Living  with Chronic Conditions: Alternative, Complementary, and Tapering Uses (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28945457
The Current Landscape of Marijuana and Pharmacogenetics (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28975060
Cannabis and Cannabinoids for Chronic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28983880
Textual research on Han-Chinese formulae collected in Tubo medical manuscript  unearthed in ‘Bum-pa-Che Tower (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28103984
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain  management – An overview of systematic reviews (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29034533
Argentina enacts first law on medical use of the cannabis plant. History and perspectives (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29044015
Cannabinoids concentration variability in cannabis olive oil galenic preparations (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29057480
Medical cannabis for the treatment of chronic pain and other disorders: misconceptions  and facts (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29067992
Social factors in marijuana use for medical and recreational purposes (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30618-7/fulltext
Traditional uses of medicinal plants reported by the indigenous communities and local  herbal practitioners of Bajaur Agency, Federally Administrated Tribal Areas, Pakistan  (abst–2017) http://www.sciencedirect.com/science/article/pii/S0378874117301976?via%3Dihub
Medical Cannabinoids in Children and Adolescents: A Systematic Review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29061872
Knowledge, Skills, and Attitudes Regarding the Use of Medical Cannabis in the Hospice  Population: An Educational Intervention (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29121790
Pharmacological Foundations of Cannabis Chemovars (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29161743
Simple and fast gas-chromatography mass spectrometry assay to assess delta 9-
tetrahydrocannabinol and cannabidiol in dogs treated with medical cannabis for canine  epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29173160
Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories:
focus on cannabinoids and ketamine (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4793-4
Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29185555
Therapeutic use of Δ9-THC and cannabidiol: evaluation of a new extraction procedure  for the preparation of cannabis-based olive oil (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29189144
Preliminary Evidence on Cannabis Effectiveness and Tolerability for Adults With  Tourette Syndrome (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28464701
A prospective observational study of problematic oral cannabinoid use (abst–2017) 
https://link.springer.com/article/10.1007%2Fs00213-017-4811-6
Practical considerations in medical cannabis administration and dosing (abst–2017)  http://www.ejinme.com/article/S0953-6205(18)30004-9/fulltext
Preserving the independence of people living with multiple sclerosis towards the end of  life (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29087751
“Retweet to Pass the Blunt”: Analyzing Geographic and Content Features of Cannabis Related Tweeting Across the United States (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29087826
Regulating Hemp and Cannabis-Based Products (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29095577
Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender,  2004-2013 (abst–2017) https://link.springer.com/article/10.1007%2Fs11121-017-0848-3
Smartphone-based ecological momentary assessment (EMA) of alcohol and cannabis use  in older adults with and without HIV infection (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317303878?via%3Dihub
Cannabis use disorder and male sex predict medical cannabis card status in a sample of  high risk adolescents (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30562-8/fulltext
Associations between medical cannabis and other drug use among unstably housed  women (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29227883
Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis (abst–2017) https://link.springer.com/article/10.1007%2Fs00415-017-8715-5
The three betrayals of the medical cannabis growing activist: From multiple victimhood  to reconstruction, redemption and activism (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29287224
Cannabis and epilepsy: An ancient treatment returns to the fore (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1525505016304127
The effect of medical marijuana laws on the health and labor supply of older adults:  Evidence from the Health and Retirement Study (abst–2017)  http://www.nber.org/papers/w22688
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep  (abst–2017) http://journals.sagepub.com/doi/abs/10.1177/0269881117699616
The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity  and Improved Executive Function after 3 Months of Treatment (full–2018)  https://www.frontiersin.org/articles/10.3389/fphar.2017.00983/full
Could cannabis liberalisation lead to wider changes in drug policies and outcomes? (full–2018) http://www.ijdp.org/article/S0955-3959(17)30324-9/fulltext
Contemporary Routes of Cannabis Consumption: A Primer for Clinicians (full–2018) http://jaoa.org/article.aspx?articleid=2671435
Cannabis in Parkinson’s Disease: Hype or help? (abst in German & English–2018)  https://www.thieme-connect.com/DOI/DOI?10.1055/s-0043-120668
The therapeutic effects of Cannabis and cannabinoids: An update from the National  Academies of Sciences, Engineering and Medicine report (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29325791
Medical use of cannabis and cannabinoids containing products – Regulations in Europe  and North America (abst–2018) http://www.ejinme.com/article/S0953-6205(18)30001-3/fulltext
The role of cannabinoids in pain control: the good, the bad, and the ugly (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29338150
Medical Marijuana: Current Concepts, Pharmacological Actions of Cannabinoid Receptor Mediated Activation, and Societal Implications (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29349551
Medical Cannabis: The Oncology Nurse’s Role in Patient Education About the Effects of  Marijuana on Cancer Palliation (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29350699
The Achilles Heel of Medical Cannabis Research—Inadequate Blinding of Placebo Controlled Trials (abst–2018)  https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2663856?redirect=true
HIV-infected cannabis users have lower circulating CD16+ monocytes and IFN-γ-
inducible protein 10 levels compared with nonusing HIV patients (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29194121
Medical cannabis: A forward vision for the clinician (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29377381
Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29338578
Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early  Observation (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29339959
Cannabis Use, Lung Cancer, and Related Issues (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29374567
Medical Cannabis for Neuropathic Pain (abst–2018)  https://link.springer.com/article/10.1007%2Fs11916-018-0658-8
Medical use of cannabis and cannabinoids containing products – Regulations in Europe
and North America (abst–2018) http://www.ejinme.com/article/S0953-6205(18)30001-3/fulltext
The therapeutic effects of Cannabis and cannabinoids: An update from the National  Academies of Sciences, Engineering and Medicine report (abst–2018)  http://www.ejinme.com/article/S0953-6205(18)30003-7/fulltext


MELANOGENESIS
Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB(1)  receptors: a keratinocyte-dependent effect (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21298280
Endocannabinoids Stimulate Human Melanogenesis via Type-1 Cannabinoid Receptor  (full–2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346111/
Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating  p38 MAPK and p42/44 MAPK (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28601556


MENINGITIS*
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis (full–2012) http://www.sciencedirect.com/science/article/pii/S0014299912008485
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390

Cryptococcal meningitis in a daily cannabis smoker without evidence of
immunodeficiency (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29374632


MENOPAUSE/OVARIECTOMY*+
The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle (full-2010) http://www.fertstert.org/article/S0015-0282%2808%2904739-0/fulltext
The effects of Cannabis sativa L. seed (hemp seed) in the ovariectomized rat model of menopause (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21069097
The type 2 cannabinoid receptor protects against age-related bone loss and ovariectomy induced bone loss by stimulating bone formation (abst–2010) http://www.thebonejournal.com/article/S8756-3282%2810%2900619-8/abstract
The Type 2 Cannabinoid Receptor Regulates Bone Mass and Ovariectomy-Induced Bone Loss by Affecting Osteoblast Differentiation and Bone Formation (full–2011) http://press.endocrine.org/doi/full/10.1210/en.2010-0930
Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women? (full–2011)  http://www.nature.com/ijo/journal/v35/n3/full/ijo2010145a.html
Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21480765
top
Circulating endocannabinoids in insulin sensitive vs Insulin resistant obese post-menopausal women. A MONET group study (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/oby.20498/full
Pathophysiology of Human Visceral Obesity: An Update (full–2013)  http://physrev.physiology.org/content/93/1/359.long
New insights into the physiology of bone regulation: the role of neuro-hormones (full–2014) http://www.biomed.cas.cz/physiolres/pdf/prepress/932668.pdf
Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25268406
Dose-response estrogen promotes osteogenic differentiation via GPR40 (FFAR1) in murine BMMSCs (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25576830
Effects of CB1 receptor agonism and antagonism on behavioural fear and physiological stress responses in adult intact, ovariectomized, and estradiol-replaced female rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26311003

Ovariectomy Alters Gene Expression of the Hippocampal Formation in Middle-Aged Rats (link to PDF–2016) http://press.endocrine.org/doi/10.1210/en.2016-1516?url_ver=Z39.88-2003&rfr_id=ori%3Arid %3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Circulating levels of endocannabinoids and oxylipins altered by dietary lipids in older women are likely associated with previously identified gene targets (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302013


METABOLIC SYNDROME
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant  for administration by ingestion or other means (Health Canada) (full–2010)  http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20851297
Cannabinoid CB1 receptor expression in relation to visceral adipose depots,  endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G  variant in humans (abst–2010) http://www.metabolismjournal.com/article/S0026-0495(09)00408-9/abstract
385 C/A polymorphism of the fatty acid amide hydrolase gene is associated with metabolic syndrome in the Chinese Han population (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258756/
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome (full–2011) http://ajpendo.physiology.org/content/300/4/E681.long
Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20838400
Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects  (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048484/?tool=pubmed
Greasing the wheels of managing overweight and obesity with omega-3 fatty acids (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210336/
Roles of G1359A polymorphism of the cannabinoid receptor gene (CNR1) on weight loss  and adipocytokines after a hypocaloric diet (full in English, abst in Spanish–2011)  http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112011000200012&lng=en&nrm=iso&tlng=en
The potential use of cannabidiol in the therapy of metabolic syndrome (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22430005
The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome (full–2013) http://www.cell.com/cell-reports/fulltext/S2211-1247%2813%2900507-X
Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23932644
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23422373
Impaired hypotensive responses induced by intrathecally injected drugs in fructose-fed rats (abst–2013) https://www.ncbi.nlm.nih.gov/pubmed/23499700
The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995979/
Development and validation of an HPLC-MS method for the simultaneous quantification of key oxysterols, endocannabinoids, and ceramides: variations in metabolic syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26563111
Host Neuro- Immuno-Endocrine Responses In Periodontal Disease (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24588827
top
Management of non-alcoholic fatty liver disease in 2015 (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691699/
Development and validation of an HPLC-MS method for the simultaneous quantification  of key oxysterols, endocannabinoids, and ceramides: variations in metabolic syndrome  (abst–2015) https://link.springer.com/article/10.1007%2Fs00216-015-9150-z
Approaches for the development of drugs for treatment of obesity and metabolic syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26648466
The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease  (abst–2015) http://www.cell.com/trends/endocrinology-metabolism/fulltext/S1043-2760(15)00140-X
Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data (abst–2016) http://www.sciencedirect.com/science/article/pii/S0002934315010244
Endocannabinoids in Feeding Behavior and Energy Homeostasis (full–2016) http://themedicalbiochemistrypage.org/endocannabinoids.php
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Metabolic syndrome in people with a psychotic illness: is cannabis protective? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965714
Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
Cannabimimetic phytochemicals in the diet – an evolutionary link to food selection and metabolic stress adaptation? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27891602
Marijuana Use and Type 2 Diabetes Mellitus: a Review (abst–2016)  https://link.springer.com/article/10.1007%2Fs11892-016-0795-6
Endocannabinoid tone is higher in healthy lean South Asian than white Caucasian men  (full–2017) https://www.nature.com/articles/s41598-017-07980-5
MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future (full–2017) http://www.eje-online.org/content/176/6/R309.long
Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke  Prevention (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665427/
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and  prebiotics (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655955/
Cannabinoids in the Cardiovascular System (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1054358917300431?via%3Dihub
Prospects for the Use of Cannabinoid Receptor Ligands for the Treatment of Metabolic  Syndrome and Atherosclerosis: Analysis of Experimental and Clinical Data (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29308855
Role of Endocannabinoids on Sweet Taste Perception, Food Preference, and Obesity related Disorders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29293950
Peripheral modulation of the endocannabinoid system in metabolic disease (abst–2018)  https://www.sciencedirect.com/science/article/pii/S1359644617304154?via%3Dihub


METHODS OF USE-CAPSULES*+
Standardized Cannabis in Multiple Sclerosis: A Case Report (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?tool=pubmed
Getting high on the endocannabinoid system (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics (abst–2015) http://link.springer.com/article/10.1007/s40262-014-0195-5
Free and Glucuronide Whole Blood Cannabinoids’ Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27899456
Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans:  Comment on Merrick et al. Cannabis and Cannabinoid Research 2016;1(1):102–112;
DOI: 10.1089/can.2015.0004 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531368/
Conversion of Cannabidiol Following Oral Administration: Authors’ Response to  Grotenhermen et al. DOI: 10.1089/can.2016.0036 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569618/
A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510776/
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28138971


METHODS OF USE-‘DABS’/HASH OIL/CONCENTRATES
Decarboxilation (article–undated) http://theweedscene.com/recipe/decarboxilation/
How-to: Paleo’s Potent Cannabis Oil (Edibles Technique) (forum post–2011)  http://boards.cannabis.com/recipes/194281-how-paleos-potent-decarboxylated-cannabis-oil-edibles-technique.html
Controlled cannabis decarboxylation – Patent US2012046352 (A1) ― 2012-02-23 (full–2012) http://worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012046352A1&KC=A1&FT=D&ND=3&date=20120223&DB=EPODOC&locale=en_EP
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic  Profile in Healthy Male Subjects (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22411724
A new method of cannabis ingestion: The dangers of dabs? (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24930049
The Dabbing Dilemma: A Call for Research on Butane Hash Oil and Other Alternate Forms of Cannabis Use (full–2015) https://www.researchgate.net/publication/280691408_The_Dabbing_Dilemma_A_Call_for_Research_on_Butane_Hash_Oil_and_Other_Alternate_Forms_of_Cannabis_Use
“Time for dabs”: Analyzing Twitter data on marijuana concentrates across the U.S. (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581982/
Butane Hash Oil Burns Associated with Marijuana Liberalization in Colorado (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675612/
Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing (link to PDF–2015)
https://www.jstage.jst.go.jp/article/jts/40/6/40_797/_article
Dabble With Danger: A Case Of Severe Respiratory Failure Following Inhalation Of Butane Hash Oil (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4596
Displays of dabbing marijuana extracts on YouTube (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26347408
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to
marijuana? (full – 2016)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/
Tracking Dabbing Using Search Query Surveillance: A Case Study in the United States (full–2016) http://www.jmir.org/2016/9/e252/
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Establishment of a New Drug Code for Marihuana Extract. Final rule (full–2016) https://www.federalregister.gov/documents/2016/12/14/2016-29941/establishment-of-a-new-drug-code-formarihuana-extract
A content analysis of tweets about high-potency marijuana (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983477/
A Case of Butane Hash Oil (Marijuana Wax)-Induced Psychosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820171
Exploring Butane Hash Oil Use: A Research Note (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26800050
Cannabis-induced psychosis associated with high potency “wax dabs” (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876313
Measuring cannabis consumption: Psychometric properties of the Daily Sessions,
Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446174/
Vaping medical marijuana (full–2017)  http://www.tandfonline.com/doi/full/10.1080/00325481.2018.1413281
To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679763/
“Tree-in-Bloom”: Severe Acute Lung Injury Induced by Vaping Cannabis Oil (1st page–2017) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201612-974LE
User characteristics and effect profile of Butane Hash Oil: An extremely high-potency  cannabis concentrate (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30255-7/fulltext
A little “dab” will do ya’ in: a case report of neuro-and cardiotoxicity following use of  cannabis concentrates (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28644052
Characterizing marijuana concentrate users: A web-based survey (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30311-3/fulltext
Associations between butane hash oil use and cannabis-related problems (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30339-3/fulltext
Evaluation of Cannabinoid and Terpenoid Content: Cannabis Flower Compared to  Supercritical CO2 Concentrate (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28926863
top


METHODS OF USE-DECARBOXYLATION
Decarboxilation (article–undated) http://theweedscene.com/recipe/decarboxilation/
How-to: Paleo’s Potent Decarboxylated Cannabis Oil (Edibles Technique) (forum post–2011) http://boards.cannabis.com/recipes/194281-how-paleos-potent-decarboxylated-cannabis-oil-ediblestechnique.html
Controlled cannabis decarboxylation – Patent US2012046352 (A1) ― 2012-02-23 (full–2012) http://worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012046352A1&KC=A1&FT&ND=3&date=20120223&DB=EPODOC&locale=en_EP
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic  Profile in Healthy Male Subjects (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22411724
Potency 101 (printable card set–2015) (good info!) http://greenstyleconsulting.com/potency-101/
Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis (full–2016)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147286
Contactless decontamination of hair samples: cannabinoids (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27074965
Decarboxylation Study of Acidic Cannabinoids: A Novel Approach Using Ultra-High Performance Supercritical Fluid Chromatography/Photodiode Array-Mass Spectrometry  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549281/
Evaluation of cannabinoids concentration and stability in standardized preparations of
cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem  mass spectrometry (abst–2017) https://www.degruyter.com/view/j/cclm.ahead-of-print/cclm-2016-1060/cclm-2016-1060.xml


METHODS OF USE-E-CIGARETTES/VAPE PENS
High School Students’ Use of Electronic Cigarettes to Vaporize Cannabis (full–2015) http://pediatrics.aappublications.org/content/136/4/611.long
E-Cigarettes: A Review of New Trends in Cannabis Use (full–2015) http://www.mdpi.com/1660-4601/12/8/9988
Vaping cannabis (marijuana): parallel concerns to e-cigs? (full – 2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860523/

Confirmation of the trials and tribulations of vaping (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13155/full
How beneficial is vaping cannabis to respiratory health compared to smoking? (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full

Electronic cigarettes and cannabis: an exploratory study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25613866
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00279/full
Tracking Dabbing Using Search Query Surveillance: A Case Study in the United States (full–2016) http://www.jmir.org/2016/9/e252/

Medical cannabis use in Canada: vapourization and modes of delivery (full–2016) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9 Analysis of a commerical marijuana e-cigarette formulation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867395/
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to  marijuana? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/
Prevalence of Use of Electronic Nicotine Delivery Systems (ENDS) to Vape Recreational Drugs by Club Patrons in South London (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27599520
Prevalence and Correlates of Vaping Cannabis in a Sample of Young Adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27631612
Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398321/
Vaping medical marijuana (full–2017)  http://www.tandfonline.com/doi/full/10.1080/00325481.2018.1413281
Youth use of electronic vapor products and blunts for administering cannabis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28214740
Predictors of Adult E-Cigarette Users Vaporizing Cannabis Using E-Cigarettes and Vape-Pens (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28323498
Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative  analysis of serum drug concentrations (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28393558
Characterizing marijuana concentrate users: A web-based survey (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30311-3/fulltext
A Cloud on the Horizon – A survey into the use of electronic vaping devices for  recreational drug and new psychoactive substance (NPS) administration (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29025078


METHODS OF USE-EDIBLES (GENERAL)*+
Congenital cataracts (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/819/
Cannabis as a Unique Functional Food (full–2011) http://apothecary-genetics.spruz.com/gfile/75r4!-!HLKELE!-!svyr5/cannabis_as_a_unique_functional_food.pdf
US Patent Application 20110097283 – CHEWING GUM COMPOSITIONS COMPRISING CANNABINOIDS (full–2011) http://www.google.com/patents/US20110097283
Simultaneous determination of delta-9-tetrahydrocannabinol cannabidiol and cannabinol in edible oil using ultra performance liquid chromatography-tandem mass spectrometry (abst–2011) http://tinyurl.com/p8rv8ug
Accidental cannabis poisoning in children: report of four cases in a tertiary care center
from southern Spain (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/21283933/abstract/%5BAccidental_cannabis_poisoning_in_children:_report_of_four_cases_in_a_tertiary_care_center_from_southern_Spain%5D_
top

Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites in urine (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/20634020/abstract/Prolonged_coma_in_a_child_due_to_hashish_ingestion_with_quantitation_of_THC_metabolites_in_urine_
Acute cannabis poisoning in a 10-month-old infant (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22652516
Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized medical marijuana: 125 dogs (2005-2010) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23216842
The Oral Cannabis Poisoning of the Child (About 36 Cases) (full–2014)  https://www.omicsonline.org/open-access/the-oral-cannabis-poisoning-of-the-child-about-cases-2150-3494.1000086.php?aid=29927%253Fabstract_id=29927
“Disease Modifying Nutricals” for multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25435020
Notes from the Field: Death Following Ingestion of an Edible Marijuana Product – Colorado, March 2014 (full–2015) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6428a6.htm
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675604/
With education, nurses can help to bridge the marijuana gap (article–2015) http://cannabistoday.bangordailynews.com/2015/07/09/home/with-education-nurses-can-help-to-bridgethe-marijuana-gap/
Half-Baked — The Retail Promotion of Marijuana Edibles (article–2015) http://www.nejm.org/doi/full/10.1056/NEJMp1416014
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products (letter–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338239
Potency 101 (printable card set–2015) (good info!) http://greenstyleconsulting.com/potency-101/
When Weed Is The Cure: A Doctor’s Case for Medical Marijuana (interview–2015) http://www.npr.org/sections/health-shots/2015/07/14/422876973/when-weed-is-the-cure-a-doctors-casefor-medical-marijuana?utm_medium=RSS&utm_campaign=authorinterviews
Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid (full–2016) http://online.liebertpub.com/doi/10.1089/can.2015.0004 High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana (full–2016) https://www.hindawi.com/journals/crit/2016/4028492/
Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines (full–2016) http://www.ajtr.org/files/ajtr0030292.pdf
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Smoking, vaping, eating: Is legalization impacting the way people use cannabis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010515/
Tasty THC: Promises and Challenges of Cannabis Edibles (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260817/
Edible Cannabis Products: It is Time for FDA Oversight (full–2016)  http://www.accp1.org/documents/2016BenjaminEdibleCannabisProducts.pdf
The use of medical-grade cannabis in patients non-responders to Nabiximols (1st page–2016) http://www.jns-journal.com/article/S0022-510X(16)30472-5/abstract
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population  (abst–2016) http://onlinelibrary.wiley.com/doi/10.1002/phar.1673/full
“Those edibles hit hard”: Exploration of Twitter data on cannabis edibles in the US (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716%2816%2930056-4/abstract
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method (abst–2016) http://www.sciencedirect.com/science/article/pii/S0731708516302722
Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27647820
Accidental cannabis poisoning in the elderly (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27900531
“It Takes Longer, but When It Hits You It Hits You!”: Videos About Marijuana Edibles on YouTube (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502544/
Measuring cannabis consumption: Psychometric properties of the Daily Sessions,  Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446174/
Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans:  Comment on Merrick et al. Cannabis and Cannabinoid Research 2016;1(1):102–112;DOI: 10.1089/can.2015.0004 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531368/
Conversion of Cannabidiol Following Oral Administration: Authors’ Response to  Grotenhermen et al. DOI: 10.1089/can.2016.0036 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569618/
A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510776/
Cannabis use among patients at a comprehensive cancer center in a state with legalized  medicinal and recreational use (full–2017)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Consumer use and understanding of labelling information on edible marijuana products  sold for recreational use in the states of Colorado and Washington (full–2017)  http://www.ijdp.org/article/S0955-3959(17)30008-7/fulltext
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the  intestinal lymphatic system and prominent immunomodulation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674070/
The Unintended Consequences of Marijuana Legalization (full–2017)  http://www.jpeds.com/article/S0022-3476(17)31081-8/fulltext
Are THC Levels in Oral Fluids and Blood Plasma Comparable after Oral Ingestion of  Edibles Containing Cannabis or THC? (1st page-2017)  http://clinchem.aaccjnls.org/content/early/2017/01/13/clinchem.2016.269795.long
Edible Marijuana Labeling and Packaging (1st page–2017)  http://journals.sagepub.com/doi/full/10.1177/0009922817691824
Evaluation of divided attention psychophysical task performance and effects on pupil
sizes following smoked, vaporized and oral cannabis administration (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28138971
How four U.S. states are regulating recreational marijuana edibles (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28343113
Subjective and physiological effects, and expired carbon monoxide concentrations in  frequent and occasional cannabis smokers following smoked, vaporized, and oral  cannabis administration (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30133-3/abstract
Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among  young adults in Colorado: Implications for health education and research (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28449191
U.S. cannabis legalization and use of vaping and edible products among youth (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30184-9/fulltext
Drowsiness and uncommon fever in a child after cannabis ingestion (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28751294
Placebo Effects of Edible Cannabis: Reported Intoxication Effects at a 30-Minute Delay  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28771093
Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing  relationship? (abst–2017) http://www.ijdp.org/article/S0955-3959(17)30292-X/fulltext
Death by self-mutilation after oral cannabis consumption (abst–2017)  http://www.legalmedicinejournal.com/article/S1344-6223(17)30258-4/fulltext
Therapeutic use of Δ9-THC and cannabidiol: evaluation of a new extraction procedure  for the preparation of cannabis-based olive oil (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29189144
Cannabis Intoxication Case Series: The Dangers of Edibles Containing  Tetrahydrocannabinol (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29103798
Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29300962


METHODS-EDIBLES (BEVERAGES, CANNABIS TEA)*+
Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian  cohort of 614 patients (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449133/
Evaluation of cannabinoids concentration and stability in standardized preparations of  cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem  mass spectrometry (abst–2017) https://www.degruyter.com/view/j/cclm.ahead-of-print/cclm-2016-1060/cclm-2016-1060.xml
top


METHODS-EDIBLES (FOODS)*+
Recreational use and overdose of ingested processed cannabis (Majoon Birjandi) in the eastern Iran (full–2012)  https://www.academia.edu/28376303/Recreational_use_and_overdose_of_ingested_processed_cannabis_Majoon_Birjandi_in_the_eastern_Iran
Cannabis Oil : chemical evaluation of an upcoming cannabis based medicine (full–2013) http://www.cannabis-med.org/data/pdf/en_2013_01_1.pdf
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251&resultClick=24
Half-Baked – The Retail Promotion of Marijuana Edibles (article–2015) http://www.nejm.org/doi/full/10.1056/NEJMp1416014
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products (letter–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338239
Stability of Tetrahydrocannabinol and Cannabidiol in Prepared Quality Control Medible Brownies (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27798074
Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition
and Relation to Pharmacodynamic Outcomes (brownies) (full–2017) https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bkx012
Extraction Method and Analysis of Cannabinoids in Cannabis Olive Oil Preparations (link to 1st page–2017) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0043-123074
Evaluation of cannabinoids concentration and stability in standardized preparations of  cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem  mass spectrometry (abst–2017) https://www.degruyter.com/view/j/cclm.ahead-of-print/cclm-2016-1060/cclm-2016-1060.xml
Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ9-Tetrahydrocannabinol in Blood and Oral Fluid following Cannabis Brownie Administration (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28188235
Cannabinoids concentration variability in cannabis olive oil galenic preparations (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29057480
Cannabis Intoxication Case Series: The Dangers of Edibles Containing  Tetrahydrocannabinol (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29103798


METHODS-EDIBLES (RAW UNHEATED CANNABIS JUICE) +
Cannabis as a Unique Functional Food (full-2011) http://apothecary-genetics.spruz.com/gfile/75r4!-!HLKELE!-!svyr5/cannabis_as_a_unique_functional_food.pdf
No Heat ACTIVE cannabis smoothie recipe…this is real. Experience report (forum post–2015) http://forum.grasscity.com/incredible-edible-herb/1369180-no-heat-active-cannabis-smoothie-recipethisreal-experience-report.html


METHODS-EDIBLES (RECIPES)
Bhang Recipes for Holi (collection- undated) http://www.indiankitchenfood.com/bhang-recipes-holi/
Recipes from “Onlinepot” (collection-undated) http://www.onlinepot.org/recipes.htm
Hemp Seed Recipes (collection-undated) http://manitobaharvest.com/recipes.html
{{Easy}} How to prepare Bhang Receipes at home Easily (collection- undated) http://www.theholi.com/2015/03/how-to-prepare-bhang-receipes.html
Edible Marijuana Recipes (collection-undated) http://theweedscene.com/edible-recipes/
5 Cannabis Recipes That You Need to Try This Spring (collection-undated)  https://www.leafly.com/news/food-travel-sex/5-cannabis-recipes-that-you-need-to-try-this-spring
Alice B. Toklas brownies: the recipe! (recipe–1994) http://www.straightdope.com/columns/read/880/alice-b-toklas-brownies-the-recipe
Cannabis Recipes (forum thread/collection–2004) http://www.icmag.com/ic/showthread.php?t=7602&highlight=elixer
Cannabutter In 7 Easy Steps! (forum thread/ recipe-2005) http://www.icmag.com/ic/showthread.php?t=12895
Moroccan Majoun (recipe–2008) http://www.chowhound.com/recipes/moroccan-majoun-10415
Magical Thai Vegan Soup (news–2008) http://herb.co/recipes/magical-thai-vegan-soup/
IC Recipe Guide (forum thread/ collection-2008)  http://www.icmag.com/ic/showthread.php?t=78074
Spiced Nuts (news–2009) http://herb.co/recipes/spiced-nuts/
Cannabis Cooking Tips From Uncle Buck (article–2010) http://beyondchronic.com/2010/12/cannabis-cooking-tips-uncle-buck/
Marijuana Recipes: Whipped Cannabis Cream (recipe–2010)  https://www.marijuanadoctors.com/blog/marijuana-recipes-whipped-cannabis-cream/
Majoon Recipe (recipe–2010) http://goodandbaked.com/recipes/desserts/majoon-recipe/
Oven-Roasted Chicken Thighs with Green Chili Sauce (recipe–2010)  http://herb.co/recipes/oven-roasted-chicken-thighs-with-green-chili-sauce/
Ask Old Hippie: What Can I Do With Marijuana Cooking Oil? (article–2010) http://beyondchronic.com/2011/09/ask-old-hippie-marijuana-cooking-oil/
top
BadKat’s CannaPharm: Canna Caps, UV Reactive GLOWING Hash Candy, Canna ‘Bombs’ & more (forum post/collection–2011) http://forum.grasscity.com/incredible-edible-herb/742831-badkats-cannapharm-canna-caps-uv-reactiveglowing-hash-candy-canna-bombs-more.html
Jalapeño Pot Poppers (recipe–2011) http://herb.co/recipes/jalape-o-pot-poppers/
How to Cook with Weed (news–2011) https://thebolditalic.com/how-to-cook-with-weed-the-bold-italic-san-francisco-2a779b94a64f
How To Blast Off With Nutella Firecrackers (recipe–2012) http://beyondchronic.com/2012/01/how-to-blast-off-nutella-firecrackers/
Cannabis Decarboxylation – THC Preparation for Unheated Edibles (news–2012) http://www.weedist.com/2012/07/cannabis-decarboxylation-weed-preparation-for-unheated-edibles/
Super Canna Bowl Chili (recipe–2012) http://herb.co/recipes/super-canna-bowl-chili/
Pineapple Express Upside Down Cake (recipe–2012) http://www.foodrepublic.com/recipes/pineapple-express-upside-down-cake/
Kitchen Kush: The best cannabutter in America? Yep, in just 7 easy steps (news–2013) http://www.thecannabist.co/2013/12/27/kitchenweed/1244/
Stoner Sundae: How to Make Weed Ice Cream (news–2013) http://www.thefader.com/2013/07/03/stoner-sundae-how-to-make-weed-ice-cream/
The notorious ‘pot brownie’ recipe from ‘The Alice B. Toklas Cookbook’ (news-2013)  http://dangerousminds.net/comments/the_notorious_pot_brownie_recipe_from_the_alice_b._toklas_cookbook
How To Make Quick & Easy Cannabutter (recipe–2013) http://herb.co/recipes/quick-easy-cannabutter/
One Bunch of Fresh Cannabis Leaves (Underground Pop-Up Weed-Dinner Green Congee) (news/recipe–2013) http://www.newyorker.com/culture/culture-desk/one-bunch-of-fresh-cannabis-leaves
How To Make Cannabis Infused Sweet Potatoes That Are Vegan, Gluten-free (recipe–2013) http://www.medicaljane.com/2014/12/01/how-to-make-vegan-gluten-free-cannabis-infused-sweet-potatoes/
Cooking with Cannabis: How to Make Weed Butter (recipe–2014) http://gizmodo.com/cooking-with-cannabis-how-to-make-weed-butter-1500453696
Cooking With Cannabis: 8 Delicious Marijuana Recipes (collection–2014) http://www.mainstreet.com/article/lifestyle/food-drink/cooking-cannabis-8-delicious-marijuanarecipes?puc=yahoo&cm_ven=YAHOO
Marijuana Spa Products You Can Make at Home (news–2014) https://www.mainstreet.com/article/marijuana-spa-products-you-can-make-home-0
Cooking with Cannabis – Ricotta Stuffed Mushrooms (news–2014)  http://www.bloomwellbend.com/cooking-cannabis-ricotta-stuffed-mushrooms/
Smokin’ mac ’n cheese ultimate comfort food (recipe) (news–2014)  http://www.thecannabist.co/2014/03/03/marijuana-recipe-kitchen-kush-smokin-mac-n-cheese-savor-entree-marijuana-enhanced/3962/
This Thai iced tea puts a different spin on “herbal infusion” (recipe) (news–2014)  http://www.thecannabist.co/2014/08/18/marijuana-recipe-thai-iced-tea-recipe-gives-new-meaning-herbal-infusion/18276/
How to Make Non-Psychoactive Cannabis & Carrot Juice (news–2015) http://www.medicaljane.com/2015/01/14/non-psychoactive-cannabis-carrot-juice-recipe/
top

Not Your Mother’s Pot Brownie (news–2015) http://hereandnow.wbur.org/2015/05/25/pot-ediblesrecipes?utm_medium=RSS&utm_campaign=storiesfromnpr
Mahjoun (Moroccan Hash Jam) (news–2015)
https://munchies.vice.com/en/recipes/mahjoun-moroccan-hash-jam
Cannabis Infused Sugar Cookies: Recipe (news/recipe–2015) https://www.hellomd.com/health-wellness/cannabis-infused-sugar-cookies-recipe 12
Go Ask Alice: The History of Toklas’ Legendary Hashish Fudge (news–2015)  http://blogs.scientificamerican.com/food-matters/go-ask-alice-the-history-of-toklas-8217-legendary-hashish-fudge/
Here’s how to make a marijuana-infused ‘weed turkey’ this Thanksgiving (news–2015) http://fusion.net/story/236079/weed-turkey-thanksgiving-dinner/
OH’s Law Of Cannabis Edible Potency (news–2015)  http://beyondchronic.com/2015/11/ohs-law-of-cannabis-edible-potency/
Golden Delight Drink (news–2015) http://herb.co/recipes/golden-delight/
Tomahawk Rib Eye (news–2015) https://www.thcmag.com/tomahawk-rib-eye/
Medicated Coffee Creamer Recipe (forum post–2015)  http://forum.grasscity.com/incredible-edible-herb/1362946-medicated-coffee-creamer-recipe.html
Delicious Bhang Recipes That You Should Definitely Try Out This Holi (collection–2016) https://www.scoopwhoop.com/bhang-recipes-for-holi/
Make your own cannabutter in seven easy steps [PHOTOS] (news/recipe–2016) http://www.denverpost.com/2016/05/26/cannabutter-marijuana-infused-butter/
Cannabis-Infused Dark Chocolate Coconut Balls (news/recipe–2016) http://www.marijuana.com/blog/news/2016/05/cannabis-infused-dark-chocolate-coconut-balls/

Cannabis Cupcakes (news–2016) https://munchies.vice.com/en/recipes/cannabis-cupcakes
Chewy granola bars are some good-for-you ganja goodness (video recipe) (news–2016)  http://www.thecannabist.co/2014/05/05/marijuana-recipes-granola-bars-chewy-kitchen-kush-raisins-nuts/11149/
How to Make a Great-Tasting Cannabis Smoothie (news–2016)  http://www.esquire.com/food-drink/drinks/recipes/a36579/cannabis-smoothie-recipe/
How To Make and Use Cannabis-Infused Butter and Oil (news–2016)  http://beyondchronic.com/2016/08/how-make-use-cannabis-infused-butter-oil/
TFT How To: Make The Best Vegan Cannabutter Ever In The Oven (news–2016)  https://thefreshtoast.com/cannabis/how-to-make-vegan-cannabutter-in-the-oven/
Celebrate Danksgiving With These Marijuana Infused Turkey Day Treats (news–2016)  http://www.laweekly.com/restaurants/celebrate-danksgiving-with-these-marijuana-infused-turkey-day-treats-7622744
5 Weed Brownie Recipes That Will Blow Your Mind (news–2016)  http://herb.co/2016/12/08/weed-brownie-recipes-2/
How to Make Pot Infused Crepes in Honor of Bastille Day in France (news–2016)  https://marijuanastocks.com/how-to-make-pot-infused-crepes-in-honor-of-bastille-day-in-france/
Recipe: Homemade Cannabis-Infused Banana Smoothie (news–2016)  https://weedy.com/news/recipe-homemade-cannabis-infused-banana-smoothie
Cannabis-Infused Turkey Sage Meatballs (news–2016) https://www.leafly.com/news/food-travel-sex/recipe-cannabis-infused-turkey-sage-meatballs-with-cranberry-orange-sauce
Marijuana Milk? It’s A Thing And We Have The Recipe (news–2016)  https://thefreshtoast.com/cannabis/got-milk-heres-how-to-make-a-killer-cannabis-version/
Mexican Hot Chocolate (news–2016) http://herb.co/recipes/mexican-hot-chocolate/
Recipe: Cannabis Courgettes à la Plancha (news–2016)  https://www.marijuanatimes.org/recipe-cannabis-courgettes-a-la-plancha/
The Benefits of Organic Hemp Milk (news-2016)  http://www.globalhealingcenter.com/natural-health/benefits-of-hemp-milk/
Ask a Stoner: How Can I Have a Merryjuana Christmas? (news–2016)  http://www.houstonpress.com/news/ask-a-stoner-how-can-i-have-a-merryjuana-christmas-9040585
Recipe: Nigerian Red Kidney Bean Stew with Cannabis Oil (news–2016)  https://www.marijuanatimes.org/recipe-nigerian-red-kidney-bean-stew-with-cannabis-oil/
T.H.Ghee (news–2016) https://www.bonappetit.com/recipe/thghee
Get Totally Baked With Weed-Filled Hamantaschen (news–2017)  http://forward.com/food/364613/get-totally-baked-with-weed-filled-hamantaschen/
Relatively Simple Modernist Marijuana Cooking: Powdered Cannabutter (news–2017)  https://thefreshtoast.com/recipes/relatively-simple-modernist-cannabis-cooking-powdered-weed-butter/
5 Ways To Utilize Leftover Marijuana Pulp From Cannabutter (news–2017)  https://thefreshtoast.com/cannabis/5-things-to-do-with-leftover-cannabutter-marijuana/
Mini cannabis pizzas can be made now, enjoyed later | Recipe (recipe–2017)  http://www.seattletimes.com/life/mini-cannabis-pizzas-can-be-made-now-enjoyed-later-recipe/
Tell Us Your Story: Marijuana Mac & Cheese Helps Ease Alzheimer’s (news–2017) https://thefreshtoast.com/cannabis/tell-us-your-story-cannabis-mac-cheese-to-help-ease-alzheimers/
This ‘Baked’ Banana Bread Can Be Made Gluten Free And Vegan (news–2017)  https://thefreshtoast.com/cannabis/this-bomb-baked-banana-bread-can-be-made-gluten-free-and-vegan/
Recipe: Bring the Heat with These Spicy Infused Chicken Wings (news-2017)  https://www.leafly.com/news/food-travel-sex/recipe-how-to-make-spicy-cannabis-infused-chicken-wings
Effortless Gourmet Breakfast: Cannabis-Spiked Chia Seed Pudding (news–2017)  https://thefreshtoast.com/recipes/effortless-gourmet-breakfast-cannabis-spiked-chia-seed-pudding/
Wake And Bake With Potzo Brei This Passover (news–2017)  http://forward.com/food/367052/wake-and-bake-with-potzo-brei-this-passover/
Carnival Sweet Potato Fries with Cannabutter Recipe (news–2017)  https://www.leafly.com/news/food-travel-sex/sweet-potato-fries-with-cannabutter-recipe
Double Down On Adulthood With This Cannabis Crème Brûlée (news–2017)  https://thefreshtoast.com/recipes/double-down-on-adulthood-with-this-cannabis-creme-brulee/
Infused Chicken Parmesan and Pasta (news–2017) https://www.leafly.com/news/food-travel-sex/marijuana-chicken-parmesan-pasta-recipe
Filling And Life Affirming Dinner: Marijuana-Infused Ma Po Tofu (news–2017)  https://thefreshtoast.com/recipes/filling-and-life-affirming-dinner-cannabis-infused-ma-po-tofu/
An Extra-Lifting Lemongrass, Cannabis Coconut Soup For A Terpinous Trip (news–2017)  https://thefreshtoast.com/recipes/an-extra-lifting-cannabis-lemongrass-coconut-soup-for-a-terpinous-trip/
Weed-infused stuffed French toast recipe: An elegant, elevated and easy breakfast (news–2017) http://www.thecannabist.co/2017/05/11/marijuana-stuffed-french-toast-recipe/79270/
Tired of Hummus? Try Cannabis-Infused Vegan White Bean Tapenade (news–2017)  https://thefreshtoast.com/cannabis/tired-of-hummus-try-cannabis-infused-vegan-white-bean-tapenade/
What Is Bhang? A History Lesson and a Recipe (news–2017)  https://www.leafly.com/news/food-travel-sex/what-is-bhang-history-and-recipes
Vegan Cannabis Fruit Snacks, Because Why Not? (news–2017)  https://thefreshtoast.com/food/vegan-cannabis-fruit-snacks-because-why-not/
Should You Mix Turmeric And Weed For Pain Management? (news–2017)  http://www.thealternativedaily.com/turmeric-and-weed-for-pain/
Chilly? Make Some Marijuana-Infused Turmeric Hot Cocoa (news–2017)  https://thefreshtoast.com/cannabis/marijuana-infused-turmeric-hot-cocoa/
TFT How To: Make These Soft Pretzels Dosed With THC (news–2017)  https://thefreshtoast.com/cannabis/tft-how-to-make-these-soft-pretzels-dosed-with-thc/
Cannabis Tea Made With Leftover Marijuana Stems? We Have A Recipe! (news–2017)  https://thefreshtoast.com/cannabis/cannabis-tea-with-leftover-marijuana-stems-we-have-a-recipe/#sthash.556g4uyy.dpuf
Homemade caramel coffee recipe: Pre-packaged cannabis coffee drinks are great, but this is better (news–2017) http://www.thecannabist.co/2017/05/25/infused-cannabis-drink-recipe-caramel-coffee/80222/
These Cannabis Prosecco Popsicles Are The Ultimate Chill Out (news–2017)  https://thefreshtoast.com/cannabis/cannabis-prosecco-popsicles-to-help-you-chill-out-this-summer/
The Ultimate Summer Food: Strawberry Salad With Coconut-Cannabis Dressing (news–2017) https://thefreshtoast.com/cannabis/the-ultimate-summer-food-strawberry-salad-with-coconut-cannabis-dressing/
Recipe: Cannabis Cornbread (news–2017) https://www.marijuanatimes.org/recipe-cannabis-cornbread/
How To Make Pot Chips Using the Leftover Leaves From Your Marijuana Harvest (news–2017) http://www.wweek.com/cannabis/2017/10/03/how-to-make-pot-chips-using-the-leftover-leaves-from-your-marijuana-harvest/


METHODS OF USE–HASHISH
Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites in urine (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/20634020/abstract/Prolonged_coma_in_a_child_due_to_hashish_ingestion_with_quantitation_of_THC_metabolites_in_urine_
Some features of teenage beer alcoholism combined with hashish addiction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21322145
Water pipe smoking and psychoactive substances (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23421061
Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical
and neurobiological evidence (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22736575
Extraction of high quality DNA from seized moroccan cannabis resin (hashish) (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790795/
“Body packers” in Israel: a case series (full-2013)  http://www.ima.org.il/FilesUpload/IMAJ/0/65/32679.pdf
Chemical profiling of different hashish seizures by gas chromatography-mass spectrometry and statistical methodology: a case report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24008198
Hashish revival in Morocco (full–2014) http://www.ijdp.org/article/S0955-3959%2814%2900003-6/fulltext
Hashish as cash in a post-Soviet Kyrgyz village (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24594222
Etno-territorial prevalence of hashishism in some Siberian areas (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25403303
Intoxication from accidental ingestion of hashish: Analysis of eight cases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25466782
Prevalence and correlates of hashish use in a national sample of high school seniors in the United States (full–2015) http://www.tandfonline.com/doi/full/10.3109/00952990.2015.1011745
Are Moroccan cannabis growers able to adapt to recent European market trend? (full–2015) http://www.ijdp.org/article/S0955-3959%2814%2900336-3/fulltext
Do consumers substitute opium for hashish? An economic analysis of simultaneous cannabinoid and opiate consumption in a legal regime (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26455552
False hashish without cannabis resin (abst–2015)  http://www.ingentaconnect.com/search/article?option1=title&value1=false+hashish&pageSize=10&index=1
What are young adults smoking in their hookahs? A latent class analysis of substances  smoked (abst-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091668/
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032490/
The legalization of cannabis derivatives in Spain: Hypothesis on a potential emerging  market (download-full in English, abst in Spanish–2016)  http://www.adicciones.es/index.php/adicciones/article/view/807/832
Hashish in Morocco and Lebanon: A comparative study (abst–2016)  http://www.ijdp.org/article/S0955-3959(16)30056-1/abstract
Cannabis cultivation in Spain: A profile of plantations, growers and production systems  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27619556
Relationship Between Frequent Recreational Cannabis (Marijuana and Hashish) Use and
Periodontitis in Adults in the United States: Nhanes 2011-12 (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27718772
Determination of delta-9-tetrahydrocannabinol content of cannabis seizures in Egypt  (full–2017) http://www.sciencedirect.com/science/article/pii/S1995764516304266
THC and CBD in blood samples and seizures in Norway: Does CBD affect THC-induced
impairment in apprehended subjects? (abst–2017)  http://www.fsijournal.org/article/S0379-0738(17)30143-3/fulltext
Death by self-mutilation after oral cannabis consumption (abst–2017)  http://www.legalmedicinejournal.com/article/S1344-6223(17)30258-4/fulltext
top


METHODS OF USE-INHALERS +
US Patent Application 20100012118 – Medicament dosage for inhaler (full–2010) http://www.freepatentsonline.com/y2010/0012118.html
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis (full–2013) http://zl.elsevier.es/en/revista/neurologia-495/articulo/clinical-experiences-with-cannabinoids-in-90328787
Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23685330
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study (full–2014) https://www.academia.edu/22926463/The_Pharmacokinetics_Efficacy_Safety_and_Ease_of_Use_of_a_Novel_Portable_MeteredDose_Cannabis_Inhaler_in_Patients_With_Chronic_Neuropathic_Pain_A_Phase_1a_Study
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152762/


METHODS OF USE-INJECTION*+
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study  (link to download–2010)  https://www.researchgate.net/publication/46306066_Does_intravenous_D9-
tetrahydrocannabinol_increase_dopamine_release_A_SPET_study
The safety of studies with intravenous Δ(9)-tetrahydrocannabinol in humans, with case histories (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21845389
Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ(9)-THC in Humans (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358754/
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans (full–2012) http://ijnp.oxfordjournals.org/content/15/9/1251.long
Cannabis in the arm: what can we learn from intravenous cannabinoid studies? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716141
N-Palmitoylethanolamine depot injection increased its tissue levels and those of other acylethanolamide lipids (full–2013) http://www.ncbi.nlm.nih.gov/pubmed/23976843
How Cannabis Causes Paranoia: Using the Intravenous Administration of Δ9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia (full–2014) http://schizophreniabulletin.oxfordjournals.org/content/early/2014/07/01/schbul.sbu098.long
In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid
Δ9-THC in mice: inhalation versus intraperitoneal injection (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340656/
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part I: Development and Validation of a Pulmonary Cannabinoid Route of Exposure for Experimental Pharmacology Studies in Rodents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24973534
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part II: Comparison of Behavioural Effects of Pulmonary Versus Parenteral Cannabinoid Exposure in Rodents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24956154
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446925
top
Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and  Vomiting: A Randomized Controlled Trial (abst–2015) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10&index=23
Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics (abst–2015) http://link.springer.com/article/10.1007/s40262-014-0195-5
Distribution of Synthetic cannabinoids JWH-210, RCS-4 and ∆ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27834143
Intravenous administration of cannabis and lethal anaphylaxis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28438101
Cannabinoid Disposition After Human Intraperitoneal Use: An Insight Into  Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer (abst–2018)  http://www.clinicaltherapeutics.com/article/S0149-2918(17)31114-1/fulltext


METHODS OF USE–MICRODOSING/LOW DOSE
A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study (full–2010)  http://www.nature.com/ijo/journal/v34/n5/full/ijo201021a.html
A low-Δ9tetrahydrocannabinol cannabis extract induces hyperphagia in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20975531
Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in  healthy human volunteers (full-2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018238/
Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol  (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage (abst–2011) http://www.sciencedirect.com/science/article/pii/S0166432811001094
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566631/
Long-term behavioral and biochemical effects of an ultra-low dose of Δ(9)-
tetrahydrocannabinol (THC): neuroprotection and ERK signaling (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22821081
Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned  gaping (a model of nausea-induced behaviour) in rats (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682714/
An ultra-low dose of tetrahydrocannabinol provides cardioprotection (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0006295213001950
Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-
THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the
least shrew (Cryptotis parva) (abst–2013)  http://www.sciencedirect.com/science/article/pii/S001429991300767X
Preparation and characterization of Δ9-tetrahydrocannabinol-loaded biodegradable
polymeric microparticles and their antitumoral efficacy on cancer cell lines (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23773072
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25042014
Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia  Reperfusion Injury (full–2015) http://www.karger.com/Article/Pdf/430165
Ultra-low doses of tetrahydrocannabinol contribute to the survival of newly-born cells in
the dentate gyrus of adult rats (2 pages–2015)  http://link.springer.com/article/10.1134/S1819712415030046
Explorative Placebo-Controlled Double-Blind Intervention Study with Low Doses of  Inhaled Δ9-Tetrahydrocannabinol and Cannabidiol Reveals No Effect on Sweet Taste
Intensity Perception and Liking in Humans (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569584/
Reversal of age-related cognitive impairments in mice by an extremely low dose of
tetrahydrocannabinol (full–2017) http://www.neurobiologyofaging.org/article/S0197-4580(17)30321-4/fulltext
Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn’s Disease, a
Randomized Controlled Trial (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28349233
A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old
mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28481360
Smoked marijuana attenuates performance and mood disruptions during simulated night shift work (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30309-5/fulltext
Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial:
Effects of Dronabinol in Obstructive Sleep Apnea (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29121334
A randomized-controlled trial of nabilone for the prevention of acute postoperative
nausea and vomiting in elective surgery. (abst in English & French–2017)
https://link.springer.com/article/10.1007%2Fs12630-017-0814-3


METHODS OF USE-NANOPLATFORMS/NANOPARTICLES/MICROSPHERES Etc
Anandamide-loaded nanoparticles: preparation and characterization (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21425945
Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation,  characterization, and cytotoxicity studies (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511186/
NANOENCAPSULATED DELTA-9-TETRAHYDROCANNABINOL – Patent US2012052119 (A1) ― 2012-03-01 (full–2012) http://tinyurl.com/oc2mnzc
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid  administration: Development, characterization and in vitro evaluation of their antitumoral efficacy (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0168365912003318
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to  prevent neuroinflammation in spinal cord injury (full–2013)  http://www.jneuroinflammation.com/content/10/1/91
Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine  xenograft model of glioblastoma multiforme (link to PDF–2013)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054795
Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide:
A Case Report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22998138
Engineering of Δ9-tetrahydrocannabinol delivery systems based on surface modified PLGA nanoplatforms (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25262411
Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25996463
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26254360
Encapsulation of cannabinoid drugs in nanostructured lipid carriers (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26952905

Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028159 Application of carbon nanotubes as the carriers of the cannabinoid, 2- arachidonoylglycerol: Towards a novel treatment strategy in colitis (abst–2016) http://www.sciencedirect.com/science/article/pii/S002432051630666X
Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory  Phytocompounds (full–2017) http://www.mdpi.com/1422-0067/18/4/709/htm
Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression
Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid
Nanoparticles (full–2017) https://www.karger.com/Article/FullText/480001
Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609560/
Lipid nanoparticles for administration of poorly water soluble neuroactive drugs (abst–2017) https://link.springer.com/article/10.1007%2Fs10544-017-0188-x
The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption  enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and  cannabidiol (CBD) in a rat model (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0928098717304025?via%3Dihub
Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic
pain for eleven days (abst–2017) http://www.nanomedjournal.com/article/S1549-9634(17)30140-5/fulltext
PTL401, a New Formulation Based on Pro-nano Dispersion Technology, Improves Oral  Cannabinoids Bioavailability in Healthy Volunteers (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29287930


METHODS OF USE-NASAL SPRAYS +
Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20545522
Bioavailability of Δ⁹-tetrahydrocannabinol following intranasal administration of a mucoadhesive gel spray delivery system in conscious rabbits (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21244195
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23517929
top


METHODS OF USE–ROSIN 
“You got to love rosin: Solventless dabs, pure, clean, natural medicine.” Exploring Twitter data on emerging trends in Rosin Tech marijuana concentrates (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30604-X/fulltext


METHODS OF USE-RSO/RICK SIMPSON’S OIL/HEMP OIL/PHOENIX OIL +
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/601/?pagenum=2
Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901602/
Cannabis Oil : chemical evaluation of an upcoming cannabis based medicine (full–2013) http://www.cannabis-med.org/data/pdf/en_2013_01_1.pdf
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases (report–2014) http://www.slideshare.net/TheHempSolution/comprehensive-report-on-the-cannabis-extract-movement
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Establishment of a New Drug Code for Marihuana Extract. Final rule (full–2016) https://www.federalregister.gov/documents/2016/12/14/2016-29941/establishment-of-a-new-drug-code-formarihuana-extract
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26757043
Review of Various Herbal Supplements as Complementary Treatments for Oral Cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26863913
Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27471078


METHODS OF USE-SECOND-HAND SMOKE/VAPOR
Cannabinoids in oral fluid following passive exposure to marijuana smoke (full–2011) http://www.clinchem.org/content/57/8/1127.long
Oral Fluid Cannabinoids in Chronic, Daily Cannabis Smokers During Sustained,  Monitored Abstinence (full–2011) http://clinchem.aaccjnls.org/content/57/8/1127.long
Evaluating the athlete’s claim of an unintentional positive urine drug test (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/23531893
Does a positive finding of tetrahydrocannabinol in the blood result from ingestion of  Indian frankincense (Boswellia serrata)? (abst–2012)  http://www.unboundmedicine.com/medline/citation/22834359/%5BDoes_a_positive_finding_of_tetrahydrocannabinol_in_the_blood_result_from_ingestion_of_Indian_frankincense_%28Boswellia_serrata%29
Current knowledge on cannabinoids in oral fluid (full–2013)  http://onlinelibrary.wiley.com/doi/10.1002/dta.1514/full
11-Nor-9-carboxy-∆9-tetrahydrocannabinol quantification in human oral fluid by liquid  chromatography-tandem mass spectrometry (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773502/
Oral Fluid Cannabinoids in Chronic Cannabis Smokers during Oral Δ9-
Tetrahydrocannabinol Therapy and Smoked Cannabis Challenge (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102264/
Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic  frequent and occasional smokers (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823692/
Assessment of different mouthwashes on cannabis oral fluid concentrations (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24453092
Non-smoker exposure to secondhand cannabis smoke I: Urine screening and confirmation results (full–2015) http://jat.oxfordjournals.org/content/39/1/1.long
Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25957157
Nonsmoker Exposure to Secondhand Cannabis Smoke III: Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects (full–2015)  http://jat.oxfordjournals.org/content/39/7/497.long
Finding cannabinoids in hair does not prove cannabis consumption (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595642/
Analysis of Cannabinoids and Their Metabolites in Human Urine (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411292
Detecting biomarkers of secondhand marijuana smoke in young children (abst–2016) http://www.nature.com/pr/journal/vaop/naam/abs/pr2016261a.html
A systematic review of passive exposure to cannabis (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27883985
Fine particles in homes of predominantly low-income families with children and  smokers: Key physical and behavioral determinants to inform indoor-air-quality  interventions (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0177718
Health effects of exposure to second- and third-hand marijuana smoke: a systematic
review (full–2017) http://cmajopen.ca/content/5/4/E814.long
Interpretation of cannabis findings in the hair of very young children: mission impossible (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29189142
Second-Hand Exposure of Staff Administering Vaporised Cannabinoid Products to  Patients in a Hospital Setting (full–2018) https://link.springer.com/article/10.1007/s40268-017-0225-5


METHODS OF USE-SMOKING*+
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/?toolmcentrez
Opioid antagonism enhances marijuana’s effects in heavy marijuana smokers (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923559/pdf/nihms201310.pdf
Does cannabis use predispose to chronic airflow obstruction? (full-2010) http://erj.ersjournals.com/content/35/1/3.full?ijkey=d1405bb2fc0ed2aff675335858f284f7f470fbbc&keytype2=tf_ipsecsha
top
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study (full-2010) http://bjp.rcpsych.org/content/197/4/285.long
Disposition of smoked cannabis with high Delta(9)-tetrahydrocannabinol content: A kinetic model (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20450927/abstract/Disposition_of_smoked_cannabis_with_high_Delta_9__tetrahydrocannabinol_content:_A_kinetic_model_
Effects of smoking cannabis on lung function (full–2011) http://www.expert-reviews.com/doi/pdf/10.1586/ers.11.40
Drug-Intake Methods and Social Identity: The Use of Marijuana in Blunts Among South-east Asian Adolescents and Emerging Adults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193281/?toolubmed
Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025094/
Characterizing smoking topography of cannabis in heavy users (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641906/
Identification of Recent Cannabis Use:Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics Following Controlled Smoked Cannabis Administration (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717336/
Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health Related Quality of Life (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080871/?tool=pubmed
US Patent EP 2560512 A1 – Smoke and Odor Elimination Filters, Devices and Methods (full–2011) http://www.google.com/patents/EP2560512A1?cl=en
Prevalence and co-use of marijuana among young adult cigarette smokers: An anonymous online national survey (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507655/
Patterns of blunt use among rural young adult african-american men (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244685/
The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546149/
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612560/
Psychomotor Performance, Subjective and Physiological Effects and Whole Blood Δ9-
Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following  Acute Smoked Cannabis (full–2012) http://jat.oxfordjournals.org/content/36/6/405.full
Cannabinoids and metabolites in expectorated oral fluid following controlled smoked  cannabis (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319321/
The changing demographic of blunt smokers across birth cohorts (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23201173
Water pipe smoking and psychoactive substances (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23421061
Availability of tobacco products associated with use of marijuana cigars (blunts) (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883305/
Statistics on cannabis users skew perceptions of cannabis use (full–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00138/full
Marijuana’s dose-dependent effects in daily marijuana smokers (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547548/
Determination of Pesticide Residues in Cannabis Smoke (full–2013) https://www.hindawi.com/journals/jt/2013/378168/
In Vitro Stability of Free and Glucuronidated Cannabinoids in Blood and Plasma
Following Controlled Smoked Cannabis (full–2013)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844293/
Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758774/
Cannabinoids in Exhaled Breath following Controlled Administration of Smoked Cannabis (full–2013) http://www.clinchem.org/content/59/12/1780.long
Current knowledge on cannabinoids in oral fluid (full–2013)  http://onlinelibrary.wiley.com/doi/10.1002/dta.1514/full
Oral Fluid Cannabinoids in Chronic Cannabis Smokers during Oral Δ9-
Tetrahydrocannabinol Therapy and Smoked Cannabis Challenge (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102264/
Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic
frequent and occasional smokers (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823692/
Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682150/
Cannabis and the Lung: No More Smoking Gun? (editorial–2013) http://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201302-034ED?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
top
Smoking mull: a grounded theory model on the dynamics of combined tobacco and cannabis use among adult men (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24168742
Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24202191
Postoperative Analgesia in the Jamaican Cannabis User (abst–2013)  http://www.tandfonline.com/doi/full/10.1080/02791072.2013.803644#.U9QCtWN8E24
Does smoking marijuana cause stroke? (abst–2013)  http://www.thepoisonreview.com/2013/01/26/does-smoking-marijuana-cause-stroke/
Marijuana ‘bong’ smoking and tuberculosis (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23551310
Getting high on the endocannabinoid system (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362971/
Inhaled medicinal cannabis and the immunocompromised patient (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25216851
Inhaled medicinal cannabis and the immunocompromised patient (full–2014) MASSC
Phase I and II Cannabinoid Disposition in Blood and Plasma of Occasional and Frequent
Smokers Following Controlled Smoked Cannabis (full–2014)  http://www.clinchem.org/content/60/4/631.long
In vitro stability of free and glucuronidated cannabinoids in urine following controlled  smoked cannabis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259566/
Recurrent myopericarditis as a complication of Marijuana use (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921097/
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based  on NHANES 2005–2010 (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297696/
Does cannabis smoking predispose to lung bulla formation? (full–2014) http://aan.sagepub.com/content/22/1/65.long
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/add.12508/full
The co-use of tobacco and cannabis among adolescents over a 30-year period (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24443776
Experiences of marijuana-vaporizer users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24821347
Just say ‘know’: how do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24894801
Assessment of different mouthwashes on cannabis oral fluid concentrations (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24453092
Acute subjective effects after smoking joints containing up to 69 mg Δ9-
tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24879495
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory  Effects and Future Therapeutic Potentials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607066/
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015)  http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Marijuana use in hepatitis C infection does not affect liver biopsy histology or treatment outcomes (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144456/
Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume (full–2015) http://ijnp.oxfordjournals.org/content/18/10/pyv061
Cannabis problem experiences among users of the tobacco-cannabis combination known as blunts (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387065/
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908634/
Are users’ most recent drug purchases representative? (full–2015)  http://www.drugandalcoholdependence.com/article/S0376-8716(14)00938-7/fulltext
Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum  Cannabis Smoking in Chronic Frequent Users (full–2015)  http://jat.oxfordjournals.org/content/39/8/580.long

Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and  confirmation results (full–2015)  http://www.researchgate.net/publication/267043767_NonSmoker_Exposure_to_Secondhand_Cannabis_Smoke._I._Urine_Screening_and_Confirmation_Results
Impact of oral fluid collection device on cannabinoid stability following smoked  cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282833/
Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on  the physiological, subjective, and behavioral/cognitive effects (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747424/
Combined effects of HIV and marijuana use on neurocognitive functioning and immune status (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950932/
How beneficial is vaping cannabis to respiratory health compared to smoking? (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25903763

What are young adults smoking in their hookahs? A latent class analysis of substances  smoked (abst-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091668/
top
Subjective and behavioral effects of marijuana the morning after smoking (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/2315429
Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics (abst–2015) http://link.springer.com/article/10.1007/s40262-014-0195-5
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26451996
In vitro stability of free and glucuronidated cannabinoids in blood and plasma collected  in plastic gray-top sodium fluoride tubes following controlled smoked cannabis (abst–2015) http://link.springer.com/article/10.1007/s11419-015-0290-9
Online survey characterizing vaporizer use among cannabis users (abst–2015)  http://www.drugandalcoholdependence.com/article/S0376-8716(15)01835-9/abstract
Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153327
No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933835/
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Medical cannabis use in Canada: vapourization and modes of delivery (full–2016) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Sex-dependent effects of cannabis-induced analgesia (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037015/
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked  cannabis in young cannabis smokers (full–2016)  http://www.nature.com/tp/journal/v6/n2/full/tp2015219a.html
Acute effects of cannabis on breath-holding duration (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965168/
Smoking, vaping, eating: Is legalization impacting the way people use cannabis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010515/
Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette (link to download–2016) https://ejournals.library.ualberta.ca/index.php/JPPS/article/view/28326/20877
Working on a Standard Joint Unit: A pilot test (link to download in English–2016, abst in Spanish) Descargar el archivo PDF
Bayesian inference for the distribution of grams of marijuana in a joint (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27346327
Alveolar haemorrhage following a cannabis water pipe (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27421143
Alterations in taste perception due to recreational drug use are due to smoking a substance rather than ingesting it (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27426619
Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27471078
A review of the additive health risk of cannabis and tobacco co-use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27476751
Does marijuana “blunt” smoking contribute to nicotine exposure?: Preliminary product testing of nicotine content in wrappers of cigars commonly used for blunt smoking (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27639129
Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27647820
Free and Glucuronide Whole Blood Cannabinoids’ Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27899456
Δ9-Tetrahydrocannabinol concentrations in exhaled breath and physiological effects  following cannabis intake – a pilot study using illicit cannabis (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0009912016300996
Δ9-Tetrahydrocannabinol concentrations in exhaled breath and physiological effects  following cannabis intake – a pilot study using illicit cannabis (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0009912016300996
Fine particles in homes of predominantly low-income families with children and  smokers: Key physical and behavioral determinants to inform indoor-air-quality
interventions (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0177718
Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’ and  individually: a placebo-controlled trial (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647681/
Measuring cannabis consumption: Psychometric properties of the Daily Sessions,  Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446174/
The Use of Cannabis for Headache Disorders (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436334/
Cannabis use among patients at a comprehensive cancer center in a state with legalized  medicinal and recreational use (full–2017)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Anatomy of a Joint: Comparing Self-Reported and Actual Dose of Cannabis and Tobacco in a Joint, and How These Are Influenced by Controlled Acute Administration (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628568/
Marijuana “bong” pseudomonas lung infection: a detrimental recreational experience  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756717/
Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences (link to download–2017) http://jpet.aspetjournals.org/content/early/2017/01/13/jpet.116.238717.long
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28138971
Population pharmacokinetics model of THC used by pulmonary route in occasional  cannabis smokers (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28167229
Lung Disease Associated With Marijuana Use (abst in English & Spanish–2017)  http://www.sciencedirect.com/science/article/pii/S1579212917302240
Youth use of electronic vapor products and blunts for administering cannabis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28214740
Does Starting to Smoke Cigars Trigger Onset of Cannabis Blunt Smoking? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28339595
Subjective and physiological effects, and expired carbon monoxide concentrations in  frequent and occasional cannabis smokers following smoked, vaporized, and oral  cannabis administration (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30133-3/abstract
The acute effect of cannabis on plasma, liver and brain ammonia dynamics, a  translational study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28456476
Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among  young adults in Colorado: Implications for health education and research (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28449191
Cannabis Smoking and Cardiovascular Health: It’s Complicated (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28548223
Cannabis and Cannabinoids for Chronic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28983880
Methodology for controlled administration of smoked synthetic cannabinoids JWH-018  and JWH-073 (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817305294?via%3Dihub
E-cigarette use, dual use of e-cigarettes and tobacco cigarettes, and frequency of cannabis use among high school students (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0306460317304847?via%3Dihub
Characterizing Blunt Smokers by Their Acquisition of Cannabis (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29300122
Cannabis Use, Lung Cancer, and Related Issues (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29374567


METHODS OF USE–SUB-LINGUAL/OROMUCOSAL
Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and  safety (link to PDF–2011) http://journals.sagepub.com/doi/abs/10.1177/1479972310391283
Medical Cannabis for Neuropathic Pain (abst–2018)  https://link.springer.com/article/10.1007%2Fs11916-018-0658-8


METHODS OF USE-SUPPOSITORIES*
Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice (full–2012) http://content.karger.com/produktedb/produkte.asp?DOI=000336871&typ=pdf
How to Make Marijuana Suppositories at Home (article–2017)  https://inhalemd.com/massachusetts-medical-cannabis-guide/how-to-make-cannabis-suppositories-at-home/


METHODS OF USE-TINCTURES*+
Marijuana Tincture (article & video–2010) http://patients4medicalmarijuana.wordpress.com/medical-use-of-cannabis-video/marijuana-tincture/
WildWill’s Glycerin Tincture HOW-TO (forum thread–2010) http://forum.grasscity.com/incredible-edible-herb/655899-wildwills-glycerin-tincture-how.html
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22411724
Optimisation and characterisation of marihuana extracts obtained by supercritical fluid extraction and focused ultrasound extraction and retention time locking GC-MS (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23505258
Establishment of a New Drug Code for Marihuana Extract. Final rule (full–2016) https://www.federalregister.gov/documents/2016/12/14/2016-29941/establishment-of-a-new-drug-code-formarihuana-extract
Why I chose to use cannabis (article–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791147/
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method (abst–2016) http://www.sciencedirect.com/science/article/pii/S0731708516302722
Quality Control of Traditional Cannabis Tinctures: Pattern, Markers, and Stability (full–2017) http://www.mdpi.com/2218-0532/84/3/567/htm
A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High Resolution Tandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the  Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28915313
top


METHODS OF USE-TOPICAL OINTMENTS +
Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/21185649/abstract/Local_application_of_the_endocannabinoid_hydrolysis_inhibitor_URB597_reduces_nociception_in_spontaneous_and_chemically_induced_models_of_osteoarthritis_
Comparative topical anti-inflammatory activity of cannabinoids and cannabivarins (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20450962
The Faces Of Medical Marijuana: An Interview With Sarah Lovering (interview-2010)  http://the420times.com/2010/04/the-faces-of-medical-marijuana/
Topical Cannabis Healing Salve (recipe–2010) http://patients4medicalmarijuana.wordpress.com/2010/04/30/topical-cannabis-healing-salve/
Balm from canna roots (forum thread–2010) http://www.greenpassion.org/showthread.php?t=20879
US Patent Application 20110052694 – USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES (full–2011) http://www.google.com/patents/US20110052694
Medical Marijuana Topical Balm Recipe for Eczema, Sore Joints, PMS Cramps (recipe–2011) http://ommplady.blogspot.com/2011/03/medical-marijuana-topical-balm-recipe.html
Topical Compositions with Cannabis Extracts United States Patent Application 20120264818 (full–2012) http://www.freepatentsonline.com/y2012/0264818.html
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643547/
Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23889474
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis (full–2015) http://darujps.biomedcentral.com/articles/10.1186/s40199-015-0131-8
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26517407
Jesus & Cannabis (article/recipe–2015) https://patients4medicalmarijuana.wordpress.com/marijuana-info/marijuana-in-the-bible/jesus-cannabis/
top
Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26095080
The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26142529
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model (full–2016) http://anndermatol.org/DOIx.php?id=10.5021/ad.2016.28.1.22
Establishment of a New Drug Code for Marihuana Extract. Final rule (full–2016) https://www.federalregister.gov/documents/2016/12/14/2016-29941/establishment-of-a-new-drug-code-formarihuana-extract
Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of  Vascular Dementia (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460147/
The oxylipin and endocannabidome responses in acute phase Plasmodium falciparum  malaria in children (full–2017)  https://malariajournal.biomedcentral.com/articles/10.1186/s12936-017-2001-y
The role of cannabinoids in dermatology (full–2017) http://www.jaad.org/article/S0190-9622(17)30308-0/fulltext
Effects of JWH015 in cytokine secretion in primary human keratinocytes and fibroblasts  and its suitability for topical/transdermal delivery (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302180/
Medical Cannabis in the Palliation of Malignant Wounds—A Case Report (article–2017) http://www.jpsmjournal.com/article/S0885-3924(16)30328-1/abstract
Topical application of THC containing products is not able to cause positive cannabinoid  finding in blood or urine (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28122323
Topical Medical Cannabis (TMC): A new treatment for wound pain-Three cases of
Pyoderma Gangrenosum (abst–2017) http://www.jpsmjournal.com/article/S0885-3924(17)30351-2/fulltext
Topical cannabinoids in dermatology (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28873100


METHODS OF USE-TRANSDERMAL PATCH +
Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20545522
US Patent Application 20110052694 – USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES (full–2011) http://www.google.com/patents/US20110052694
TRANSDERMAL DELIVERY OF CANNABINOIDS – Patent US2012034293 (A1)― 2012-02-09 (full–2012) http://worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012034293A1&KC=A1&FT&ND=3&date=20120209&DB=EPODOC&locale=en_EP
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neuro-degeneration in a rodent model of an alcohol use disorder (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096899/
top


METHODS OF USE-VAPORIZERS*+
Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20451365
Cannabinoid-opioid interaction in chronic pain (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/22048225/abstract/Cannabinoid_opioid_interaction_in_chronic_pain_
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566631/
Simple Method: Isolating & Extracting INDIVIDUAL Cannabinoids … from BadKittySmiles (forum post–2012) http://forum.grasscity.com/incredible-edible-herb/1051569-simple-method-isolating-extracting-individualcannabinoids-badkittysmiles.html
Cannabis and the Lung: No More Smoking Gun? (editorial–2013) http://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201302-034ED?url_ver=Z39.88-2003&rfr_idri:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Getting high on the endocannabinoid system (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
A protocol for the delivery of cannabidiol (CBD) and combined CBD and [increment]9-tetrahydrocannabinol (THC) by vaporisation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid
Δ9-THC in mice: inhalation versus intraperitoneal injection (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340656/
Experiences of marijuana-vaporizer users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24821347
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part I: Development and Validation of a Pulmonary Cannabinoid Route of Exposure for Experimental Pharmacology Studies in Rodents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24973534
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part II: Comparison of Behavioural Effects of Pulmonary Versus Parenteral Cannabinoid Exposure in Rodents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24956154
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol (full–2015) http://www.clinchem.org/content/61/6/850.long
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Mull it over: cannabis vaporizers and harm reduction (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13139/full
No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456813/
Vaping cannabis (marijuana): parallel concerns to e-cigs? (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860523/
In the weeds: a baseline view of cannabis use among legalizing states and their
neighbours (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216038/
Confirmation of the trials and tribulations of vaping (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13155/full
How beneficial is vaping cannabis to respiratory health compared to smoking? (article-2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Canadian Tobacco Alcohol and Drugs (CTADS): 2013 summary (summary–2015)  https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-survey/2013-summary.html
Electronic cigarettes and cannabis: an exploratory study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25613866
Online survey characterizing vaporizer use among cannabis users (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901835-9/abstract
top
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26451996
Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147286
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/
No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933835/
Tracking Dabbing Using Search Query Surveillance: A Case Study in the United States (full-2016) http://www.jmir.org/2016/9/e252/
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Medical cannabis use in Canada: vapourization and modes of delivery (full–2016)  https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis (full–2016) https://www.dovepress.com/a-preliminary-evaluation-of-the-relationship-of-cannabinoid-blood-conc-peer-reviewed-fulltext-articleJPR
Smoking, vaping, eating: Is legalization impacting the way people use cannabis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010515/
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the  Treatment of Neuropathic Pain from Spinal Cord Injury and Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007175/
Cannabis Legalization: Focusing on Patient Needs: Five Recommendations on Access, Affordability, and Research (report–2016) http://cfamm.ca/patient-recommendations/
Smoking, vaping, eating: Is legalization impacting the way people use cannabis? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26992484
Inhaled delivery of Δ9-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology (abst–2016) http://www.sciencedirect.com/science/article/pii/S002839081630226X
A review of the additive health risk of cannabis and tobacco co-use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27476751
Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27647820
Prevalence and correlates of “Vaping” as a route of cannabis administration in medical cannabis patients (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27770657
Free and Glucuronide Whole Blood Cannabinoids’ Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27899456
Measuring cannabis consumption: Psychometric properties of the Daily Sessions,  Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446174/
Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398321/
Vaping medical marijuana (full–2017)  http://www.tandfonline.com/doi/full/10.1080/00325481.2018.1413281
Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences (link to download–2017) http://jpet.aspetjournals.org/content/early/2017/01/13/jpet.116.238717.long
Medical Cannabis in the Palliation of Malignant Wounds—A Case Report (article–2017) http://www.jpsmjournal.com/article/S0885-3924(16)30328-1/abstract
“Tree-in-Bloom”: Severe Acute Lung Injury Induced by Vaping Cannabis Oil (1st page–2017) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201612-974LE
Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28138971
Carbonyl Compounds Produced by Vaporizing Cannabis Oil Thinning Agents (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28355118
Subjective and physiological effects, and expired carbon monoxide concentrations in  frequent and occasional cannabis smokers following smoked, vaporized, and oral  cannabis administration (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30133-3/abstract
The acute effect of cannabis on plasma, liver and brain ammonia dynamics, a  translational study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28456476
Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among  young adults in Colorado: Implications for health education and research (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28449191
U.S. cannabis legalization and use of vaping and edible products among youth (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30184-9/fulltext
Cannabis and Cannabinoids for Chronic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28983880
A Cloud on the Horizon – A survey into the use of electronic vaping devices for  recreational drug and new psychoactive substance (NPS) administration (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/29025078
Second-Hand Exposure of Staff Administering Vaporised Cannabinoid Products to  Patients in a Hospital Setting (full–2018) https://link.springer.com/article/10.1007/s40268-017-0225-5
Medical Cannabis for Neuropathic Pain (abst–2018)  https://link.springer.com/article/10.1007%2Fs11916-018-0658-8


METHODS OF USE-VARIOUS*+
MEDICINAL USE OF CANNABIS: HISTORY AND CURRENT STATUS (full–undated ) http://www.parl.gc.ca/content/sen/committee/371/ille/presentation/kalant-e.htm
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant for administration by ingestion or other means (Health Canada) (full-2010) http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Dosage & Routes of Cannabis and Cannabinoid Administration (article/forum repost-2010) http://www.420magazine.com/forums/methods-use-various/173948-dosage-routes-cannabis-cannabinoidadministration.html
Scientific Opinion on the safety of hemp (Cannabis genus) for use as animal feed (full-2011) (deceptive title) http://www.hanf-info.ch/info/en/IMG/pdf/EIHA-11-05-31_EIHA-Statement_on_THC_in_feed.pdf
Effect of Cannabis sativa on Hematological Indices in Rats and Men (full–2011)  http://docsdrive.com/pdfs/ansinet/pjn/2011/313-316.pdf
Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes  (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025094/
The medicinal use of cannabis and cannabinoids: an international survey on methods of intake (abst-2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=482
Medical Marijuana: Clearing Away the Smoke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
It can’t hurt to ask; a patient-centered quality of service assessment of health canada’s  medical cannabis policy and program (full–2012)  https://harmreductionjournal.biomedcentral.com/articles/10.1186/1477-7517-9-2
Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the  cannabinoids [Health Canada, 2013] (full–2013) http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Cannabis Oil : chemical evaluation of an upcoming cannabis based medicine (full–2013) http://www.cannabis-med.org/data/pdf/en_2013_01_1.pdf
Integrating Cannabis Into Clinical Care (article–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875042/
Cloud point extraction of Δ(9)-tetrahydrocannabinol from cannabis resin (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23354583
Getting high on the endocannabinoid system (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
Pharmacokinetics and relative bioavailability of THC and THC-solid dispersion orally to  mice at single dose (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24956859

Responsible and controlled use: Older cannabis users and harm reduction (full–2015) http://www.ijdp.org/article/S0955-3959(15)00075-4/fulltext
In the weeds: a baseline view of cannabis use among legalizing states and their  neighbours (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216038/
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604175/
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use (full–2016)  http://onlinelibrary.wiley.com/doi/10.1111/add.13390/full
Medical cannabis use in Canada: vapourization and modes of delivery (full–2016)  https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9
A user’s guide to cannabinoid therapies in oncology (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
COMPREHENSIVE MEDICAL MARIJUANA PATIENT STUDY (link to PDF–2016) https://www.hellomd.com/medical-marijuana-patient-survey
Chapter 3 – Medical Cannabis Formulations (abst-2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000035
top
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27530738

Medical Marijuana: Just the Beginning of a Long, Strange Trip? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27660328
Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312634/
Measuring cannabis consumption: Psychometric properties of the Daily Sessions,  Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446174/
Cannabis use among patients at a comprehensive cancer center in a state with legalized  medicinal and recreational use (full–2017) http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398321/
Cannabis Guidelines (article–2017) https://cjon.ons.org/cjon/21/4/cannabis-guidelines
Evaluation of divided attention psychophysical task performance and effects on pupil  sizes following smoked, vaporized and oral cannabis administration (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28138971
Youth use of electronic vapor products and blunts for administering cannabis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28214740
Predictors of Adult E-Cigarette Users Vaporizing Cannabis Using E-Cigarettes and Vape-Pens (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28323498
Subjective and physiological effects, and expired carbon monoxide concentrations in  frequent and occasional cannabis smokers following smoked, vaporized, and oral  cannabis administration (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30133-3/abstract
Variation in cannabis potency and prices in a newly-legal market: Evidence from 30  million cannabis sales in Washington State (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28556310
Cannabis and Cannabinoids for Chronic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28983880
System-specific activity in response to Δ9 -tetrahydrocannabinol: A functional magnetic  resonance imaging study in awake male rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29057576
Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of  conversion in vivo of CBD to THC (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29129557
Practical considerations in medical cannabis administration and dosing (abst–2017)  http://www.ejinme.com/article/S0953-6205(18)30004-9/fulltext
Contemporary Routes of Cannabis Consumption: A Primer for Clinicians (full–2018) http://jaoa.org/article.aspx?articleid=2671435


MIDLIFE ADULT
Pretreatment with Δ9-tetrahydrocannabinol (THC) increases cocaine-stimulated activity  in adolescent but not adult male rats (full–2011)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242894/
Immune thrombocytopenia in children and adults: what’s the same, what’s different?  (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232253/
Prevalences of illicit drug use in people aged 50 years and over from two surveys (full–2012) http://ageing.oxfordjournals.org/content/41/4/553.long
Still Dazed and Confused: Midlife Marijuana Use by the Baby Boom Generation (abst–2013) http://www.tandfonline.com/doi/abs/10.1080/01639625.2014.889994
Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on
social behavior in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24933531
A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25241766
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the  California Men’s Health Study (full–2015) http://www.goldjournal.net/article/S0090-4295(14)01206-0/fulltext
Synthetic cannabinoids and acute kidney injury (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569229/
Synthetic cannabinoids as a cause for black carbonaceous bronchoalveolar lavage (2)  (download–2015) http://casereports.bmj.com/content/2015/bcr-2015-211391.full.pdf
Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study (full–2016) http://archinte.jamanetwork.com/article.aspx?articleid=2484906
National Estimates of Marijuana Use and Related Indicators — National Survey on Drug Use and Health, United States, 2002–2014 (full–2016) http://www.cdc.gov/mmwr/volumes/65/ss/ss6511a1.htm?s_cid=ss6511a1_e
Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based Cohort Study of 45 000 Swedish Men (full–2016)  http://stroke.ahajournals.org/content/48/2/265.long
Minimal Physical Health Risk Associated With Long-term Cannabis Use—But Buyer  Beware (1st page–2016) http://jama.jamanetwork.com/article.aspx?articleid=2526619
The Effect of Medical Marijuana on Sickness Absence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27416978
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568641
Prevalence and correlates of “Vaping” as a route of cannabis administration in medical cannabis patients (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27770657
A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27810656
From adolescent to elder rats: Motivation for palatable food and cannabinoids receptors (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27935269
Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28008372
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.epilepsybehavior.com/article/S1525-5050(16)30334-1/fulltext
An Australian nationwide survey on medicinal cannabis use for epilepsy: History of  antiepileptic drug treatment predicts medicinal cannabis use (full–2017)  http://www.epilepsybehavior.com/article/S1525-5050(17)30073-2/fulltext
Association Between Use of Cannabis in Adolescence and Weight Change into Midlife  (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0168897
Associations between Cannabis Use and Physical Health Problems in Early Midlife: A  Longitudinal Comparison of Persistent Cannabis versus Tobacco Users (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936934/
Cannabis use among patients at a comprehensive cancer center in a state with legalized  medicinal and recreational use (full–2017)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders (1st page–2017) http://jamanetwork.com/journals/jama/article-abstract/2610319
Social correlates of health status, quality of life, and mood states in patients treated with  cannabidiol for epilepsy (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30731-4/fulltext
Cannabis use and bone mineral density: NHANES 2007–2010 (abst–2017) 
http://link.springer.com/article/10.1007%2Fs11657-017-0320-9
Cannabis use patterns and motives: A comparison of younger, middle-aged, and older  medical cannabis dispensary patients (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28340421
Predictors of Adult E-Cigarette Users Vaporizing Cannabis Using E-Cigarettes and Vape-Pens (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28323498
Determinants of peripheral airway function in adults with and without asthma (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28397998
Prevalence, correlates, and trends in tobacco use and cessation among current, former,  and never adult marijuana users with a history of tobacco use, 2005-2014 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28525833
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in
adults (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30262-4/fulltext
Loose regulation of medical marijuana programs associated with higher rates of adult  marijuana use but not cannabis use disorder (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28600874
Structural Neuroimaging Correlates of Alcohol and Cannabis Use in Adolescents and  Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28646566
Longitudinal pathways from unconventional personal attributes in the late 20s to  cannabis use prior to sexual intercourse in the late 30s (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28648991
Cannabis use, attitudes, and legal status in the U.S.: A review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28705601
Acute and long-term effects of Δ9-tetrahydrocannabinol on object recognition and  anxiety-like activity are age- and strain-dependent in mice (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0091305716302672?via%3Dihub
Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29185555
Regulating Cannabis Social Clubs: A comparative analysis of legal and self-regulatory  practices in Spain, Belgium and Uruguay (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28189980


MIGRAINE/HEADACHE*+
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant
for administration by ingestion or other means (Health Canada) (full–2010)  http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Alterations of the endocannabinoid system in an animal model of migraine: Evaluation in cerebral areas of rat (abst-2010) http://journals.sagepub.com/doi/full/10.1111/j.1468-2982.2009.01924.x
The endocannabinoid system and migraine (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20353780
Effects of anandamide in migraine: data from an animal model (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072518/
Migraines, Marijuana, and Chocolate (article-2011) http://www.psychologytoday.com/blog/your-brain-food/201109/migraines-marijuana-and-chocolate
The Use of Marijuana or Synthetic Cannabinoids for the Treatment of Headache (1st page-2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01848.x/abstract
Use of cannabis among 139 cluster headache sufferers (download–2012)  http://scholar.google.com/scholar_url?url=https://www.researchgate.net/profile/Elizabeth_Leroux/publication/278871004_Cluster_Headache_Cluster_Headache_and_Cannabis/links/563f912008ae45b5d28d30e8.pdf&hl=en&sa=X&scisig=AAGBfm2FeWNia7xmI9Y7qQcIo3XFnscxeA&nossl=1&oi=scholarr
Hallucinogens and cannabinoids for headache (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/23030539
Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular system (abst–2012) http://journals.lww.com/pain/Abstract/2012/11000/Olvanil_acts_on_transient_receptor_potential.13.aspx
Headache after substance abuse: A diagnostic dilemma (abst-2012)  http://www.ncbi.nlm.nih.gov/pubmed/22245279
Irritable Bowel Syndrome and Migraine: Bystanders or Partners? (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714407/
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and “Triptan” Receptors: Implications in Migraine (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771033/
Effect of Cannabinoid Receptor Activation on Spreading Depression (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586901/
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model (full–2014) http://www.thejournalofheadacheandpain.com/content/pdf/1129-2377-15-14.pdf
Exposure to Bisphenol A Exacerbates Migraine-Like Behaviors in a Multibehavior Model of Rat Migraine (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908719/
Nocebo and placebo modulation of hypobaric hypoxia headache involves the  cyclooxygenase-prostaglandins pathway (full–2014) Benedetti_Pain_2014_OA.pdf
Intraganglionic injection of a nitric oxide donator induces afferent mechanical sensitization that is attenuated by palmitoylethanolamide (link to download–2014)  https://www.researchgate.net/publication/260149956_Intraganglionic_injection_of_a_nitric_oxide_donator_induces_afferent_mechanical_sensitization_that_is_attenuated_by_palmitoylethanolamide
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the
therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (full–2014) http://tinyurl.com/hss39v9
top
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586320/
Effects of peripheral FAAH blockade on NTG-induced hyperalgesia-evaluation of URB937 in an animal model of migraine (full–2015)  https://escholarship.org/uc/item/8px8692t
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522350/
The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat (download–2015) http://publicatio.bibl.u-szeged.hu/6219/1/Nagy-G.%20G.%20Felt%C3%B6lt%C3%A9skor%20gener%C3%A1lt%281%29.pdf
Osler on Migraine (abst in English & French–2015)  https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/osler-onmigraine/C43113C5FDBE60556E91B8468AB538DE
Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25910421
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It’s Been … (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26015168
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/phar.1673/full
The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25903763
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25958314
top
Endovanilloids are potential activators of the trigeminovascular nocisensor complex (full–2016) http://thejournalofheadacheandpain.springeropen.com/articles/10.1186/s10194-016-0644-7
Variants in the CNR1 gene predispose to headache with nausea in the presence of life  stress (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347942/
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/phar.1673/full
Childhood Maltreatment in the Migraine Patient (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27194425
Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27834685
Interactions between the Kynurenine and the Endocannabinoid System with Special  Emphasis on Migraine (full–2017) http://www.mdpi.com/1422-0067/18/8/1617/htm
The Use of Cannabis for Headache Disorders (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436334/
Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat (full–2017)  http://www.sciencedirect.com/science/article/pii/S0014299917307239?via%3Dihub
Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are
associated with neurological phenotypes in humans (full–2017)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187926
Cannabis for Pain and Headaches: Primer (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28281107
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28372506
Plasma levels of the endocannabinoid anandamide, related N-acylethanolamines and  linoleic acid-derived oxylipins in patients with migraine (abst–2017)  http://www.plefa.com/article/S0952-3278(17)30041-8/fulltext
Nitroglycerin increases serotonin transporter expression in rat spinal cord but anandamide modulated this effect (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0891061817300340
Inhibition of monoacylglycerol lipase: Another signalling pathway for potential  therapeutic targets in migraine? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28816506
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep  (abst-2017) http://journals.sagepub.com/doi/abs/10.1177/0269881117699616
The role of cannabinoids in pain control: the good, the bad, and the ugly (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29338150


MILITARY and CANNABINOIDS
Survey on the use of psychotropic drugs by twelve military police units in the municipalities of Goiânia and Aparecida de Goiânia, state of Goiás, Brazil (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000400012&lng=en&nrm=iso&tlng=en
Survey of alcohol, tobacco, and cannabis use in the French army (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20390703
Cannabis use among military veterans after residential treatment for posttraumatic stress disorder (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21261407
Impact of Lowering Confirmatory Test Cutoff Value in Pre-Enlistment Urine
Cannabinoids Screening: About Five Years’ Experience in the French Gendarmerie (full–2012) https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bks067
Prevalence of Cannabis Use Disorder Diagnoses Among Veterans in 2002, 2008, and 2009 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22564034
The underdiagnosis of cannabis use disorders and other Axis-I disorders among military veterans within VHA (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22808884
Spice: a new “legal” herbal mixture abused by young active duty military personnel (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22489593
Synthetic Cannabinoid and Cathinone Use Among US Soldiers (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23007932
Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23025133
Alcohol and cannabis consumption in the French Army: determination of consumer profiles to focus on prevention and care (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22128723
Cognitive ability in early adulthood as a predictor of habitual drug use during later military service and civilian life: the Vietnam Experience Study (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22520690
Substance use disorders in the U.S. Armed Forces, 2000-2011 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23231051
The accuracy of self-reported data concerning recent cannabis use in the French armed forces (full–2013) http://eurpub.oxfordjournals.org/content/23/2/328.long
Correspondence (letter to the editor): Cannabis Therapy (letter–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601285/
Synthetic Cannabinoid Overdose in a 20-Year-Old Male US Soldier (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23327506
Is serving in the armed forces associated with tobacco or cannabis initiation? A study of onset sequences before and after joining the French armed forces (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23685331
Poor sleep quality as a risk factor for lapse following a cannabis quit attempt (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23098380
Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23617872
The impact of perceived sleep quality and sleep efficiency/duration on cannabis use  during a self-guided quit attempt (abst–2013)  http://www.sciencedirect.com/science/article/pii/S030646031300172X
Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25263309
Spicing up the military: Use and effects of synthetic cannabis in substance abusing army personnel (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24727109
Physical activity and cannabis cessation (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24629045
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated  nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over  design study (full–2015) http://www.psyneuen-journal.com/article/S0306-4530%2814%2900413-2/fulltext
Prevalence of psychotropic drug use in military police units (full–2015) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232015000601843&lng=en&nrm=iso&tlng=en
Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates (article–2015) http://journalofethics.ama-assn.org/2015/06/pfor2-1506.html
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Difficulties in emotion regulation are associated with panic symptom severity following a quit attempt among cannabis dependent veterans (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25034429
The prospective effects of perceived and laboratory indices of distress tolerance on  cannabis use following a self-guided quit attempt (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26727009
Cannabis use among Navy personnel in Sri Lanka: a cross sectional study (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794863/
Associations of Posttraumatic Stress Disorder Symptoms With Marijuana and Synthetic Cannabis Use Among Young Adult U.S. Veterans: A Pilot Investigation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869907/
Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment  (full–2016) http://journals.lww.com/tnpj/Fulltext/2016/01000/Cannabis_for_posttraumatic_stress_disorder__A.6.aspx
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475408
PTSD and Cannabis-Related Coping Among Recent Veterans in New York City (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475281/
Factors associated with substance use among Spanish military personnel involved in  “Bosnia-Herzegovina”. (link to PDF in English, abst in Spanish–2017)  http://adicciones.es/index.php/adicciones/article/view/734
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and
cued-arousal among veterans who screen positive for PTSD (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0306460317300072
Synthetic Pot: Not Your Grandfather’s Marijuana (abst–2017)  http://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(16)30185-7


MISCELLANEOUS STUFF–STUDIES
VICTOR LICATA : A RUSH TO JUDGEMENT (ebook–undated) http://reefermadnessmuseum.org/VictorLIcata/Chap00_Index.htm
Drug War Clock: Money Spent on the War On Drugs this Year (links to studies-undated) http://www.drugsense.org/cms/wodclock
Outline for a Marijuana Medical Handbook – Tod Mikuriya (undated) http://www.ukcia.org/medical/marijuanamedicalhandbook.php
THE LEGEND OF THE HOT TAMALE PEDDLER: What the Newspapers were saying: (news–undated) http://reefermadnessmuseum.org/chap11/NewsPaper.htm
Hemp Hurds As Paper Making Material: Bulletin 404, USDA 1916 (full–1916) http://www.gutenberg.org/files/17855/17855-h/17855-h.htm
Problems of modern hemp breeding, with particular reference to the breeding of varieties of hemp containing little or no hashish (full–1956) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1956-01-01_3_page007.html
The Use of the Cannabis Drugs in India (full–1957) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1957-01-01_1_page003.html
Suppressive Effects of 2-thiouracil on Differentiation and Flowering in Cannabis Sativa (abst–1960) http://www.ncbi.nlm.nih.gov/pubmed/13713898
Sweet v. Parsley and Public Welfare Offences (full–1969) http://onlinelibrary.wiley.com/doi/10.1111/j.1468-2230.1969.tb02306.x/epdf
Mr. X by Carl Sagan (article-1969) http://marijuana-uses.com/mr-x/
Effects of Chronic Smoking of Cannabis in Jamaica (download–1972) http://cifas.us/pdf/Comitas%20Pdf%20Files/Long%20Manuscripts/1972%20Effects%20of%20Chronic%20Smoking%20of%20Cannabis%20in%20Jamaica.pdf
Marijuana and Mutism (abst-1972) http://ajp.psychiatryonline.org/doi/abs/10.1176/ajp.129.4.475
Kif in Morocco (abst–1975) http://www.ncbi.nlm.nih.gov/pubmed/1104494
Cannabinoid Profile and Elemental Uptake of Cannabis sativa L. as Influenced by Soil Characteristics (full-1975) http://www.votehemp.com/PDF/Cannabinoid_Profile_and_Elemental_Uptake_of_Cannabis_sativa_L._as_I nfluenced_by_Soil_Characteristics-1975.pdf
Physical assessment of 30 chronic cannabis users and 30 matched controls (1st page–1976) http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.1976.tb49895.x/abstract
A note on the cannabinoid content of Jamaican ganja (abst–1976) http://www.ncbi.nlm.nih.gov/pubmed/1051625
Gynecomastia and cannabis smoking: A nonassociation among US Army soldiers  (download-1977) Gynecomastia and Cannabis Smoking
Marijuana – The First Twelve Thousand Years (book–1980) http://www.druglibrary.org/Schaffer/hemp/history/first12000/abel.htm
Sequential appearance of cannabinoids during seedling development (full–1980) https://www.realhemp.com/marihuana-84/
Ingestion of Hashish Oil-filled Condoms (abst–1980) http://www.ncbi.nlm.nih.gov/pubmed/7207349
Bias and the cannabis researcher (abst–1981) http://www.ncbi.nlm.nih.gov/pubmed/6271821
Structure, development and composition of glandular trichomes of Cannabis (link to PDF–1984) https://www.realhemp.com/mahlberg-cannabis-research/structure-development-and-composition-ofglandular-trichomes-of-cannabis/
Illicit traffic and abuse of cannabis in Canada (full–1985) http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1985-01-01_4_page006.html
The effects of marijuana on human physical aggression (full–1985)  https://www.scribd.com/document/121297701/Rodney-Myerscough-and-Stuart-Taylor-The-Effects-of-Marijuana-on-HumanPhysical-Aggression
Barba Jacob and the history of marihuana (abst–1986) http://www.ncbi.nlm.nih.gov/pubmed/3296662
Retrieving impacted cannabis resin with ear drops (full-1987) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1492799/?tool=pubmed
UV-B radiation effects on photosynthesis, growth and cannabinoid production of two Cannabis sativa chemotypes (full–1987)  http://factpub.org/wiki/index.php/UVB_radiation_effects_on_photosynthesis,_growth_and_cannabinoid_production_of_two_Cannabis_sativa_chemotypes._Lydon,J
The Business of Drug Dealing in Milwaukee (download–1988) http://cifas.us/analyses/dealing.pdf
Stability of Cannabinoids in Dried Samples of Cannabis Dating from Around 1896-1905 (abst–1990) http://www.ncbi.nlm.nih.gov/pubmed/2314109
The Intangible Rewards from Crime: The Case of Domestic Marijuana Cultivation (abst-1991) http://cad.sagepub.com/content/37/4/506.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=marihuana&searchid=1&FIRSTINDEX=1840&resourcetype=HWCIT
From Ganja to Crack: Caribbean Participation in the Underground Economy in Brooklyn, 1976-1986. Part 1. Establishment of the Marijuana Economy (abst–1991) http://www.tandfonline.com/doi/abs/10.3109/10826089109058909
Flashback Following Use of Cannabis-a Review (abst–1991) http://www.ncbi.nlm.nih.gov/pubmed/1761271
The Effect of Marijuana Decriminalization on Hospital Emergency Room Drug Episodes: 1975–1978 (download–1993) http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.552.4535&rep=rep1&type=pdf
Economics of Cannabis Legalization (full–1993) https://pdfs.semanticscholar.org/baf7/9244b58d0e69b237cef4264707e1311f14ff.pdf
Economics of Legalization (full–1994) http://norml.org/component/zoo/category/economics-of-cannabis-legalization
Preference for High- Versus Low-potency Marijuana (abst–1994) http://www.ncbi.nlm.nih.gov/pubmed/7862719
DRUG USE AND HUMAN RIGHTS: PRIVACY, VULNERABILITY, DISABILITY, AND HUMAN RIGHTS INFRINGEMENTS (article–1996) http://cifas.us/analyses/Gilmore1.html
The effectiveness of Drug Abuse Resistance Education (project DARE): 5-year follow-up  results (abst–1996) http://www.ncbi.nlm.nih.gov/pubmed/8781009
Essential oil of Cannabis sativa L. strains (full–1997)  http://www.internationalhempassociation.org/jiha/jiha4208.html
Cannabis Hemp: The Invisible Prohibition Revealed (link to PDF–1997) http://www.constitutionalcannabis.com/uploads/1/3/5/9/13590809/sots_web.pdf
Immunochemical localization of tetrahydrocannabinol (THC) in cryofixed glandular  trichomes of Cannabis (Cannabaceae) (link to PDF–1997)  http://www.amjbot.org/content/84/3/336.full.pdf+html
Feasibility of Industrial Hemp Production in the United States Pacific Northwest (link to PDF–1998) https://catalog.extension.oregonstate.edu/sb681
Drugs in Prehistory: Chemical Analysis of Ancient Human Hair (abst–1998) http://www.fsijournal.org/article/S0379-0738%2899%2900204-2/abstract
Drugs in Prehistory: Chemical Analysis of Ancient Human Hair (link to download–1998) https://www.researchgate.net/publication/12579718_Drugs_in_prehistory_Chemical_analysis_of_ancient_ human_hair
Providing medical marijuana: the importance of cannabis clubs (abst–1998) http://www.ncbi.nlm.nih.gov/pubmed/9692380
Schedules of controlled substances: rescheduling of the Food and Drug Administration approved product containing synthetic dronabinol [(-) – [DELTA] less than 9 greater than – (trans)-tetrahydrocannabinol] in sesame oil and encapsulated in soft gelatin capsules from schedule II to schedule III. Department of Justice (DOJ), Drug Enforcement Administration (DEA) Final rule (full–1999) http://www.deadiversion.usdoj.gov/fed_regs/rules/1999/fr0702.htm
top
A Critical Look at the D.A.R.E. Program and Effective Youth Programs (3 articles-1999) https://web.stanford.edu/class/e297c/poverty_prejudice/ganginterv/criticallook.htm
The Relationship between Research and Drug Policy in the United States (article–1999) http://cifas.us/analyses/laniel.html
Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10080239
Project DARE: no effects at 10-year follow-up (abst–1999) http://www.ncbi.nlm.nih.gov/pubmed/10450631
The Science of Marijuana (book–2000) http://www.green215.com/sites/all/files/education_articles/Science%20Cannabis.pdf
Cannabinoid mimics in chocolate utilized as an argument in court (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10876983
New Tropical Industrial Hemp (full–2001) http://www.hempreport.com/issues/17/australia16.html
Industrial Hemp (Cannabis sativa L.) as a Papermaking Raw Material in Minnesota: Technical, Economic, and Environmental Considerations (full–2001) http://www.votehemp.com/PDF/hemp.pdf
Cannabis: an environmentally and economically viable method for climate change mitigation (revised 2001) (thesis–2001) http://www.hempreport.com/issues/17/pdf/deeleythesis.pdf
Distortion of Teatree Stems by Twine As a Means to Determine the Number of Years That the Stems Have Been Used to Support Cannabis Plants (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11451066
Cannabis-induced Koro in Americans (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11784462
The economics of cannabis-cultivation in Europe (full-2002) http://www.cedro-uva.org/lib/jansen.economics.html
Chronic Cannabis Use in the Compassionate Investigational New Drug Program: An Examination of Benefits and Adverse Effects of Legal Clinical Cannabis (full–2002) http://proxy.baremetal.com/cannabiscoalition.ca/chronic.pdf
The endocannabinoid system in invertebrates (link to PDF–2002) http://citeseerx.ist.psu.edu/viewdoc/summary? doi=10.1.1.724.8151&rank=69&q=cannabinoid&osm=&ossid=
The Ganja Complex: Rastafari and Marijuana (download–2002) http://cifas.us/pdf/Fieldwork%20and%20Research/Cannabis/Books/Hamid/2002_GanjaComplex_Hamid%202.pdf
Remediation of benzo[a]pyrene and chrysene-contaminated soil with industrial hemp (Cannabis sativa) (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12655808
Cannabis and the evidence that led to its international control: a cautionary tale  (download–2003) http://onlinelibrary.wiley.com/doi/10.1046/j.1360-0443.2003.00325.x/pdf
A Brief History of Cannabis Policies in Spain (1968–2003) (full–2003) http://jod.sagepub.com/content/34/3/623.full.pdf+html
Patent 6503492 – Antiperspirant or deodorant compositions (full–2003) http://www.google.com/patents/US6503492
Cannabis (marijuana) contamination of United States and foreign paper currency (full–2004) http://jat.oxfordjournals.org/content/28/6/439.long
California and U.S. Officials Conspired to Block Prop 215 (article–2004) http://www.os-extra.cannabisclinicians.org/wp-content/uploads/2014/04/McCartney-Conspiracy-04.pdf
Burns from illegal drug manufacture: case series and management (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15273473
A biological oil adsorption filter (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15556187
God forbid! Substance use among religious and non-religious youth (full–2005) http://www.ncbi.nlm.nih.gov/pubmed/16262516
Cannabimimetic Effects of Osteopathic Manipulative Treatment (full–2005) http://jaoa.org/article.aspx?articleid=2093088&resultClick=1
Mother’s milk and the muffin man: grassroots innovations in medical marijuana delivery systems (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16537333
Cultivation of Cannabis sativa L. in northern Morocco (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/21338017
Fibre crops as alternative land use for radioactively contaminated arable land (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15795030
Waterborne Lead Exposure Affects Brain Endocannabinoid Content in Male but Not Female Fathead Minnows (Pimephales Promelas) (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15527869
Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16191670
Marijuana Production in the United States (full–2006) http://www.drugscience.org/Archive/bcr2/MJCropReport_2006.pdf
top
Explicit and Implicit Effects of Anti-marijuana and Anti-tobacco Tv Advertisements (abst–2006) http://www.sciencedirect.com/science/article/pii/S0306460306000955
Cannabis and Endocannabinoids: The Old Man and the Teenagers (full–2007) http://www.farm.ucl.ac.be/Full-texts-FARM/Lambert-2007-1.pdf
“Usual” cannabis abuse producing an unusual incident (abst–2007) (The Valsalva maneuver is performed by attempting to forcibly exhale while keeping the mouth and nose closed. Don’t do it!) (abst in English & German–2007) https://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-970377
Apparent increase in biomass and see productivity in hemp (Cannabis sativa) resulting from branch proliferation caused by the European corn borer (Ostrinia nubilalis) (abst–2007) http://www.agr.gc.ca/eng/abstract/?id=9561000000564
Production of THC acid by the biosynthetic enzyme secreted from transgenic Pichia  pastoris (download-2007) https://www.google.com/url?url=http://scholar.google.com/scholar_url%3Furl%3Dhttp://citeseerx.ist.psu.edu/viewdoc/download%253Fdoi%253D10.1.1.528.7504%2526rep%253Drep1%2526type%253Dpdf%26hl%3Den%26sa%3DX%26scisig%3DAAGBfm1nW5930sfWsldbAL_3pXxESixhFQ%26nossl%3D1%26oi%3Dscholarr&rct=j&q=&esrc=s&sa=X&ved=0ahUKEwiV1uzGzOzYAhUFLKwKHS2ZDsYQgAMIJygBMAA&usg=AOvVaw1TD4W9_fQik8fMSwNDUc3x
The Army’s Conquest-by-Cannabinoid Fantasy (article–2008) http://www.beyondthc.com/wp-content/uploads/2014/06/Ketchum-THM-issue-color.pdf
Scheduling process at DEA – the example of cannabidiol (abst–2008) http://www.fasebj.org/cgi/content/meeting_abstract/22/1_MeetingAbstracts/711.1
N-arachidonoyl dopamine is a possible factor of the rate of tentacle formation in freshwater hydra (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18409382
Fungal biotransformation of cannabinoids: potential for new effective drugs (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19333876
Cannabinoids Excite Circadian Clock Neurons (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927117/?tool=pmcentrez
Tea catechins’ affinity for human cannabinoid receptors (full–2010) http://www.thefreelibrary.com/Tea+catechins%27+affinity+for+human+cannabinoid+receptors.-a0221094461
Characteristics of Cannabis sativa L.: seed morphology, germination and growth  characteristics, and distinction from Hibiscus cannabinus L (link to PDF–2010)  https://www.jstage.jst.go.jp/article/yakushi/130/2/130_2_237/_article
Necessity or nastiness? The hidden law denying cannabis for medical use (full/news–2010) http://profdavidnutt.wordpress.com/2010/12/13/necessity-or-nastiness-the-hidden-law-denying-cannabis-for-medicinal-use/
A Sociological Theory of Drug Sales, Gifts, and Frauds (full–2010) http://journals.sagepub.com/doi/full/10.1177/0011128710386199
Colonic perforation: a lethal consequence of cannabis body packing (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20569954
Stable isotope models to predict geographic origin and cultivation conditions of marijuana (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20470741
The results of an experimental indoor hydroponic Cannabis growing study, using the ‘Screen of Green’ (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20462712
Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008 (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20487147/abstract/Potency_trends_of_%CE%949_THC_and_other_cannabinoids_in_confiscated_cannabis_preparations_from_1993_to_2008_
The case for small-scale domestic cannabis cultivation (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20176465
top
The feasibility of converting Cannabis sativa L. oil into biodiesel (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20624607
Effect of various concentrations of Crocus sativus and Cannabis sativa extracts on luminescent biosensor Escherichia coli SM10 S1 (full–2011) http://jjm.ajums.ac.ir/_jjm/documents/Issue%2012,%20S35-41MM.pdf
Bilateral testicular self-castration due to cannabis abuse: a case report (full–2011) (warning-graphic pictures) http://www.jmedicalcasereports.com/content/5/1/404
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281798/
Cannabinomimetic lipid from a marine cyanobacterium (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325759/
High-performance sport, marijuana, and cannabimimetics (full–2011) http://jat.oxfordjournals.org/content/35/9/624.long
“But my Doctor Recommended Pot”: Medical Marijuana and the Patient-Physician Relationship (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208453/
Examining the Health and Drug Exposures among Canadian Children Residing in Drug Producing Homes (full–2011) http://www.jpeds.com/article/S0022-3476(11)00522-1/fulltext
Medical marijuana: medical necessity versus political agenda (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628147/
How well do international drug conventions protect public health? (full–2011) http://www.hr-dp.org/files/2015/07/16/Room-CND-2012_%281%29.pdf
Study on spectral reflectance characteristics of hemp canopies (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21322234
Attempted ignition of petrol vapour by lit cigarettes and lit cannabis resin joints (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21605828
Bioconversion of industrial hemp to ethanol and methane: the benefits of steam pre-treatment and co-production (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21111616
Cadmium Tolerance and Bioaccumulation of 18 Hemp Accessions (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21938417
Reported value of cannabis seizures in Australian newspapers: are they accurate? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21219493
Molecular analysis of genetic fidelity in Cannabis sativa L. plants grown from synthetic (encapsulated) seeds following in vitro storage (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21805186
Investigations into the Hypothesis of Transgenic Cannabis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22211569
The Effect of Electrical Lighting Power and Irradiance on Indoor-Grown Cannabis Potency and Yield (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22211717
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22337285
Cannabis use in a central region of Tunisia (abst in English–2011)  http://www.ncbi.nlm.nih.gov/pubmed/22407249 (full in French)  http://www.jle.com/fr/revues/san/edocs/consommation_de_cannabis_dans_une_region_du_centre_tunisien_291967/article.phtml?tab=texte
top
EVALUATION ALLELOPATHIC EFFECT OF HEMP (CANNABIS SATIVA L.) ON GERMINATION AND GROWTH OF THREE KINDS OF WEEDS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=246119
High on Life? Medical Marijuana Laws and Suicide (full–2012) http://ftp.iza.org/dp6280.pdf
Medical Marijuana Laws and Teen Marijuana Use (full–2012) http://ftp.iza.org/dp6592.pdf
The medicalisation of revolt: a sociological analysis of medical cannabis users (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1467-9566.2012.01476.x/full
Clinical Service Desires of Medical Cannabis Patients (full–2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-12.pdf
Societal images of Cannabis use: comparing three countries (full–2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-21.pdf
The Relationship between Plants Used to Sustain Finches (Fringillidae) and Uses for Human Medicine in Southeast Spain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350861/?tool=pubmed
Cannabis sativa – An Important Subsistence Pollen Source for Apis mellifera (full–2012) http://iosrjournals.org/iosr-jpbs/papers/vol1-issue4/A0140103.pdf
Cannabis in the Media: Film Prespectives on the Least Illicit Schedule 1 Drug (full–2012) http://entheology.com/research/cannabis-in-the-media-film-perspectives-on-the-least-illicit-schedule-idrug/
Marine Cyanobacterial Fatty Acid Amides Acting on Cannabinoid Receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748600/
Antimicrobial Activity of Cannabis sativa L. (full–2012) http://file.scirp.org/Html/10-8801078_18123.htm
Prevalence of Synthetic Cannabinoids in U.S. Athletes: Initial Findings (full–2012) https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bks066
Effects of parabolic flight and spaceflight on the endocannabinoid system in humans  (download–2012) https://pdfs.semanticscholar.org/700c/01d83f2bc080f6ba242cc9c927394f5bf111.pdf
Cannabinoid-like anti-inflammatory compounds from flax fiber (link to PDF–2012) http://link.springer.com/article/10.2478%2Fs11658-012-0023-6
The medicalisation of revolt: a sociological analysis of medical cannabis users (link to PDF–2012) http://www.stcm.ch/en/files/paper_pedersen—sandberg.pdf
Cannabis Genome Uncloaked: Commentary on the Scientific Implications (article–2012) http://tinyurl.com/zqfrpew
Using dopamine research to generate rational cannabinoid drug policy (abst–2012)  http://onlinelibrary.wiley.com/doi/10.1002/dta.1410/full
Is today’s marijuana more potent simply because it’s fresher? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23169764
Cannabis – from cultivar to chemovar (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22362625
Evolution of the Content of THC and Other Major Cannabinoids in Drug-Type Cannabis Cuttings and Seedlings During Growth of Plants (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22390363
Chemiluminescence detection of cannabinoids and related compounds with acidic potassium permanganate (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22461321
top
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their anti-tumoral efficacy (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22580111
Left-handedness is statistically linked to lifetime experimentation with illicit drugs (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22594814
A survey of the potency of Japanese illicit cannabis in fiscal year 2010 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22554871
Shiva, lord of bhang (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22742944
Prevalence of Cannabis Use Disorder Diagnoses Among Veterans in 2002, 2008, and 2009 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22564034
An age–period–cohort analysis of cannabis use prevalence and frequency in Germany, 1990–2009 (abst–2012) http://jech.bmj.com/content/early/2011/10/20/jech-2011-200180
The underdiagnosis of cannabis use disorders and other Axis-I disorders among military veterans within VHA (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22808884
The prevalence of substance use among patients at a dental school clinic in Michigan (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22855903
Comparison of Random and Postaccident Urine Drug Tests in Southern Indiana Coal Miners (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22895464
Why small-scale cannabis growers stay small: Five mechanisms that prevent small-scale growers from going large scale (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23036648
Profiles of illicit drug use during annual key holiday and control periods in Australia: wastewater analysis in an urban, a semi-rural and a vacation area (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23072541
Predictors of stigmatization towards use of various illicit drugs among emerging adults (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23061324
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23280038
The New Politics of Marijuana Legalization: Why Opinion is Changing (full–2013) http://www.brookings.edu/research/papers/2013/05/29-politics-marijuana-legalization-galston-dionne
top
Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107777/
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076635
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584982/
Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677619/
Why should Cannabis be Considered Doping in Sports? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654312/
Identity Formation, Marijuana and “The Self”: A Study of Cannabis Normalization among University Students (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847659/
Weeding out the information: an ethnographic approach to exploring how young people sense of the evidence on cannabis (full–2013) http://www.harmreductionjournal.com/content/10/1/34
“Body packers” in Israel: a case series (full–2013) http://www.ima.org.il/FilesUpload/IMAJ/0/65/32679.pdf
Extraction of high quality DNA from seized moroccan cannabis resin (hashish) (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790795/

Viking and early Middle Ages northern Scandinavian textiles proven to be made with hemp (full–2013) http://www.nature.com/srep/2013/131018/srep02686/pdf/srep02686.pdf
Do societal wealth, family affluence and gender account for trends in adolescent cannabis use? A 30 country cross-national study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947129/
Statistics on cannabis users skew perceptions of cannabis use (full–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00138/full
US Patent Application 20130251824 – Recycling cannabinoid extractor (full–2013) http://www.faqs.org/patents/app/20130251824
From “Social Supply” to “Real Dealing”: Drift, Friendship, and Trust in Drug-Dealing Careers (full–2013) http://jod.sagepub.com/content/43/4/392.full.pdf+html
In planta imaging of Δ9-tetrahydrocannabinolic acid in Cannabis sativa L. with hyperspectral coherent anti-Stokes Raman scattering microscopy (full–2013) http://os.tnw.utwente.nl/publications/pdf/237.pdf
The Future of Marijuana in the United States (download-thesis–2013)  https://scholarsbank.uoregon.edu/xmlui/handle/1794/13615
Secondary Metabolites from Eupenicillium parvum and Their in Vitro Binding Affinity
for Human Opioid and Cannabinoid Receptors (link to 1st page–2013)  https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0033-1351099.pdf
Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23291209
Cloud point extraction of Δ(9)-tetrahydrocannabinol from cannabis resin (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23354583
top
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23588562
Effects of Schedule I drug laws on neuroscience research and treatment innovation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23756634
Cannabis use in a Swiss male prison: Qualitative study exploring detainees’ and staffs’ perspectives (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23773686
Life Cycle Assessment of Hemp Cultivation and Use of Hemp-Based Thermal Insulator Materials in Buildings (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23745970
Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A time series analysis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23867051
Nematicidal activities of Cannabis sativa L. and Zanthoxylum alatum Roxb. against Meloidogyne incognita (abst–2013) http://www.sciencedirect.com/science/article/pii/S0926669012003494
Use of Silk Road, the online drug marketplace, in the UK, Australia and the USA (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24372954
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0033-1352335
An Examination of Opinions Toward Marijuana Policies Among High School Seniors in the United States (full–2014) http://www.tandfonline.com/doi/full/10.1080/02791072.2014.962716#tabModule
Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints (full–2014) http://www.biomedcentral.com/content/pdf/1471-2474-15-258.pdf
Words Can Be Deceiving: A Review of Variation Among Legally Effective Medical Marijuana Laws in the United States (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314612/
Hashish revival in Morocco (full–2014) http://www.ijdp.org/article/S0955-3959%2814%2900003-6/fulltext
top
Couples’ Marijuana Use Is Inversely Related to Their Intimate Partner Violence Over the First 9 Years of Marriage (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282761/
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010 (full–2014) http://archinte.jamanetwork.com/article.aspx?articleid=1898878
Cannabinoid modulation of drug reward and the implications of marijuana legalization (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442758/
Prevalence of Early phytocannabinoid chemistry to endocannabinoids and beyond (link to download–2014)  https://www.researchgate.net/publication/266945311_Early_phytocannabinoid_chemistry_to_endocannabinoids_and_beyond
“A Little Dab Will Do Ya”: An Emergency Department Case Series Related to a New Form of “High-Potency” Marijuana Known as “Wax” (article–2014) http://www.annemergmed.com/article/S0196-0644%2814%2901025-7/fulltext

Genetic identification of Cannabis sativa using chloroplast trnL-F gene (abst–2014)  http://www.fsigenetics.com/article/S1872-4973%2814%2900219-1/fulltext
Identification and quantification of synthetic cannabinoids in ‘spice-like’ herbal mixtures : A snapshot of the German situation in the autumn of 2012 (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/23723183
Hashish as cash in a post-Soviet Kyrgyz village (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24594222
Behaviours of psychotropic substances in indoor and outdoor environments of Rome, Italy (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24705952
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical Grade Cannabis (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24747979
Just say ‘know’: how do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24894801
Post-Soviet Central Asia: A summary of the drug situation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24954816
Fifty years of ‘cannabinoid research’ and the need for a new nomenclature (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch8/summary
Interconnected carbon nanosheets derived from hemp for ultrafast supercapacitors with high energy (abst–2014) http://pubs.acs.org/doi/abs/10.1021/nn400731g
Effective Phytoextraction of Cadmium (Cd) with Increasing Concentration of Total Phenolics and Free Proline in Cannabis sativa (L) Plant Under Various Treatments of Fertilizers, Plant Growth Regulators and Sodium Salt (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25174425
Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25181993
Mooreamide A: A Cannabinomimetic Lipid from the Marine Cyanobacterium Moorea bouillonii (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25204580
top
Production, perceptions, and punishment: Restrictive deterrence in the context of cannabis cultivation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25223245
Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25263309
Omega-3 fatty acid production from enzyme saccharified hemp hydrolysate using a novel marine thraustochytrid strain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25497057
Frequent electronic media communication with friends is associated with higher adolescent substance use (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25471077
Using Web searches to track interest in synthetic cannabinoids (aka ‘herbal incense’)  (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/dar.12189/full
The globalisation of cannabis cultivation: A growing challenge (full–2015) http://www.ijdp.org/article/S0955-3959%2815%2900003-1/fulltext
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
Cannabis in medicine: a national educational needs assessment among Canadian physicians (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374299/
Global patterns of domestic cannabis cultivation: Sample characteristics and patterns of growing across eleven countries (full–2015) http://www.ijdp.org/article/S0955-3959%2814%2900363-6/fulltext
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Human rights, public health and medicinal cannabis use (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662098/
Cannabis Mobile Apps: A Content Analysis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705020/
U.S. Policy Responses to Calls for the Medical Use of Cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553645/
Enrichment and identification of Δ(9)-Tetrahydrocannabinolic acid synthase from Pichia pastoris culture supernatants (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560726/
Are cannabis laws used for political repression in the Arab Spring countries? (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13065/full
Marijuana gears up for production high in US labs (article–2015) http://www.nature.com/news/marijuana-gears-up-for-production-high-in-us-labs-1.17129
Marijuana Research with Human Subjects (article–2015) http://www.fda.gov/newsevents/publichealthfocus/ucm421173.htm

Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample (full–2015) http://journals.sagepub.com/doi/full/10.1177/0269881115574493
High prevalence of cannabis use among Aka foragers of the Congo Basin and its possible  relationship to helminthiasis (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/26031406
Predicting Alcohol, Cigarette, and Marijuana Use From Preferential Music Consumption (full–2015) http://journals.sagepub.com/doi/full/10.1177/0047237915607283
top
Assessing the harms of cannabis cultivation in Belgium (full–2015) http://www.ijdp.org/article/S0955-3959(14)00359-4/fulltext 
“Should I Buy or Should I Grow?” How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25655217
Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661483
Stability of cosmetic emulsion containing different amount of hemp oil (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25704610
From substance use to homelessness or vice versa? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25989002
UNGASS 2016: Insights from Europe on the development of global cannabis policy and the need for reform of the global drug policy regime (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26795703
Production of Δ9-tetrahydrocannabinolic acid from cannabigerolic acid by whole cells of Pichia (Komagataella) pastoris expressing Δ9-tetrahydrocannabinolic acid synthase from Cannabis sativa L. (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25994576
Δ9-Tetrahydrocannabinolicacid synthase production in Pichia pastoris enables chemical synthesis of cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26197418
Are the last grade medical students aware of the danger of synthetic cannabinoids? (abst–2015) http://www.jflmjournal.org/article/S1752-928X%2815%2900220-6/abstract
Phytoaccumulation of Heavy Metals in Natural Vegetation at the Municipal Wastewater Site in Abbottabad, Pakistan (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26366840
Merck Manual – Marijuana (Cannabis) Professional version (full–2016) http://www.merckmanuals.com/professional/special-subjects/recreational-drugs-and-intoxicants/marijuanacannabis
Merck Manual – Marijuana (Cannabis) Consumer version (full–2016) http://www.merckmanuals.com/home/special-subjects/recreational-drugs-and-intoxicants/marijuana
δ-Ctenitoxin-Pn1a, a Peptide from Phoneutria nigriventer Spider Venom, Shows Antinociceptive Effect Involving Opioid and Cannabinoid Systems, in Rats (full–2016) http://www.mdpi.com/2072-6651/8/4/106/htm
Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00108/full
High Time for Conservation: Adding the Environment to the Debate on Marijuana Liberalization (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776720/ Indirect Modulation of the Endocannabinoid System by Specific Fractions of Nutmeg Total Extract (full–2016)  http://www.beyondthc.com/wp-content/uploads/2016/06/El-Alfy2016_nutmeg-endocannabinoid-system-FAAH-inhibitor.pdf
Beyond Cannabis: Plants and the Endocannabinoid System (full–2016) http://ge.tt/3Rgtrsa2
Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug Related Emergency Department Visits (full–2016) http://www.ncbi.nlm.nih.gov/books/NBK384680/
Analysis of a commerical marijuana e-cigarette formulation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867395/
A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems (full–2016) https://jvat.biomedcentral.com/articles/10.1186/s40409-016-0091-6
Marijuana-Related Posts on Instagram (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939096/
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase (full – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27806235
The US as an example of how not to legalize marijuana? (download–2016)  http://onlinelibrary.wiley.com/doi/10.1111/add.13498/pdf
Cannabis Legalization: Focusing on Patient Needs: Five Recommendations on Access,  Affordability, and Research (report–2016) http://cfamm.ca/patient-recommendations/
The Effect of Medical Marijuana on Sickness Absence (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27416978
The effect of cannabis on regular cannabis consumers’ ability to ride a bicycle (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26739323
A Genetic Component to National Differences in Happiness (abst–2016) http://link.springer.com/article/10.1007/s10902-015-9712-y
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26769333
Systematic review of the toxicological and radiological features of body packing (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26932867
Tightening the Dutch coffee shop policy: Evaluation of the private club and the residence criterion (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26944718
Cannabis policy and the uptake of treatment for cannabis-related problems (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27004985
Estimating the production, consumption and export of cannabis: The Dutch case (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27048853
Bayesian inference for the distribution of grams of marijuana in a joint (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27346327
Phytotoxic Effect of Fiber Hemp Essential Oil on Germination of Some Weeds and Crops (abst–2016) http://www.tandfonline.com/doi/abs/10.1080/0972060X.2015.1137236? journalCode=teop20
Potential therapeutic targets and the role of technology in developing novel cannabinoid drugs from cyanobacteria (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27416557
Determining Cannabis Use Status From a Photograph: An Assessment of the “Jay-dar” in Neuropsychologists (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27779445
top
Newly incident cannabis use in the United States, 2002-2011: a regional and state level
benchmark (full–2017) https://peerj.com/articles/3616/
Identification of a Widespread Palmitoylethanolamide Contamination in Standard
Laboratory Glassware (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510777/
Anatomy of a Joint: Comparing Self-Reported and Actual Dose of Cannabis and Tobacco in a Joint, and How These Are Influenced by Controlled Acute Administration (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628568/
Commercial herbal medicines used as African traditional medicines: Ngoma Herbal  Tonic Immune Booster interferes with a rapid urine drug screening test (full-2017)  https://www.ajol.info/index.php/samj/article/view/161438/151005
Cannabidiol Does Not Convert to Δ9-Tetrahydrocannabinol in an In Vivo Animal Model  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744690/
Engineering yeasts as platform organisms for cannabinoid biosynthesis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0168165617315201?via%3Dihub
Smoked marijuana attenuates performance and mood disruptions during simulated  night shift work (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30309-5/fulltext
The three betrayals of the medical cannabis growing activist: From multiple victimhood
to reconstruction, redemption and activism (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29287224


MITOCHONDRIA +
Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white  adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways (full–2010) http://diabetes.diabetesjournals.org/content/59/11/2826.full.pdf+html
Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells (1st page-2010) https://www.karger.com/Article/Abstract/312686
Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20514518
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the  crosstalk between apoptosis and autophagy (full–2011)  http://mct.aacrjournals.org/content/10/7/1161.long
Cannabinoid type 1 receptor mediates depot-specific effects on differentiation,  inflammation and oxidative metabolism in inguinal and epididymal white adipocytes  (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303536/
Resistance to diet-induced adiposity in cannabinoid receptor-1 deficient mice is not due to impaired adipocyte function (full–2011)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307495/
The Cannabinoid WIN 55212-2 Mitigates Apoptosis and Mitochondrial Dysfunction After Hypoxia Ischemia (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21909954
Honokiol isolated from Magnolia officinalis stimulates osteoblast function and inhibits
the release of bone-resorbing mediators (abst–2011)  http://www.sciencedirect.com/science/article/pii/S1567576911002220
Therapeutic Potential of Cannabinoids in the Treatment of Neuroinflammation  Associated with Parkinson’s Disease (abst–2011)  https://www.ncbi.nlm.nih.gov/pubmed/21699489
Review article: Endocannabinoids in neuroendopsychology: multiphasic control of mitochondrial function (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3342.full?sid=dd42995f-c629-4f8c-86a0-5e962e352fda
Antimetastatic activity of honokiol in osteosarcoma (full–2012)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.26434/full
Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent  Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer (full–2012)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924623/
Cannabinoid-associated cell death mechanisms in tumor models (Review) (full–2012) http://www.spandidos-publications.com/ijo/41/2/407
Cannabinoid Receptor Antagonist-Induced Striated Muscle Toxicity and Ethylmalonic Adipic Aciduria in Beagle Dogs (full–2012)  http://toxsci.oxfordjournals.org/content/129/2/268.full
Mitochondrial CB(1) receptors regulate neuronal energy metabolism (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22388959
The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22206897
The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria (abst–2012) http://www.springerlink.com/content/54jm40088728t0pn/
Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM233  (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22875710
Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22841538
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877544/
Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain (full–2013) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462013000400380&lng=en&nrm=iso&tlng=en
Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse brain mitochondria (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902808/
Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial bio-genesis in a cell culture model of Parkinson’s Disease (abst-2013) http://jnnp.bmj.com/content/84/11/e2.58.abstract
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuro-inflammation and apoptosis after neonatal ischemic brain damage (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23376684
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014364a.html
The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells:
Involvement of both mitochondrial and death receptor pathways (full–2014)  http://www.placentajournal.org/article/S0143-4004%2814%2900823-6/fulltext
Involvement of cannabinoid receptor-1 activation in mitochondrial depolarizing effect of  lipopolysaccharide in human spermatozoa (full–2014)  http://onlinelibrary.wiley.com/doi/10.1111/j.2047-2927.2014.00210.x/full
Mitochondria: A Possible Nexus for the Regulation of Energy Homeostasis by the Endocannabinoid System? (full–2014)  http://ajpendo.physiology.org/content/ajpendo/307/1/E1.full.pdf
top
Cannabinoid Type 1 (CB1) Receptors on Sim1-Expressing Neurons Regulate Energy  Expenditure in Male Mice (full–2014) http://press.endocrine.org/doi/10.1210/en.2014-1437
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein  DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for  Neuroprotection (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23893294
The Potential Therapeutic Effects of THC on Alzheimer’s Disease (abst–2014) http://iospress.metapress.com/content/8421pvx80144t354/?p=ff122a13e6cf4bf78324e26d253bd883&pi=8
Cannabinoid-induced changes in respiration of brain mitochondria (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25195527
Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446347
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/glia.22742/full
Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189 (full–2015) http://www.mdpi.com/1422-0067/16/1/758/htm
top

Cannabidiol protects against doxorubicin-induced cardiomyopathy by modulating mitochondrial function and biogenesis (full–2015) http://static.smallworldlabs.com/molmedcommunity/content/pdfstore/14_261_Hao.pdf
Lack of hypophagia in CB1 null mice is associated to decreased hypothalamic POMC and CART expression (full–2015)  http://ijnp.oxfordjournals.org/content/early/2015/03/09/ijnp.pyv011.long
Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0141600
Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0145244
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516969/
New horizons for newborn brain protection: enhancing endogenous neuroprotection  (full–2015) http://fn.bmj.com/content/100/6/F541
Dissecting the cannabinergic control of behavior: The where matters (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/bies.201500046/abstract;jsessionid=222EC084D6C5E7ECF95BFF9D2752CFE4.f01t01
Cannabinoid-Induced Changes in the Activity of Electron Transport Chain Complexes of Brain Mitochondria (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25820672
Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843798
6B.09: EFFECT OF CANNABINOID RECEPTOR ACTIVATION ON ABERRANT ITOCHONDRIAL BIO-ENERGETICS IN HYPERTROPHIED CARDIAC MYOCYTES (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26102932
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26431622
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565754
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00027/full
Cannabinoid receptor type-1: breaking the dogmas (full–2016)  http://f1000research.com/articles/5-990/v1
Modulation of cellular redox homeostasis by the endocannabinoid system (full–2016) http://rsob.royalsocietypublishing.org/content/6/4/150276
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by  restoring proteins involved in mitochondrial biogenesis (full–2016)  http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=10314&path%5B%5D=32486
top
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679742/
Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it’s role in metabolic defects and neuronal apoptosis after TBI (full–2016)  http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-016-0257-8
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via  autolysosome destabilization (full–2016)  http://www.tandfonline.com/doi/full/10.1080/15548627.2016.1213927
Cannabinoid CB1 Receptors Are Localized in Striated Muscle Mitochondria and Regulate Mitochondrial Respiration (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078489/
Alteration of SLP2‐like immunolabeling in mitochondria signifies early cellular damage in developing and adult mouse brain (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784115/
Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of  Cannabinoid Receptors and Lipid Metabolic Regulators (full–2016)  http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00241/full
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial  bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in
hippocampal neurons (full–2016)  http://www.sciencedirect.com/science/article/pii/S221323171630338X
Harvesting Benefits from Cannabinoids (article–2016)  http://www.cell.com/cell/fulltext/S0092-8674(16)31675-0
Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity (abst–2016) http://www.spandidos-publications.com/10.3892/ijmm.2016.2475
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer’s Disease and Mild Cognitive Impairment (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26825096
Arachidonyl-2-Chloroethylamide Alleviates Cerebral Ischemia Injury Through Glycogen  Synthase Kinase-3β-Mediated Mitochondrial Biogenesis and Functional Improvement  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820679
Delineating the molecular mechanisms of tamoxifen’s oncolytic actions in estrogen  receptor-negative cancers (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27083550
Experimental Evidence that 3-Methylglutaric Acid Disturbs Mitochondrial Function and  Induced Oxidative Stress in Rat Brain Synaptosomes: New Converging Mechanisms (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27278758
Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase  sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27309350
Endocannabinoid System in Neurological Disorders (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27364363
The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27373318
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with  Amyotrophic Lateral Sclerosis (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27714895
Using proteomics to discover novel biomarkers for fatty liver development and response  to CB1R antagonist treatment in an obese mouse model (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27928909
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target (full–2017)  http://journal.frontiersin.org/article/10.3389/fnins.2017.00030/full
Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in  the rat brain: involvement of CB1 and NMDA receptors (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340665/
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and  Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663723/
CB1 Receptors Signaling in the Brain: Extracting Specificity from Ubiquity (link to PDF–2017) http://www.nature.com/npp/journal/vaop/naam/abs/npp2017206a.html?foxtrotcallback=true
(S)Pot on Mitochondria: Cannabinoids Disrupt Cellular Respiration to Limit Neuronal  Activity (abst–2017) http://www.cell.com/cell-metabolism/fulltext/S1550-4131(16)30653-
2?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1550413116306532%3Fshowall%3Dtrue
URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical  Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA  Receptors (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28092019
Anandamide oxidative metabolism-induced endoplasmic reticulum stress and apoptosis  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28220271
URB597 reduces biochemical, behavioral and morphological alterations in two  neurotoxic models in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28157650
Strokes are possible complications of cannabinoids use (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28237318
Synaptic functions of endocannabinoid signaling in health and disease (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817302861
Functional Analysis of Mitochondrial CB1 Cannabinoid Receptors (mtCB1) in the Brain  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28750801
2-arachidonoylglycerol metabolism is differently modulated by oligomeric and fibrillar  conformations of amyloid beta in synaptic terminals (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28844762
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28853159
Ceramide binding to anandamide increases its half-life and potentiates its cytotoxicity in  human neuroblastoma cells (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0009308416301244
Activation of cannabinoid receptor 1 is involved in protection against mitochondrial  dysfunction and cerebral ischaemic tolerance induced by isoflurane preconditioning  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29045576
Linking Mitochondria and Synaptic Transmission: The CB1 Receptor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29058339
Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid-induced  damage to hippocampal neurons: Dependence on the degree of injury (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28963903
A cannabinoid link between mitochondria and memory (abst–2017)  http://www.nature.com/nature/journal/v539/n7630/abs/nature20127.html
Indoxyl sulfate upregulates the cannabinoid type 1 receptor gene via an ATF3/c-Jun  complex-mediated signaling pathway in the model of uremic cardiomyopathy (abst–2017) http://www.internationaljournalofcardiology.com/article/S0167-5273(17)34436-4/fulltext
The synthetic cannabinoid WIN-55,212-55,212 induced-apoptosis in cytotrophoblasts  cells by a mechanism dependent on CB1 receptor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28495606
Synthetic Cannabinoid Abuse and a Rare Alpha-1-Antitrypsin Mutant Causing Acute  Fulminant Hepatitis: A Case Report and Review of the Literature (full–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733121/
Thallium-Induced Toxicity in Rat Brain Crude Synaptosomal/Mitochondrial Fractions is  Sensitive to Anti-excitatory and Antioxidant Agents (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29313218
Omega-3 fatty acids and adipose tissue biology (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0098299717301620?via%3Dihub
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration:
reversal by cannabidiol (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0361923017303714


MOOD/EMOTIONS
Mixed mood disorder (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/228/?pagenum=2
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/437/?pagenum=2
Uni-Morbid and Co-Occurring Marijuana and Tobacco Use: Examination of Concurrent  Associations with Negative Mood States (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861285/?tool=pubmed
The endocannabinoid system modulates the valence of the emotion associated to food  ingestion (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116974/
Do patients think cannabis causes schizophrenia? – A qualitative study on the causal  beliefs of cannabis using patients with schizophrenia (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954921/?tool=pmcentrez
Effect of dietary fat on endocannabinoids and related mediators: consequences on  energy homeostasis, inflammation and mood (abst-2010)  http://www.ncbi.nlm.nih.gov/pubmed/20013888
CB1 receptor deficiency decreases wheel-running activity: consequences on emotional  behaviours and hippocampal neurogenesis (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20138171
Endocannabinoids and voluntary activity in mice: runner’s high and long-term  consequences in emotional behaviors (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20353785
Attraction to cannabis among men with schizophrenia: a phenomenological study (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20420097
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181427/pdf/fnbeh-05-00064.pdf
Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in  Cannabinoid CB1 Receptor–Deficient Mice Parallel the Effects of Chronic Stress (full–2011) http://cercor.oxfordjournals.org/content/21/9/2056.full
Effects of endocannabinoid system modulation on cognitive and emotional behavior  (full–2011) http://journal.frontiersin
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and  Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing  Dopamine D1 Receptors (full-2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156975/
Endocannabinoid system dysfunction in mood and related disorders (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21916860 
Cannabinoids and emotionality: a neuroanatomical perspective (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21827834
The endocannabinoid system in the regulation of emotions throughout lifespan: a  discussion on therapeutic perspectives (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21693551
Three cases of “spice” exposure (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21740143
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH  C385A) is associated with emotional–motivational reactivity (full–2012)  http://link.springer.com/article/10.1007/s00213-012-2785-y/fulltext.html
The endocannabinoid system: a key modulator of emotions and cognition (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490098/
Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664416/
Placebo-induced improvements: how therapeutic rituals affect the patient’s brain (full–2012) http://www.jams-kpi.com/article/S2005-2901%2812%2900031-3/fulltext
Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351574/
Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood  disorder patients and mice selectively bred for high and low fear (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22534181
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional  Context Processing in Schizophrenia (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22716146
Anti-obesity effects of the combined administration of CB1 receptor antagonist  rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-induced
obese mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22473329
Endocannabinoid system and mood disorders: Priming a target for new therapies (full–2013) http://www.sciencedirect.com/science/article/pii/S0163725812002409?via%3Dihub
Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629308/
The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD) (full-2013)  http://journal.frontiersin.org/Journal/10.3389/fnbeh.2013.00100/full#B12
The endocannabinoid system and emotional processing: A pharmacological fMRI study  with ∆9-tetrahydrocannabinol (full–2013)  http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900195-8/fulltext
Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on  Emotional Learning and LTP in a Rat Model of Depression (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924526/
Novelty-Induced Emotional Arousal Modulates Cannabinoid Effects on Recognition  Memory and Adrenocortical Activity (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656371/
Can Marijuana Reduce Social Pain? (full–2013)  http://journals.sagepub.com/doi/full/10.1177/1948550613488949
Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and  mood in rats (abst–2013)  http://www.sciencedirect.com/science/article/pii/S009130571300097X
The endocannabinoid system: An emotional buffer in the modulation of memory  function (abst–2013)  http://www.sciencedirect.com/science/article/pii/S1074742713002669
Cannabis abuse is associated with better emotional memory in schizophrenia: A  functional magnetic resonance imaging study (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23906663
The endocannabinoid system: An emotional buffer in the modulation of memory  function (abst–2013)  http://www.sciencedirect.com/science/article/pii/S1074742713002669
Neural responses to subliminally presented cannabis and other emotionally evocative  cues in cannabis-dependent individuals (abst–2013)  https://link.springer.com/article/10.1007%2Fs00213-013-3342-z
Cannabinoids and glucocorticoids modulate emotional memory after stress (abst–2013) http://www.sciencedirect.com/science/article/pii/S0149763413001929
Emotional, endocrine and brain anandamide response to social challenge in infant male  rats (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23660109
Creativity in cannabis-users and in drug addicts in maintenance treatment and in  rehabilitation (abst in English & German–2013)  https://link.springer.com/article/10.1007%2Fs40211-012-0045-3
Use of micronutrients attenuates cannabis and nicotine abuse as evidenced from a  reversal design: a case study (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23909004
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional  Memory Formation via Functional Interactions with the Ventral Tegmental Area (full–2014) http://www.jneurosci.org/content/34/39/13096.long
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on  facial emotion recognition: A randomised, double-blind, placebo-controlled study in
cannabis users (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398332/
Endogenous cannabinoid release within prefrontal-limbic pathways affects memory  consolidation of emotional training (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280626/
Genetic Variations in the Human Cannabinoid Receptor Gene Are Associated with  Happiness (full–2014)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0093771
Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and  Anhedonia Induced by LPS in Rats (full–2014)  http://ijnp.oxfordjournals.org/content/18/6/pyu111
Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on
Emotional Processing (full–2014)  http://www.nature.com/npp/journal/v39/n12/full/npp2014132a.html
The vital role of constitutive GPCR activity in the mesolimbic dopamine system (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944632/
The association between cannabis use and mood disorders: A longitudinal study (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25451420
Physical activity and the endocannabinoid system: an overview (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24526057
Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25392292
Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary  investigation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25052875
The influence of personality on the sensitivity to subjective effects of Δ9-
tetrahydrocannabinol (abst–2014) http://www.psy-journal.com/article/S0165-1781(14)00831-2/fulltext
Effects of mood inductions by meal ambiance and moderate alcohol consumption on  endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial  (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126421
Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial  Memory Retrieval in Rats (full–2015) http://www.jneurosci.org/content/35/41/13962.long
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis  pain (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770330/
Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain  Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189 (full–2015)  http://www.mdpi.com/1422-0067/16/1/758/htm
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult  emotional memory (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640936/
Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by  Parkinson’s Disease Patients in Colorado (full–2015)  http://www.hindawi.com/journals/ecam/2015/874849/
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation  of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful  experiences (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0166432815001023
Influence of single and repeated cannabidiol administration on emotional behavior and  markers of cell proliferation and neurogenesis in non-stressed mice (abst–2015)  http://www.sciencedirect.com/science/article/pii/S027858461530004X
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent  emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26747370
Difficulties in emotion regulation are associated with panic symptom severity following a quit attempt among cannabis dependent veterans (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25034429
Effect of nucleus accumbens shell 5-HT4 receptors on the impairment of ACPA-induced  emotional memory consolidation in male Wistar rats (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26340366
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons  and Modulates Reward and Aversion-Related Emotional Salience (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26681496
Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social  behavior and emotionality at different developmental ages in rats (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25914159
Placebo and nocebo effects: a complex interplay between psychological factors and  neurochemical networks (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25928679
Marijuana dependence moderates the effect of posttraumatic stress disorder on trauma  cue reactivity in substance dependent patients (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0376871615018293
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use  on Cognitive Function and Mood (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157060
Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302052/
Discriminability of personality profiles in isolated and Co-morbid marijuana and nicotine users (full–2016) http://www.psy-journal.com/article/S0165-1781(16)30273-6/fulltext
Exercise deprivation increases negative mood in exercise-addicted subjects and modifies their biochemical markers (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26812592
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0028390816303550
The use of the Emotional – Object Recognition as an assay to assess learning and memory associated to an aversive stimulus in rodents (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0165027016302199
A Genetic Component to National Differences in Happiness (abst–2016)  http://link.springer.com/article/10.1007/s10902-015-9712-y
Simvastatin and Bezafibrate ameliorate Emotional disorder Induced by High fat diet in  C57BL/6 mice (full–2017) https://www.nature.com/articles/s41598-017-02576-5
Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for  the Endogenous Cannabinoid System and Neuroinflammation (full–2017)  http://journal.frontiersin.org/article/10.3389/fnbeh.2017.00015/full
Effects of cannabis use and subclinical depression on the P3 event-related potential in an emotion processing task (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371467/
Use of ketamine for acute suicidal ideation in a patient with chronic pain on prescribed  cannabinoids (full–2017) http://casereports.bmj.com/content/2017/bcr-2017-222059.long
Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to  cannabinoid-induced effects (full–2017)  http://www.sciencedirect.com/science/article/pii/S0024320517306069?via%3Dihub
Social cognitive predictors of treatment outcome in cannabis dependence (full–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30981-4/fulltext
Treatment seeking in cannabis dependence: The role of social cognition (full–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(16)31002-X/fulltext
Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist,  rimonabant, on emotional processing (download–2017) thcint.com
Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders (1st page–2017) http://jamanetwork.com/journals/jama/article-abstract/2610319
Lifelong imbalanced LA/ALA intake impairs emotional and cognitive behavior via  changes in brain endocannabinoid system (abst–2017)  http://www.jlr.org/content/58/2/301.abstract
Social correlates of health status, quality of life, and mood states in patients treated with  cannabidiol for epilepsy (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30731-4/fulltext
Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity  Levels (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28319590
Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28636769
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28757328
The involvement of cannabinoids and mTOR in the reconsolidation of an emotional  memory in the hippocampal-amygdala-insular circuit (abst–2017)  http://www.europeanneuropsychopharmacology.com/article/S0924-977X(17)30025-1/fulltext
Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity  Levels (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28319590
Smoked marijuana attenuates performance and mood disruptions during simulated night shift work (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30309-5/fulltext
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress  (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30220-X/fulltext
Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28268256
Associations of anxiety sensitivity and emotional symptoms with the subjective effects of alcohol, cigarettes, and cannabis in adolescents (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28544955
Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit  composition: A biomarker axis in stress-induced cognitive and emotional impairment  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28456011
Associations of anxiety sensitivity and emotional symptoms with the subjective effects of alcohol, cigarettes, and cannabis in adolescents (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28544955
The endocannabinoid system modulating levels of consciousness, emotions and likely  dream contents (abst–2017) http://www.eurekaselect.com/150392/article
How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning (abst–2017)  http://journals.sagepub.com/doi/abs/10.1177/1087054716685842?url_ver=Z39.882003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Impact of dietary fats on brain functions (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29046155
Emotional disorders induced by Hemopressin and RVD-hemopressin(α) administration in rats (abst–2017) http://www.sciencedirect.com/science/article/pii/S1734114017303663?via%3Dihub
Current evidence of cannabinoid-based analgesia obtained in preclinical and human  experimental settings (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29160600
Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic  deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids  imbalance (abst–2017)  http://www.jneurosci.org/content/early/2017/06/20/JNEUROSCI.3516-16.2017
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28599212
Efficacy and safety of cannabis for treating children with refractory epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29115760
Smartphone-based ecological momentary assessment (EMA) of alcohol and cannabis use  in older adults with and without HIV infection (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317303878?via%3Dihub
A Qualitative Study on the Effects of Psychoactive Substance use upon Artistic Creativity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29185845
Altered orbitofrontal activity and dorsal striatal connectivity during emotion processing  in dependent marijuana users after 28 days of abstinence (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4803-6
The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity  and Improved Executive Function after 3 Months of Treatment (full–2018)  https://www.frontiersin.org/articles/10.3389/fphar.2017.00983/full
Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and  Related Comorbidities (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29372545
Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress
Disorder (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29388710


MORNING SICKNESS +
Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21170540
Medical Marijuana: Can Pot Help Pregnant Women With Vomiting and Nausea? (article–2011) http://patients4medicalmarijuana.wordpress.com/2011/01/13/pregnancy-and-medical-marijuana-can-pothelp-pregnant-women-with-vomiting-and-nausea/
Plasma Anandamide and Related N-acylethanolamide Levels are not Elevated in Pregnancies Complicated by Hyperemesis Gravidarum (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24117326


MORTALITY RATES/DEATH*+
Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20565525
An index of fatal toxicity for drugs of misuse (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20104506
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment  and mortality in rats submitted to sepsis by cecal ligation and puncture (abst-2010)  http://www.ncbi.nlm.nih.gov/pubmed/20561509
Denial of hepatic transplantation on the basis of smoking: is it ethical? (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20154621
Colonic perforation: a lethal consequence of cannabis body packing (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20569954
Pharmacologically induced hypothermia with cannabinoid receptor agonist WIN55, 212-
2 after cardiopulmonary resuscitation (abst–2010)  https://www.ncbi.nlm.nih.gov/pubmed/20890199
A summary of the health harms of drugs – Section 5 Cannabis (full–2011) http://www.nta.nhs.uk/uploads/healthharmsfinal-v1.pdf
Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: Evidence from an experimental murine model (full–2011)  http://jpet.aspetjournals.org/content/early/2011/06/14/jpet.111.182717.long
Too many mouldy joints – marijuana and chronic pulmonary aspergillosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103256/?tool=pubmed
Annual Causes of Death in the United States (article–2011) http://drugwarfacts.org/cms/?q=node/30
Fatal alveolar haemorrhage following a “bang” of cannabis (abst in English, full in French–2011) http://www.em-consulte.com/rmr/article/651286/
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of
oxidative stress and inflammation (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21279327
High on Life? Medical Marijuana Laws and Suicide (full–2012) http://ftp.iza.org/dp6280.pdf
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392453/
top
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures (full–2012) http://www.seizure-journal.com/article/S1059-1311%2812%2900057-X/fulltext
Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by  pressure overload in mice (full–2012)  http://eurheartj.oxfordjournals.org/content/33/24/3124.full
Cannabis misinterpretation and misadventure in a coroner’s court (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23155125
Cannabis, possible cardiac deaths and the coroner in Ireland (abst–2012)  https://www.ncbi.nlm.nih.gov/pubmed/22231902
Early survival of comatose patients after severe traumatic brain injury with the dual  cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22696266
Cannabinoid 1 (CB1) receptor mediates WIN55, 212-2 induced hypothermia and  improved survival in a rat post-cardiac arrest model (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22289684
Adult mortality and blood feeding behavioral effects of α-amyrin acetate, a novel  bioactive compound on in vivo exposed females of Anopheles stephensi Liston (Diptera:
Culicidae) (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22167372
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076635
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005175.pub3/full
Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576207/
K2 Toxicity: Fatal Case of Psychiatric Complications Following AM2201 Exposure (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319529/
Toxicological Findings of Synthetic Cannabinoids in Recreational Users (full–2013) https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bkt068
Effect and occurrence of synthetic cannabinoids (abst in English–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23736196 (full in Norwegian ) http://tidsskriftet.no/2012/10/oversiktsartikkel/syntetiske-cannabinoider-effekt-og-forekomst
Evaluation of trends in marijuana toxicosis in dogs living in a state with legalized medical marijuana: 125 dogs (2005-2010) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23216842
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell  carcinoma of the head and neck (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23601830
Diacylglycerol lipase regulates lifespan and oxidative stress response by inversely modulating TOR signaling in Drosophila and C. elegans (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/?term=24889782
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010 (full–2014) http://archinte.jamanetwork.com/article.aspx?articleid=1898878
Plasma-Free Fatty Acids, Fatty Acid-Binding Protein 4, and Mortality in Older Adults (from the Cardiovascular Health Study) (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162821/
The culpability of drivers killed in New Zealand road crashes and their use of alcohol and other drugs (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24636874
Effect of Marijuana Use on Outcomes in Traumatic Brain Injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25264643
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25634572
Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381706/
Notes from the Field: Death Following Ingestion of an Edible Marijuana Product – Colorado, March 2014 (full–2015) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6428a6.htm
top

Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence  of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-
Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and  Other Cannabinoids in Arrested Drivers Versus Deceased Drivers (full–2015)  https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bkv095
Patterns of Natural and Human-Caused Mortality Factors of a Rare Forest Carnivore, the  Fisher (Pekania pennanti) in California (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633177/
Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers? (link to PDF-2015) https://www.semanticscholar.org/paper/Do-Medical-Marijuana-Laws-Reduce-Addiction-and-Dea-PowellLiccardo/de1ed809a834f74de4cb902b7546bc3dc17ef231
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Point-of-care heart-type fatty acid binding protein versus high-sensitivity troponin T testing in emergency patients at high risk for acute coronary syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25666938
Case reports of synthetic cannabinoid XLR-11 associated fatalities (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25979131
Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25950588
Maternal marijuana use and neonatal morbidity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26026918
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue  squamous cell carcinoma: associations with clinicopathological parameters and patients’ survival (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26459312
The effects of adolescent cannabinoid exposure on seizure susceptibility and lethality in  adult male rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26711091
Association between marijuana use and adverse obstetrical and neonatal outcomes  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26401751
Deaths linked to synthetic cannabinoids (abst–2015)  http://link.springer.com/article/10.1007/s12024-015-9669-5/fulltext.html
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899060/
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase (full–2016) https://www.ncbi.nlm.nih.gov/pubmed/27806235
Restraint use and risky driving behaviors across drug types and drug and alcohol  combinations for drivers involved in a fatal motor vehicle collision on U.S. roadways  (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819806/
What failed BIA 10–2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020770/
Synthetic cannabinoid drug use as a cause or contributory cause of death (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26795398
Trends of novel psychoactive substances (NPSs) and their fatal cases (abst–2016) http://link.springer.com/article/10.1007/s11419-015-0286-5
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome (abst–2016) http://link.springer.com/article/10.1007%2Fs40262-015-0363-2
A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27314752
Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015 (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30215-0/fulltext
State Medical Marijuana Laws and the Prevalence of Opioids Detected Among Fatally  Injured Drivers (abst–2016)  http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2016.303426?journalCode=ajph
Acute Effects of Synthetic Cannabinoids: Update 2015 (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27715709
MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27759479
US Traffic Fatalities, 1985–2014, and Their Relationship to Medical Marijuana Laws (abst–2016) http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2016.303577
Involvement of Central Endothelin ETA and Cannabinoid CB1 Receptors and Arginine  Vasopressin Release in Sepsis Induced by Cecal Ligation and Puncture in Rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26925810
Marijuana Use and Short-Term Outcomes in Patients Hospitalized for Acute Myocardial  (interview–2016) https://medicalresearch.com/heart-disease/marijuana-use-short-term-outcomes-patients-hospitalized-acute-myocardial/22914/
New challenges in toxicology of new psychoactive substances exemplified by fatal cases  after UR-144 and UR-144 with pentedrone administration determined by LC-ESI-MSMS in blood (full in Polish & English-2017) https://www.termedia.pl/Journal/-82/Artykul-31005
Elevation of arachidonoylethanolamide levels by activation of the endocannabinoid  system protects against colitis and ameliorates remote organ lesions in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740744/
Cannabis, alcohol and fatal road accidents (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678710/
Thermolytic degradation of synthetic cannabinoids: chemical exposures and  pharmacological consequences (link to download–2017)  http://jpet.aspetjournals.org/content/early/2017/01/13/jpet.116.238717.long
Rocky Mountain High: Preventing Cannabis-Related Injuries (1st page–2017)  http://www.jenonline.org/article/S0099-1767(16)30339-7/abstract
Synthetic Cannabinoids: psychopharmacology, clinical aspects, and psychotic onset  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28412921
Intravenous administration of cannabis and lethal anaphylaxis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28438101
Fatal Intoxication by 5F-ADB and Diphenidine: Detection, Quantification, and
Investigation of their Main Metabolic Pathways in Human by LC/MS/MS and LC/QTOFMS  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28544560
Crash Fatality Rates After Recreational Marijuana Legalization in Washington and  Colorado (abst–2017) http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2017.303848
Synthetic cannabinoid “Black Mamba” infidelity in patients presenting for emergency  stabilization in Colorado: a P SCAN Cohort (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28862050
How Does Marijuana Effect Outcomes After Trauma in ICU Patients? A Propensity  Matched Analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28787375
Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression (abst–2017)  https://link.springer.com/article/10.1007%2Fs00432-017-2527-y
Developmental effects of cannabidiol and Δ9-tetrahydrocannabinol in zebrafish (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29106691
Death by self-mutilation after oral cannabis consumption (abst–2017)  http://www.legalmedicinejournal.com/article/S1344-6223(17)30258-4/fulltext
Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and ABCHMINACA (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29133010
Maternal Cannabinoid Use Alters Cannabinoid (CB1) and Endothelin (ETB) Receptor  Expression in the Brains of Dams but Not Their Offspring (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29131068
Identification of 5-Fluoro ADB in Human Whole Blood in Four Death Cases (abst–2017)  https://academic.oup.com/jat/advance-article-abstract/doi/10.1093/jat/bkx088/4656135?redirectedFrom=fulltext
Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic  Cannabinoid Use (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29194599
A new challenge in forensic toxicology exemplified by a case of murder under the  influence of a synthetic cannabinoid – AM-2201 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28668480
Examining the relationship between medical cannabis laws and cardiovascular deaths in the US (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29227828


MOTION SICKNESS +
Motion Sickness, Stress and the Endocannabinoid System (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873996/?toolmcentrez
Effects of parabolic flight and spaceflight on the endocannabinoid system in humans (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23023882
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24508383
top


MRSA/METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS*+
The Faces Of Medical Marijuana: An Interview With Sarah Lovering (interview–2010) http://the420times.com/2010/04/the-faces-of-medical-marijuana/
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Topical Compositions with Cannabis Extracts United States Patent Application
20120264818 (full–2012) http://www.freepatentsonline.com/y2012/0264818.html
Transcriptional Profiles of the Response of Methicillin-Resistant Staphylococcus aureus to Pentacyclic Triterpenoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577688/
2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV (full–2013) http://www.jleukbio.org/content/93/2/267.long
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25586586
Immunoregulatory Role of Cannabinoids during Infectious Disease (full–2017)  https://www.karger.com/Article/FullText/481824


MULTIPLE SCLEROSIS/MS*+
Standardized Cannabis in Multiple Sclerosis: A Case Report (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?tool=pubmed
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835560/?tool=pmcentrez
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
The endocannabinoid system as a target for the treatment of neurodegenerative disease  (full-2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931550/
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant  for administration by ingestion or other means (Health Canada) (full–2010)  http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people  with multiple sclerosis (link to download-2010)  https://www.researchgate.net/publication/44683223_Metaanalysis_of_the_efficacy_and_safety_of_Sativex_nabiximols_on_spasticity_in_people_with_multiple_sclerosis
The development of cannabinoid CBII receptor agonists for the treatment of central  neuropathies (link to download–2010) http://www.eurekaselect.com/85808/article
Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists  (link to download–2010) http://www.eurekaselect.com/85221/article
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00195.x/full
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=314
top
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20353778
Multiple sclerosis-related central pain disorders (abst–2010)  https://www.ncbi.nlm.nih.gov/pubmed/20425191
Pharmacological Management of Pain in Patients with Multiple Sclerosis (abst–2010) https://link.springer.com/article/10.2165%2F11537930-000000000-00000
The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in  two case-control groups from Spain (abst–2010)  http://journals.sagepub.com/doi/pdf/10.1177/1352458509355071
Anandamide inhibits Theiler’s virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors (full–2011) http://www.jneuroinflammation.com/content/pdf/1742-2094-8-102.pdf
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165959/
Gadolinium-HU-308-incorporated micelles (full–2011) http://www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165948/
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 (IRF3) activation and IFN-{beta} expression: relevance to therapeutic effects in models of multiple sclerosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060486/
Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis (full–2011) http://msj.sagepub.com/content/17/3/259.long
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in  health and disease (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624216/
Emerging treatment options for spasticity in multiple sclerosis; clinical utility of cannabinoids (link to download–2011) http://www.dovepress.com/articles.php?article_id=7675
Role of Cannabinoids in Multiple Sclerosis (link to PDF-2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21094240
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21310228
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21310467
top
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=322
Treating pain in multiple sclerosis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21916786
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21456949/abstract/THC_and_CBD_oromucosal_spray__Sativex%C2%AE__in_the_management_of_spasticity_associated_with_multiple_sclerosis_
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21449854
FROM GHENNAB TO CANNABIS: HOPES TO FIND A CURE FOR MULTIPLE SCLEROSIS ARE FLOURISHING (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=228000
A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’ (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22646020
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression  in relapsing multiple sclerosis (abst–2011)  http://journals.sagepub.com/doi/full/10.1177/1352458510388680
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408184/
Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial (full–2012) http://jnnp.bmj.com/content/83/11/1125.long
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols) (full–2012) http://msj.sagepub.com/content/18/2/219.long
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423911/pdf/ISRN.NEUROLOGY2012-802649.pdf
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437528/
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial (full–2012) http://www.cmaj.ca/content/184/10/1143.long
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Cannabinoid modulation of neuroinflammatory disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Cannabidiol in humans-the quest for therapeutic targets (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/24281562
Medical Marijuana: Clearing Away the Smoke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
Multimodal stepped care approach with acupuncture and PPAR-α agonist
palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain (full–2012) http://aim.bmj.com/content/30/1/53.long
Palmitoylethanolamide in the Treatment of Chronic Pain Caused by Different
Etiopathogenesis (full–2012)  https://academic.oup.com/painmedicine/article/13/9/1121/1864240
Neuroprotective agents: cannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21420365
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB(1) receptor-mediated anti-inflammatory effects (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22342378
top
Cannabinoid receptor 2 agonists inhibit migration of activated dendritic cells via modulation of MMP-9 (abst–2012) http://www.jimmunol.org/content/188/1_Supplement/173.23.abstract?sid=919f9469-cb24-4dbd-9884-1985caa8604a
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22784399
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22583441
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22509986
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22509985
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22954177
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22971837
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids (abst in English–2012) http://www.ncbi.nlm.nih.gov/pubmed/23011861  (abst in Spanish) https://www.neurologia.com/articulo/2012362
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23072659
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/glia.22366/abstract
What place for cannabis extract in MS? (abst–2012) http://dtb.bmj.com/content/50/12/141.abstract
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23180178
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/25876933
A CB₁/CB₂ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral  autoimmune model of multiple sclerosis by restoring self-tolerance to myelin (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812001487
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625014/
top
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076907
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062511
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
Multiple sclerosis and the blood-central nervous system barrier (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562587/
Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648912/
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors (full–2013) http://www.sciencedirect.com/science/article/pii/S0969996113001939
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis (full–2013) http://zl.elsevier.es/en/revista/neurologia-495/articulo/clinical-experiences-with-cannabinoids-in-90328787
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists (full–2013) http://www.fasebj.org/content/28/1/117.long
Cannabinoids: Do they have the potential to treat the symptoms of multiple sclerosis? (full–2013) http://www.wjgnet.com/2218-6212/full/v3/i4/87.htm
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial (link to PDF–2013) http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2813%2970159-5/abstract
Control of experimental spasticity by targeting the degradation of endocannabinoids
using selective fatty acid amide hydrolase inhibitors (link to download–2013)  https://www.researchgate.net/publication/236460848_Control_of_experimental_spasticity_by_targeting_the_degradation_of_endocannabinoids_using_selective_fatty_acid_amide_hydrolase_inhibitors
Medicinal Cannabis and Painful Sensory Neuropathy (editorial–2013) http://journalofethics.ama-assn.org/2013/05/oped1-1305.html
Therapeutic potential of cannabinoid medicines (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24006213
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23621668
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829360
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22371074
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24115748
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23892791
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23517929
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24289844
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide  in multiple sclerosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23447381

top
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology (full-2014) http://www.neurology.org/content/82/17/1556.long
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience (full–2014) http://www.karger.com/Article/FullText/357743
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies (full–2014) http://www.karger.com/Article/FullText/357742
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis (full–2014) http://www.neurology.org/content/82/12/1083.full
Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts (full–2014) http://journal.frontiersin.org/Journal/10.3389/fphys.2014.00100/full
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
Current and future drugs for treatment of MS-associated bladder dysfunction (full–2014) http://www.sciencedirect.com/science/article/pii/S187706571401728X
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268035/
Medical marijuana for cancer (full–2014) http://onlinelibrary.wiley.com/doi/10.3322/caac.21260/full
Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by IFN-β: a longitudinal study in multiple sclerosis patients (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/cei.12443/full
top
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary (full–2014)
http://www.clinicaltherapeutics.com/article/S0149-2918%2814%2900684-5/fulltext
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways (full–2014) http://www.karger.com/Article/Pdf/367615
Endocannabinoid signalling and the deteriorating brain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170074/
Report On Medical Cannabis Research, What the Science Says (article–2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24392812
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice – Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24525548
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24671907
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical Grade Cannabis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747979
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24943098
Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental l-DOPA-induced dyskinesia (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/syn.21740/abstract
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25121144
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25298214
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25331416
top
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25350886
“Disease Modifying Nutricals” for multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25435020
Activity of liver enzymes in multiple sclerosis patients with Hot-nature diet and cosupplemented hemp seed, evening primrose oils intervention (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25453518
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation (full–2015) http://www.hindawi.com/journals/np/2015/656582/
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/glia.22742/full
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/pme.12569/full
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent energy in activated encephalitogenic T cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis (full–2015) http://darujps.biomedcentral.com/articles/10.1186/s40199-015-0131-8
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Activation of Cannabinoid CB2 receptors Reduces Hyperalgesia in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/cns.12349/full
HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/cbdd.12637/full
The therapeutic potential of cannabinoids for movement disorders (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357541/
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0367-5
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507161/
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549715/
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604175/
Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis (link to PDF–2015) http://www.europeanreview.org/article/10049
The entourage effect: Synergistic actions of plant cannabinoids (letter–2015)  https://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015)  http://jama.jamanetwork.com/article.aspx?articleid=2338230
Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/ane.12287/full
top
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0306452215000858
The role of cannabinoids and leptin in neurological diseases (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25880465
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935384
Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis (abst–2015) http://informahealthcare.com/doi/abs/10.1586/14737175.2015.1067607
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408162
Use of Cannabinoids for Spasticity and Pain Management in MS (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26705757
Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26571097
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26289497
Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study (abst–2015) http://link.springer.com/article/10.1007/s10072-015-2392-x
Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26365444
Walking improvements with nabiximols in patients with multiple sclerosis (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26239223
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst–2015) http://link.springer.com/article/10.1007%2Fs11481-014-9575-8
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710104/
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00027/full
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms (full–2016) http://www.karger.com/Article/FullText/444235
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain (full–2016) http://www.karger.com/Article/FullText/444234
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing Remitting Multiple Sclerosis (full–2016) http://link.springer.com/article/10.1007/s13311-016-0420-z/fulltext.html
Modulation of cellular redox homeostasis by the endocannabinoid system (full–2016) http://rsob.royalsocietypublishing.org/content/6/4/150276
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0603-x
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity (full–2016) http://jnnp.bmj.com/content/early/2016/05/08/jnnp-2015-312591.long
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0682-8
The impact of drugs for multiple sclerosis on sleep (full–2016) http://journals.sagepub.com/doi/full/10.1177/1352458516664034
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis (full–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16304476
The use of medical-grade cannabis in patients non-responders to Nabiximols (1st page–2016) http://www.jns-journal.com/article/S0022-510X(16)30472-5/abstract
Cannabis and Cannabinoids (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2592497
A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26750641
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions (abst–2016) http://www.eurekaselect.com/138448/article
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26764336
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
Cannabinoids and autoimmune diseases: A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876387
Development and Pharmacological Characterization of Selective Blockers of 2- Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b01812
Cannabinoids: Medical implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26912385
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27003093
Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301459
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00397
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27160412
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis (abst–2016) http://www.msard-journal.com/article/S2211-0348(16)30056-6/abstract
Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis (abst in English & Spanish–2016) http://www.elsevier.es/es-revista-enfermeria-clinica-35-articulo-manejo-los-sintomas-asociados-espasticidad-S11308621163008826
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816309021
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27772772
Potential Future Pharmacological Treatment of Bladder Dysfunction (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26990140
Medical Cannabis – another piece in the mosaic of autoimmunity? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27859024
Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27904961
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27919478
Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28041663
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of  THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity (abst–2016)  https://www.karger.com/Article/Abstract/445943
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (full–2017) http://journal.frontiersin.org/article/10.3389/fncel.2016.00294/full
We are not alone: a case for the human microbiome in extra intestinal diseases (full–2017) https://gutpathogens.biomedcentral.com/articles/10.1186/s13099-017-0163-3
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis  Pathophysiology? (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337874/
Cannabis and cognitive functioning in multiple sclerosis: The role of gender (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468765/
Cannabis and Multiple Sclerosis—The Way Forward (full–2017)  http://journal.frontiersin.org/article/10.3389/fneur.2017.00299/full
Understanding Patients’ Process to Use Medical Marijuana: A Southern New Jersey  Community Engagement Project (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513646/
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
Cannabis-induced alterations in brain activation during a test of information processing  speed in patients with MS (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433500/
(-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor  Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412277/
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues  for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the  intestinal lymphatic system and prominent immunomodulation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674070/
Immunoregulatory Role of Cannabinoids during Infectious Disease (full–2017)  https://www.karger.com/Article/FullText/481824
Chapter 4 Neuropathic Pain in Multiple Sclerosis—Current Therapeutic Intervention and
Future Treatment Perspectives (full–2017)
https://www.ncbi.nlm.nih.gov/books/NBK470151/
The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis:  Rationale, study design, and methodology (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704890/
Cannabidiol as a Therapy for ASIA Syndrome? An Editorial on a Novel Study (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4046
Systematic review of safeness and therapeutic efficacy of cannabis in patients with
multiple sclerosis, neuropathic pain, and in oncological patients treated with  chemotherapy (abst in English–2017) https://www.ncbi.nlm.nih.gov/pubmed/29119763  (full in Italian) http://www.epiprev.it/articolo_scientifico/revisione-sistematica-sull%E2%80%99efficacia-terapeutica-e-la-sicurezza-della-cannabis
Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with  multiple sclerosis: a systematic review and meta-analysis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28058780
Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-
Tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28189366
Cannabinoids therapeutic use: what is our current understanding following the  introduction of THC, THC:CBD oromucosal spray and others? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28276775
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients  with relapsing-remitting multiple sclerosis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28284340
The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0376871617300881
The effect of symptom-controlling medication on gait outcomes in people with multiple  sclerosis: a systematic review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28376639
Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A  randomised controlled crossover trial (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/27624148
Neuroprotection in oxidative stress-related neurodegenerative diseases: role of  endocannabinoid system modulation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28497982
Perspectives of Cannabinoid type 2 receptor (CB2R) ligands in neurodegenerative  disorders: Structure Affinity Relationship (SAfiR) and Structure Activity Relationship
(SAR) Studies (abst–2017) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.7b00155
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28637354
At the intersection of neurology and psychiatry : the impact of the differential diagnosis  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653514
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral  blood mononuclear cells of progressive multiple sclerosis patients (abst–2017)  http://www.jns-journal.com/article/S0022-510X(17)30392-1/fulltext
Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis (abst–2017)  http://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00724
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28757328
2-arachidonoylglycerol reduces proteoglycans and enhances remyelination in a  progressive model of demyelination (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28751457
Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based  investigation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28735833
Managing neuropathic pain in multiple sclerosis: Pharmacological interventions (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28875858
Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review  and meta-analysis of randomized clinical trials (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28917371
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain  management – An overview of systematic reviews (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29034533
THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study (abst–2017) https://link.springer.com/article/10.1007%2Fs10072-017-3148-6
Sativex in the management of multiple sclerosis-related spasticity: An overview of the  last decade of clinical evaluation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29055461
Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29185555
Preserving the independence of people living with multiple sclerosis towards the end of  life (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29087751
Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis (abst–2017) https://link.springer.com/article/10.1007%2Fs00415-017-8715-5
The therapeutic effects of Cannabis and cannabinoids: An update from the National  Academies of Sciences, Engineering and Medicine report (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29325791
top


MUSCLES/MUSCLE RELAXANT +
Cannabis Overdose (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/96/?pagenum=3
Rectal spasms (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/791/
Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways (full–2010) http://diabetes.diabetesjournals.org/content/59/11/2826.full.pdf+html
Localization and function of cannabinoid receptors in the corpus cavernosum: basis for  modulation of nitric oxide synthase nerve activity (full–2010)  http://www.europeanurology.com/article/S0302-2838(08)01499-1/fulltext
The endocannabinoid signaling system: a marriage of PUFA and musculoskeletal health (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20934863
Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20498181
The cannabinoid receptor type 2 is time-dependently expressed during skeletal muscle wound healing in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20535492
High levels of N-palmitoylethanolamide and N-stearoylethanolamide in microdialysate samples from myalgic trapezius muscle in women (full–2011) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0027257
Expression of the cannabinoid system in muscle: effects of a high fat diet and CB1 receptor blockade (full–2011) http://www.biochemj.org/content/433/1/175
Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by
an effect outside the central nervous system in mice (full–2011)  http://link.springer.com/article/10.1007%2Fs00125-011-2082-z
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21449854
Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21336842
Cannabinoid Receptor Antagonist-Induced Striated Muscle Toxicity and Ethylmalonic-Adipic Aciduria in Beagle Dogs (full–2012) http://toxsci.oxfordjournals.org/content/129/2/268.full
Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial (full–2012)  http://jnnp.bmj.com/content/83/11/1125.long
Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22051448
top
Cannabinoids and muscular pain. Effectiveness of the local administration in rat (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22354705
The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22943701
Effect of omega-3 polyunsaturated fatty acids on the endocannabinoid system in osteoblast-like cells and muscle (abst–2012) http://docs.lib.purdue.edu/dissertations/AAI3444794/
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth muscle cell proliferation and neointima formation (full–2013) http://www.jlr.org/content/early/2013/03/11/jlr.M035147.long
GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060314
Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23707281
Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23518784
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23924692
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23428645
Magnolol inhibits colonic motility through down-regulation of voltage-sensitive L-type Ca(2+) channels of colonic smooth muscle cells in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23972358
Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation (abst–2013)
http://www.ncbi.nlm.nih.gov/pubmed/23906924
Signaling cross-talk between cannabinoid and muscarinic systems actives Rho-kinase and increases the contractile responses of the bovine ciliary muscle (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23396229
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066524/
Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis (full–2014) http://hyper.ahajournals.org/content/64/3/619.long
top
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure (full–2014) http://ajpheart.physiology.org/content/307/11/H1655
Effects of Two Different Specific Neck Exercise Interventions on Palmitoylethanolamide  and Stearoylethanolamide Concentrations in the Interstitium of the Trapezius Muscle in  Women with Chronic Neck Shoulder Pain (full–2014)  http://painmedicine.oxfordjournals.org/content/15/8/1379.long
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue (full–2014)  http://onlinelibrary.wiley.com/enhanced/doi/10.1111/bph.12298
Effects of cannabinoids on tension induced by acetylcholine and choline in slow skeletal muscle fibers of the frog (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24218022
Clinical endocannabinoid deficiency (CECD) revisited: can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24977967
Presence and Colocalization of Type-1 Cannabinoid Receptors with Acetylcholine Receptors in the Motor End-Plate of Twitch Skeletal Muscle Fibers in the Frog (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25161032
Severe rhabdomyolysis and intracranial hemorrhage associated with synthetic cannabinoid: a case report (abst in English–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25179201 (abst in Japanese) http://medicalfinder.jp/doi/abs/10.11477/mf.1436102331
Capsaicin and N-Arachidonoyl-dopamine (NADA) Decrease Tension by Activating Both Cannabinoid and Vanilloid Receptors in Fast Skeletal Muscle Fibers of the Frog (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25228331
The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuro neuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24911079
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446925
CB2R orchestrates fibrogenesis through regulation of inflammatory response during the repair of skeletal muscle contusion (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466920/
Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0145244
top
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice  (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722239/
Endocannabinoid signaling at the periphery: 50 years after THC (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420685/
Beneficial effects of cannabinoid receptor type 2 (CB2R) in injured skeletal muscle postcontusion (full–2015) http://www.hh.um.es/pdf/Vol_30/30_6/Yu-30-737-749-2015.pdf
Direct activation of the proposed anti-diabetic receptor, GPR119 in cardiomyoblasts decreases markers of muscle metabolic activity (abst–2015) http://www.sciencedirect.com/science/article/pii/S0303720715000106
Cannabinoid Receptor 1 and Acute Resistance Exercise – In vivo and In vitro Studies in Human Skeletal Muscle (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25796352
The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25912803
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/zgg4vmz
Deletion of G-protein coupled receptor 55 promotes obesity by reducing physical activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26447738
β-caryophyllene-complexed in β-cyclodextrin Produces Antihyperalgesic Activity in Animal Model for Fibromyalgia (abst–2015) http://www.fasebj.org/content/29/1_Supplement/616.4.abstract?sid=edf921ac-0690-4aa6-ac81-0546314dd384
CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/acel.12438/full
Docosahexaenoic acid-supplementation prior to fasting prevents muscle atrophy in mice (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/jcsm.12103/full
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801305/
Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26880264
β-caryophyllene, a dietary cannabinoid, complexed with β-cyclodextrin produced antihyperalgesic effect involving the inhibition of Fos expression in superficial dorsal horn (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26883973
Circulating levels of endocannabinoids and oxylipins altered by dietary lipids in older women are likely associated with previously identified gene targets (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302013
Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27904961
Rimonabant improves metabolic parameters partially attributed to restoration of high
voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice (full–2017)  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000600602&lng=en&nrm=iso&tlng=en (full–in varous languages)  http://www.scielo.br/scieloOrg/php/translate.php?pid=S0100-
879X2017000600602&caller=www.scielo.br&lang=en&tlang=en&script=sci_arttext
Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats
through peripheral cannabinoid receptor activation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28722246
Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and  Associated Diseases (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28913816
Diversity effect of capsaicin on different types of skeletal muscle (abst–2017)  https://link.springer.com/article/10.1007%2Fs11010-017-3206-7
Peripheral Endocannabinoids Associated with Energy Expenditure in Native Americans
of Southwestern Heritage (abst–2017) https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/jc.2017-02257/4780813?redirectedFrom=fulltext


MUSCULAR DYSTROPHY/MD*+
Aberrant Location of Inhibitory Synaptic Marker Proteins in the Hippocampus of Dystrophin-Deficient Mice: Implications for Cognitive Impairment in Duchenne Muscular Dystrophy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178163/
Use of cannabinoids in the treatment of degenerative skeletal muscle diseases:  Applicaton #20170304217 (full–2017) http://www.freshpatents.com/-dt20171026ptan20170304217.php
top


Advertisements